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Abstract 
Cutaneous injury triggers a significant immune response. Cells of the innate and 
adaptive systems are recruited to coordinate repair, prevent infection and limit 
damage. It remains unclear if different aetiologies of injury influences the 
characteristics of the immune response as well as the long-term impact post 
injury. 
A murine model was used to characterise the immune response. A 8% TBSA full 
thickness dorsal burn or excision injury was used. At days 1,3,7,14,28 and 
84 post injury mice were euthanased; whole blood was collected for 
haematology and cytokine profiling, and inguinal lymph nodes were 
harvested for immune cell populations including dendritic and T cells.  
Both the innate and adaptive immune responses differed between the two 
aetiologies. The burn injury generated a rapid and greater acute cytokine 
response displaying both Th1 and Th2 cytokine profiles resulting in changes to 
the innate cells, with a drive towards monocyte to macrophage differentiation 
following burn injury. The dendritic cell profile differed between the two injury 
groups, with reduced dendritic cell maturation that persisted to day 84 post-injury. 
The cytokine and dendritic cell profiles appeared to impact the adaptive response, 
with reduced T cell activation after burn injury which was sustained to the later 
time points.  
The data suggests there are significant differences in the immune response, 
which is dependent on injury aetiology. The burn injury had sustained an 
immunological change that was not apparent following excisional injury. This may 
explain in part the long-term implications of burn injury, such as increased 
incidence of infection and malignancy, and provides a basis for further 
investigation to guide clinical intervention after burn injury. 
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Introduction 
1.1: Introduction 
Burn injuries have a significant global impact medically and socio-
economically. The World Health Organisation has estimated that 195,000 burn 
related deaths occur worldwide per year. Furthermore, burn injury is ranked 
34th of all causes of disability-adjusted life years (DALYs) from 21 different 
worldwide regions; where DALYs are defined as the sum of years of life lost 
secondary to premature mortality and the years lived with disability (disability 
defined as short and long-term health loss aside from death, and health 
defined in terms of function, including mobility, pain affect and cognition) [1]. 
The loss of economic contribution following the initial recovery post burn is 
linked to the age at the time of injury, to local scar outcome limiting physical 
and psychological function [2] and the widespread systemic impact [3-7].  
In the United Kingdom approximately 250,000 people sustain a burn injury 
each year. The burn patient population cohort is heterogenous, 30% of 
admissions are paediatric which includes over half of the severe burns 
reported [8]. Of the 175,000 patients attending medical services 13,000 
require hospital admission, of which 1000 require formal fluid resuscitation 
due to the extent of the injury, and approximately 300 deaths are reported per 
year [8].  The remainder of burn injury admissions are non-severe injuries but 
may require a range of interventions to achieve expedient wound healing. The 
incidence of burn injury in the UK has remained fairly constant over the last 
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decade with an average of 20.6 per 100,000 (12,400 based on population of 
62 million) in England and Wales between 2005 and 2009 admitted to the 
National Health Services for burn injury [9]. Similar burn injury admission rates 
are seen in other developed countries, with a single centre In Western 
Australia (WA) reporting that the majority (86%) of burn injuries seen over a 
25 year period were non major injuries [10], with 60% of the total patients 
having burns of less than 1% total body surface area (TBSA) [11]. This 
strongly suggests a large proportion of health care service demands are 
secondary to what can be termed as a non-severe burn injury (<10% TBSA 
without inhalation injury) [12]. The linkage of the hospital data in WA has 
reported an impact on the life time risk of a range of subsequent pathologies 
despite the majority of the burn injuries being non-severe [3, 5, 6, 13, 14].  
Following burn injury, patients have a high incidence of infection and sepsis 
compared to other categories of trauma [15, 16]. This has been attributed to 
multiple factors including disturbances in the wound microflora (initially sterile 
with progressive colonisation within 7 days) [17-19].  In addition, a persistent 
systemic inflammatory response syndrome (SIRS) predisposes the 
development of subsequent compensatory anti-inflammatory response 
syndrome (CARS), which renders these patients vulnerable to infectious 
challenge [20]. The burn patients have a differing cytokine profile (increased 
IL-6 & IL-8) with increased incidence in the development clinical complications 
associated with this in comparison to other trauma of the same standard 
measure (Injury Severity Score (ISS) [21, 22]. Standardised trauma outcome 
scoring systems such as the Injury Severity Scoring (ISS) system are 
supportive of this disparity in the immune response to different injury as burns 
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have a poorer than predicted outcome which is not observed in other forms of 
trauma [23]. The cytokine profiles observed in burn injury correlate clinically 
with the presence of SIRS, characterised by hypo or hyperthermia, 
tachycardia, tachypnoea and leucocytosis. In consequence a suppressed T 
cell response may follow SIRS, characterised clinically by cutaneous anergy, 
hypothermia, leukopenia, infection susceptibility and failure to clear infection 
(CARS) [20, 24-27].  
In response to the clinical differences observed between burn and non-burn 
patients The National Institute of General Medical Sciences (NIGMS) 
embarked on a large collaborative research program known as “Inflammation 
and the Host Response to Injury”. This program supported research into the 
immune response to different injury types which involved profiling immune 
cells during the acute phase response. This included transcriptome profiles 
which demonstrated that although there are many changes to gene 
expression that are common between different injury aetiologies there are 
also some distinct signatures that appear to be related to the different 
aetiologies of injury [28].  
There is also evidence that a sexual dimorphism exists in the immune 
response following trauma. At present the exact interactions between the sex 
hormones and the immune systems are unclear. Clinically, male burn injury 
patients have a lower morbidity and mortality in both the acute and long-term 
settings, whereas female mortality rates are over twice that of males [5, 29, 
30]. In contrast the opposite is seen in non-burn injury with females having a 
lower morbidity and mortality in both trauma and surgical injury [31, 32]. Most 
literature reports that the differences seen between genders cease after the 
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ages of 50-65 years, coinciding with female menopause [30, 32, 33]. The 
gender disparity following burn and non-burn further supports that there is a 
difference in the cell-mediated immunity following different injury [34, 35]. 
Recent epidemiological studies have demonstrated that the long term 
sequelae observed following burn injury is more severe than in other 
cutaneous trauma. This includes an increased lifetime risk of cardiac 
dysfunction, an increased incidence of malignancy and increased age 
adjusted mortality in burns injury patients.  The data demonstrating an 
association of burn injury to long-term sequelae has been consistently 
observed in several population-based studies [3, 5, 6, 14, 36, 37]. While it is 
clear the burns cohort differ to the general population with regards to 
increased lifestyle risk factors, a higher incidence of lower socioeconomic 
status as well as a higher number of indigenous patients when compared to, 
data analysis in these papers used well accepted methods to adjust for these 
co-variances that are known to have an impact on health outcomes [3, 5, 6, 
14, 36, 37]. Furthermore, studies of paediatric patients have also observed 
similar increases in post burn injury sequalae, including an increase in age 
adjusted mortality, minimising the likely impact of lifestyle factors on the 
observed differences [37]. The differences in the long-term impact post burn 
and non-burn trauma have also been identified in population based studies, 
demonstrating a greater impact in burn injury when compared to other trauma 
types [3].  
The cardiac changes have been observed in both animal and human scientific 
studies and population-based studies [3, 38]. With regards to the malignant 
change, it has been observed that there is a greater prevalence for non-
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cutaneous malignant change in females [39-43]. This supports the literature 
surrounding the gender dimorphism that occurs in the inflammatory response 
post trauma suggesting the presence of a long-term impact and alteration to 
the immune system following burn injury. 
In summary, there is clear evidence from both clinical and population based 
studies of differences in the impact following trauma of different aetiology, 
both in the acute and long-term setting. However, to date there has been 
limited investigation into why the aetiology matters. There is also paucity in 
the literature with regards to the impact of non-severe burn injury, with the 
focus of most studies confined to major/severe burn injury. Therefore the work 
presented in this thesis has focused on understanding differences in the 
immune response to different injury types to investigate whether the impact on 
the immune response drives the differences seen in the clinical consequences 
for patients. The work has also focused on non-severe burn injury as this 
represents the majority of the clinical caseload in developed countries. Further 
to this, there is a need to understand the systemic impact of the burn injury 
with respect to the inflammation and the immune response. The 
understanding of the underlying mechanism will drive therapeutic 
opportunities into the future.  
The following chapters provide the context by exploring the structure of the 
skin, the relevant immune systems, the sequelae of injury and outlining the 
current knowledge on which the experimental design was established. 
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1.2: The Skin 
The skin is the largest organ of the body and accounts for up to 15% of total 
body weight and on average covers an area of 1.7m2 [44]. The skin is host to 
a number of cell types which each plays a role in enabling the skin to perform 
a multitude of functions, including; protection from physical, chemical and 
pathological insults, thermoregulation, electrolyte and fluid balance. The 
function of the skin is related to its architecture and the presence of 
appendage structures.  In consequence significant injury to the skin and 
disruption to these structures can result in circulatory shock, ARDS and multi-
organ failure [45, 46].  
The skin is broadly divided into 2 layers, the epidermis and dermis. The 
epidermis primarily contains keratinocytes, as well as melanocytes, Merkel 
cells and scattered Langerhans cells (LCs). Langerhans cells are antigen 
presenting cells (APCs) unique to the epidermis. The dermis primarily 
consists of fibroblasts, which are responsible for the secretion of collagen, 
elastic fibers and the production of ground substance [47]. In addition there 
are dendritic cells (DCs) that are the APCs of the dermis. The dermis contains 
the capillary and lymphatic networks that support these structures and the 
epidermis. Other immune cells of the dermis include natural killer cells and 
gamma delta T cells (see section 1.3.3). 
The use of murine models in the study of the skin and the immune system 
have been used for many years and has provided significant insight into skin 
function, wound repair and the immune response. However, despite many 
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structural and functional similarities, some key differences must be 
acknowledged [48]. Human skin is thicker & stiffer than murine skin due to 
more epidermal layers and a thicker dermis. Mice have more densely packed 
hair follicles and a different transition point between epidermis and dermis 
known as the dermal-epidermal junction, which is relatively flat with the 
exception of the hair follicles causing multiple involutions [49, 50]. In contrast 
in humans there are fewer hair follicles and the dermis abuts the epidermis 
[49, 50]. Mouse skin is more prone to wound contraction due to the presence 
of the panniculous carnosum that is mostly absent in humans [50]. Despite 
these differences the mouse remains an important model to investigate skin 
and the immune response to injury [50, 51]. 
 1.2.1: The Epidermis 
The epidermis consists primarily of keratinocytes, other cells present include 
melanocytes, Langerhans cells and Merkel cells. The epidermis is subdivided 
into stratified layers (Figure 1.1). 
The basal cell layer is the deepest layer of the epidermis at the interface 
between the epidermis and dermal layers (the dermoepidermal junction). 
These cells attach to the basement membrane via hemidesmosomes and 
anchoring filaments [44]. As a consequence of the basement membrane the 
immune cells within the epidermis (Langerhans cells) take longer to reach the 
draining lymph nodes [52]. The stratum spinosum layer contains larger 
amounts of keratin [53]. The stratum granulosum is the intermediate layer with 
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the stratum lucidum also found in thicker skin such as the glabourous skin on 
the palms and soles; it is considered a sub-division of the stratum corneum 
and enhances the barrier function in these areas. The stratum corneum 
follows and is the most superficial layer containing the now fully keratinised 
cells [44]. Keratinocytes comprise almost 95% of the epidermis. Their main 
function is the production of keratin, they facilitate in cellular adhesions and 
create the water tight layer that is essential for protection, control of electrolyte 
balance and thermoregulation [44].  
1.2.2: The Dermis 
The dermis provides the structural support of the skin, and contains many of 
the cells and structures that relate to its multiple functions. Cells present 
include fibroblasts, dendritic cells, tissue resident T cells, and mast cells. In 
addition to these cell types dermal appendages such as the sebaceous 
glands, apocrine glands and hair follicles are also present [44]. The dermal 
appendages play a role in wound healing as they are enveloped and closely 
associated with keratinocytes thus facilitating  re-epithelialisation [50]. 
Fibroblasts make up the majority of the cells in the dermis and are responsible 
for production of the extracellular matrix (ECM), including collagen and elastin 
fibres which occurs in the acellular deeper reticular layer [47, 54]. The 
collagen provides structural support and the elastin allows for recoil. It is 
predominantly these proteins and other aspects of the ECM that change 
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following injury and contributes to the loss of function that is observed in 
scarred skin.  
Dendritic cells are a type of antigen presenting cell (APC) that regulate 
immunity, their position in both the dermis and epidermis allows them to 
encounter foreign antigens and inflammatory signals in the skin, after which 
they undergo a series of changes to stimulate local immunity and/or migrate 
to the draining lymph nodes of the region to promote the immune response 
[55].  
The dermal plexus and cutaneous nerves are found in the superficial layer of 
the dermis [44, 47]. These draining lymphatic vessels begin in the dermis and 
traverse through the deeper layers and eventually access the local lymph 
nodes (LNs). The LNs are connected to the peripheral circulation via an artery 
and vein as well as the afferent and efferent lymphatic vessels and are 
arranged in a series of chains [47]. It is at these primary and secondary 
lymphatic structures where immune cells communicate with peripheral and 
circulatory cells, thus connecting the innate and adaptive systems. 
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Figure 1.1: Skin Structure: A) Anatomy and histology of the skin; B) Important 
histological zones and location of different cell types including the relationship of the 
Langerhans cells, melanocytes and fibroblasts to the layers of the skin (Figure adapted from 
[56]). 
  
1.2.3: Normal skin regeneration  
The keratinocytes found in the epidermis originate from the basal cell layer 
and differentiate as they migrate through the epidermal layers where they 
eventually become flattened enucleated squames that are keratinised forming 
the impermeable stratum corneum. This process of epidermal turnover from 
the basal cell layer to the desquamation takes approximately 2-4 weeks [57]. 
As previously discussed, the fibroblast is the primary cell of the dermis, which 
is a spindle shaped cell that produces collagen and elastin. Unlike 
keratinocytes found in the epidermis this cell infrequently replicates and 
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dermal turnover, defined as degradation remodelling and collagen production 
is slow in normal skin [57].  
1.3: Cutaneous Injury 
A full thickness injury to the skin is thus named as it inflicts damage through 
all skin layers, epidermis to sub-dermis. Whether elective surgery or traumatic 
injury this initiates a complex multifactorial cascade of cellular events which 
involves both the innate and adaptive immune response (Figure 1.2) [58, 59]. 
The described stages of wound healing comprise of three major overlapping 
phases: inflammation; re-epithelialisation and granulation tissue formation; 
remodelling [60]. These phases can all be influenced by the local and 
systemic immunological environment and the cytokine milieu and as such 
alter the wound healing process. The immune response generated is critical 
to the wound repair process and if disrupted, wound healing may be severely 
compromised, resulting in chronic wound formation, delayed healing and/or 
sepsis. In conjunction with genetic predisposition, these alternate pathways of 
wound healing can result in the formation of hypertrophic scarring which can 
impact on patient function, leading to disability associated with their scar [61]. 
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Figure 1.2: Stages of cutaneous wound healing. Within hours the inflammatory phase 
begins which involves haemostasis and the influx of inflammatory cells to the wound. The 
cytokines and growth factors release during this time include TGF-b, IL-1α, IL-6 and TNFα. 
During inflammatory cell recruitment chemokines such as MIP1α, MIP1β and MCP1 are 
released. Within days the proliferation phase begins as keratinocytes begin re-
epithelialisation and fibroblasts facilitate the formation of granulation. T cells are recruited and 
coordinate the transition from inflammation through to proliferation until wound closure 
occurs. The remodeling phase begins and the scar matures and collagen deposition occurs. 
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 1.3.1: Inflammatory phase of wound healing 
The initial response to injury commences with haemostasis to limit blood loss 
and initiate vessel repair. In addition, this initial response aims to reduce 
exposure to the external environment and microbes to limit risk of sepsis and 
stimulate repair of damaged structures (Figure1.3).  
Following trauma and resultant injury, damaged vascular endothelial cells 
initiate haemostasis. Platelets are recruited to the damaged tissue site and 
subsequent interaction between clotting factors and collagen activates the 
platelets resulting in aggregation.  Activation of the coagulation cascade 
occurs and results in the formation of a platelet plug [63]. At the end of the 
haemostasis phase the clot serves as a barrier to microorganisms, provides a 
matrix for recruited cells and acts as a reservoir of growth factors such as 
platelet derived growth factor (PDGF) and transforming growth factor beta 
(TGF-β) which initiates inflammatory cell infiltrate (neutrophils and monocytes) 
(Figure 1.3)   [64][65]. In addition, the complement cascade is activated and 
aids in the recruitment of neutrophils and monocytes to the site of injury as 
well as initiating mast cell, basophil and eosinophil degranulation [66]. 
Clinically this stage post injury is evident by the 4 cardinal signs of 
inflammation; dolor (pain); calor (heat), rubor (erythema), tumour (swelling) as 
described by described by Celsus (ca 30 BC–38 AD). Later Virchow added 
functio laesa; loss of function [67]. 
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Figure 1.3: Inflammatory stages of wound healing. Representation of a non-burn 
wound between 24-48hr following initial injury where platelet aggregation has formed a fibrin 
clot and infiltrating innate immune cells such a neutrophils are present to aid in clearance of 
debris and bacteria. (Adapted from [68]). 
1.3.2: Proliferation phase of wound healing 
The proliferation phase occurs within days of the injury, there is formation of 
granulation tissue and subsequently development of the extracellular matrix 
(ECM) which enables re-epithelialisation to occur (Figure 1.4) [69]. By day 4 
the surrounding fibroblasts invade the wound and start to produce the 
extracellular matrix required to support growth and migration of new cells and 
micro-vessels at the wound base, known as granulation tissue [70]. The 
provisional matrix is comprised of fibrin and fibronectin, these act as a scaffold 
for the migration of epithelial cells in addition to providing a template for the 
formation of the granulation tissue [64]. If at this stage the balance of the 
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cytokine milieu is not favourable, proliferation can be interrupted and a chronic 
wound can ensue [71-74]. 
At the time of initial injury, the tissue destruction and hypoxia stimulate 
activated macrophages to release fibroblast growth factor and angiogenesis 
factors. In addition, epidermal cells are stimulated to release vascular 
endothelial-cell growth factor (VEGF). In response to these growth factors 
Endothelial cells are stimulated and migrate into the wound site forming new 
vessels [64]. As epidermal cells migrate the ECM degrades, they dissect the 
wound and separate healthy tissue from the eschar [64, 75].  
Wound contraction is initiated early following injury and peaks at 14 days post. 
This process is secondary to modified contractile fibroblasts that contain the 
actin filament (similar to filaments found in smooth muscle) known as 
myofibroblasts [76].  This process occurs greatest in full thickness injuries and 
can account for a 40% reduction in the wound size [76]. This process is 
greater in non-human mammalian skin such as mice due to the presence of 
the panniculous carnosus. The process of wound contraction is likely a 
protective evolutionary mechanism that follows wounding to limit 
haemorrhage. 
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Figure 1.4: Proliferative stage of wound healing. Represents a wound between 5-10 
days post injury. An eschar has formed, the innate cells present have reduced and 
neovascularisation and epithelial migration occur under the eschar. (Adapted from [68]). 
1.3.3: Remodelling phase of wound healing 
A relatively acellular scar replaces granulation tissue when there is an 
adequate amount of collagen within the wound space (Figure 1.5). The few 
remaining fibroblasts within the scar assume the myofibroblast phenotype 
approximately 2 weeks following injury. They become more contractile and 
are able to secrete collagen proteins into the extracellular matrix [60].This 
allows for connective tissue compaction and further wound contraction. As the 
scar matures, collagen turnover occurs and the type III collagen is gradually 
replaced by type I. This is a more fibrous collagen forming longer stands, 
resulting in the rigid structure that we recognise as scar [64, 77].   
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Figure 1.5: Remodelling Stage of Wound Healing. Represents a scar approximately 1 
month post injury. Collagen has been laid down by fibroblasts; the wound has contracted and 
does not contain normal skin appendages. As a result restoration of function is not complete 
in scarred skin as it is unable to perform all the same functions as seen in un-scarred skin 
(Adapted from [68]). 
1.3.4: Thermal injury 
A burn wound can be created by thermal, chemical, electrical, friction or ultra 
violet light injury which induce protein denaturation and cell death [78]. A burn 
wound differs to an excised wound and is described by Jackson’s model 
where 3 zones of injury are recognised;  the central zone of coagulation, the 
zone of stasis and the outer zone of erythema (Figure 1.6) [79]. The 
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pathophysiology of burn injury is different to other injury mechanisms in 
several ways. Firstly the damage or heat effect causes increased capillary 
permeability that allows for plasma leak and as such patients are susceptible 
to volume depletion and shock. Secondly, anaemia and blood loss does not 
solely occur from haemorrhage as seen with other traumatic wounds. It is a 
cumulative process that includes losses from the burn wound itself, red blood 
cell sequestration and erythrocyte damage. Further to this, there are often 
losses following the surgical management of the burn wound in addition to 
myelosupression and anaemia of critical illness [80]. 
! [56] 
Figure 1.6: Jacksons’ model of burn injury. Outlining the 3 zones of injury seen 
following a burn injury. At the peripheral edge of the injury is the zone of hyperaemia, within 
this zone lays the zone of stasis, and finally the central zone of coagulation. 
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In the zone of coagulation there is protein denaturation resulting in alteration 
of tissue structures and properties as well as complete destruction of the sub-
papillary vasculature [56, 81]. In the zone of stasis there is oedema and 
inflammation secondary to vasodilation and increased microvascular 
permeability. This zone has the potential for dynamic changes, specifically 
wound progression or wound salvage. Where there is a reduction in perfusion 
further ischemia and wound progression ensue increasing the area of 
necrosis [82]. In contrast, appropriate resuscitation and increase perfusion 
may result in tissue salvage [81]. The zone of hyperaemia is the outermost 
zone where the perfusion is increased secondary to the inflammatory 
response. In large TBSA burns this area can cause large fluid shifts and 
haemodynamic changes in the patient, including shock. This area will recover 
without intervention unless complicated by sepsis or profound hypotension 
[56, 81]. 
Burn wounds are complex, often they are not uniform with a variety of 
different depths, making clinical assessment of wounds challenging. Although 
the mechanism and pathophysiology of injury differs from that of other 
cutaneous injury, it is believed that burns heal with the same overlapping 
phases as previously discussed. The depth of a burn impacts the rate of 
healing as healing is facilitated by the presence of remaining or surrounding 
viable cells from the dermis and epidermis that secrete the necessary growth 
factors and cytokines to drive healing [78]. 
Erythema describes a superficial burn that involves the epidermis: It heals 
rapidly and seldom leaves a scar. A partial thickness burn can be superficial or 
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deep depending on the depth of involvement of the dermal layers. A 
superficial partial thickness burn extends into the papillary dermis, resulting in 
blistering (separation of the dermo-epidermal junction), erythema and 
oedema. Whereas a deep partial thickness burn extends into the reticular 
dermis, and is accompanied by slow capillary refill and therefore appears pale 
in association with reduced sensation and oedema [56]. A full thickness burn 
extends into the subcutaneous tissues, burn injuries beyond the fascia and 
into the muscle or bone are considered a sub-dermal burn, the skin will be 
charred or pale in appearance and is insensate due to the destruction of 
cutaneous innervation [79].  
As previously discussed, burn wounds are capable of dynamic change, 
including progression [83].  Burn wound progression is the process whereby 
the damage in the zone of stasis can progress during the acute inflammatory 
phase secondary to microvascular damage compromising vessel patency 
resulting further ischaemia and a deeper burn wound [82, 83].  There are 
other processes that may also contribute to the progression of a burn wound, 
such as prolonged survival of peripheral neutrophils which has previously 
been observed in burn patients [56]. This prolonged neutrophil survival may 
contribute to burn wound progression as there is extended exposure to 
release of reactive oxygen species (ROS) & proteases, in addition neutrophils 
can also aggregate in the venules surrounding the burn wound resulting in 
stasis and subsequent damage via a pressure gradient [56]. Both apoptosis 
and necrosis occur during burn wound progression, where apoptosis involves 
shrinkage and condensation of cell contents and the DNA fragments; necrosis 
involves cellular swelling with depletion of intracellular stores [56]. This unique 
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feature of burn wound progression is important clinically as there is greater 
morbidity and mortality associated with increased depth, therefore prevention 
of progression with appropriate resuscitation, oedema control and nutrition are 
required to limit the adverse outcomes associated with depth [84]. At present 
the exact mechanisms of the pathophysiology of the burn that alters the 
wound that results in progression remains unclear.  
1.4: The Immune System 
The immune system functions to provide recognition and defense against 
injury and disease as well as promote tissue repair. In humans and other 
mammals the immune system is classified into the innate and adaptive 
systems (previously known as humoral and cell-mediated responses). 
1.4.1: Innate cells 
The innate system is a non-specific first response to injury or a disease 
process. It rapidly responds to danger signals (section 1.4.1.1) and generates 
a response that either extinguishes the threat or engages the more specific 
antigen dependent adaptive T cell response via antigen presenting cells. The 
threshold for this activation is complex and multi-factorial (section 1.4.3). The 
cells of the innate system are categorised as granulocytes and agranulocytes 
(Figure 1.7) [85]. Lymphocytes, which are agranulocytes are part of the 
adaptive system and are engaged by antigen presenting cells (APCs) such as 
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dendritic cells (DCs) which bridge the innate and adaptive responses. In 
addition to the cellular components, the innate system it is also comprised of 
the complement system, which will not be discussed in this thesis. 
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Figure 1.7: The Innate and adaptive systems.  The innate and adaptive systems have 
differing cell types that complement the role of each system. The innate cells are comprised 
of the granulocytes; which release their contents to facilitate cleansing of cellular debris and 
microbes. The agranulocytes include the monocyte/macrophages and dendritic cells. These 
cells in addition to specialised T cells bridge the gap between the innate and adaptive 
systems. The adaptive system primarily includes the B and T lymphocytes that are antigen 
specific and have ‘memory’ function.  
Granulocytes (aka polynuclear cells) are a collection of innate cells that have 
granules within their cytoplasms. The granulocytes encompass several cells 
types, including the neutrophils, eosinophils, basophils and mast cells [85].  
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Neutrophils arise from haemopoetic stem cells and are the dominant white 
cell in the systemic circulation of humans, making up to 50-70%, whereas in 
mice the populations are between 10-25% [51]. Their half-life is approximately 
6-8 hours, with the marrow producing 5-10x1010 cells/day [69, 85]. Following 
injury and the initiation of the inflammatory cascade, there is an intravascular 
chemokine gradient generated which aids the neutrophils in locating the 
necrotic foci [69]. These cells contain granules that when released facilitate 
lysis of microbes (particularly pyogenic bacteria) and cellular debris aiming to 
cleanse the wound and reduce bacterial load [85]. 
Eosinophils are derived from the bone marrow, following release from the 
marrow they circulate and traffic to peripheral sites (predominately mucosa) 
where they are involved in immune surveillance. They play a significant role in 
allergy and have the capacity for extracellular killing (proficient for parasites) 
via release of pre-formed granules. When activated, these granules generate 
a respiratory burst (active oxygen metabolites) in addition to pro-inflammatory 
cytokine production or release (IL-13, IFN-γ and TNFα) [87, 88]. Eosinophils 
contain/produce over 35 chemokines, cytokines or growth factors and as such 
play a large role in inflammation, both injury and allergy [88]. 
Basophils account for less than 1 % of the white cell population and are 
associated with allergic immune responses. Upon activation they degranulate 
and release pre-formed granules of histamine, which promotes vasodilation at 
the site of injury in addition to erythema and oedema classically associated 
with inflammation [85]. 
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Agranulocytes (aka mononuclear cells), unlike the granulocytes contain no 
granules within their cytoplasm and populations include monocytes, 
macrophages and lymphocytes [85]. 
Monocytes are short-lived circulating antigen presenting cells derived from the 
bone marrow. In steady state conditions monocytes have a short cell cycle 
and undergo spontaneous apoptosis, however in the presence of a stimulus 
apoptosis is delayed [89, 90].  The recruitment of monocytes from the bone 
marrow occurs secondary to high levels of chemokines including MCP-1 and 
GM-CSF [91]. Following extravasation into the tissues, monocytes 
differentiate into macrophages or dendritic cells, under the influence of GM-
CSF and IL-4, this process is inhibited by IFN-γ and TGF-β [92].  
Macrophages are derived from monocytes and following their differentiation 
they settle in the tissues and mature. In contrast to neutrophils, these cells are 
long-lived and are found in abundance in connective tissues, blood vessels 
and lymphoid tissue where they commonly encounter foreign material. They 
are able to phagocytose and are capable of combating microbes that reside 
within host cells. In addition they can also present antigen to T cells and 
therefore engage the adaptive response in a similar way to dendritic cells [87]. 
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1.4.2: Dendritic cells (DCs) 
Dendritic cells are specialised antigen presenting cells (APC) that bridge the 
gap between the innate and the adaptive systems. Antigens captured by DCs 
are processed and presented to CD4+ T cells via MHC class II presentation or 
to CD8+ T cell via MHC class I, a process known as cross-presentation. When 
presentation occurs in an inflammatory setting, the threshold for T cell 
activation is reached and the adaptive immune response is engaged.  
Dendritic cells have several lineages and can be characterised as 
conventional (cDCs) which are mostly circulatory or plasmacytoid (pDCs) 
which reside in the tissues. During DC differentiation and homeostasis, the 
lymphoid tissue resident cDCs, pDCs and monocytes share a common 
granulocyte macrophage precursor (GMP) that differentiates to a 
macrophage-dendritic cells progenitor (MDP) (Figure 1.8) [93, 94].  From this 
stems the common dendritic cell precursor (CDP) which gives rise to the 
aforementioned pre-DC and pDC. The pre-DCs circulate and either resides in 
the lymphoid or non-lymphoid tissue where they differentiate to their terminal 
sub-types. Depletion of a subset of T cells known as T regulatory cells 
appears to augment pre-cDC and cDC division, particularly in the lymphoid 
organs [93].  
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Figure 1.8: Dendritic cell lineage. Illustrating the common dendritic cell precursor (CDP) 
from which stems the pre-DCs that differentiate further and terminate as either lymphoid 
resident subpopulations (CD8+) or non-lymphoid tissue resident subpopulations (CD11b+). 
Dendritic cells are capable of presentation of antigen to T cells in situ, in 
addition, a proportion of a skin subtype, CD8a- DCs are capable of migration 
to local skin draining lymph nodes where they signal the adaptive immune 
response (Figure 1.9). During normal immune surveillance (tolerance) no T 
cell response will be initiated, however during infection or inflammation these 
DC will mature during migration to the draining lymph node and their 
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phenotype, maturation status and cytokine production profile (IL-12) leads to 
the onset of an adaptive immune response.  
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Figure 1.9: Tissue resident dendritic cell subpopulations. CD8a-CD103+; CD8a-
CD11bhi dendritic cells shown here migrating to the draining LN following antigen 
presentation. Here they engage with CD4+ T cells or CD8+ T cells depending on the DC 
subpopulation. CD11b+ DCs are of myeloid origin. 
1.4.3: Adaptive cells 
The adaptive immune system is primarily antigen dependent and aims to 
provide an appropriate response to the injury to allow for restoration of normal 
function [85]. This response is initiated by the inflammatory cells of the innate 
system in addition to antigen presenting cells, such as DCs.  
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T cells comprise 50-60% of the total blood lymphocytes, the remainder are 
made up from B-cell populations [96].  
Naïve T cells have a unique T cell antigen receptor (TCR), which has an 
affinity for its antigen in addition to major histocompatibility complex (MHC). 
These cells sample their environment in the secondary lymphoid tissue via 
their interaction with APC such as DCs [97]. During the process of immune 
tolerance (i.e. in the steady-state) a small number of DCs mature and migrate 
to the node where they present self-antigen. Should a T cell have escaped 
central tolerance and engages with the DC carrying self-antigen apoptosis 
should occur [98]. These lymphocytes mature and differentiate following 
engagement with APCs in the presence of co-stimulatory signals and the 
required cytokine profile. It has been observed that the threshold for 
activation, i.e. the amount of antigen dose required to activate T cells is 
variable with some authors postulating that T cells make an assessment of 
antigen dose that ultimately determine their activation [97]. This is often 
observed during inflammation, but can arise in its absence, resulting in 
autoimmune disease. Following activation and differentiation to their terminal 
effector functions, they are able to release from the lymphoid tissue to migrate 
to the periphery to exert their function (Figure 1.10) [97].  
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Figure 1.10: T Cell tolerance and activation: Dendritic cells migrate to the draining 
lymph nodes and lymphoid tissues and engage with naïve T cells via antigen recognition. In 
the stead-state, when the threshold is not reached, apoptosis should occur, a process known 
as ‘tolerance’. During inflammatory conditions, the threshold is reached and T cell clonal 
expansion occurs with activation and differentiation.   
T lymphocytes are classified according to their surface markers as well as 
their cytokine production profile, at present numerous different CD4+ sub-
populations have been described. In this thesis, T-helper 1 (Th1) T cells, T-
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helper 2 (Th2) T cells, T-helper 17 (Th17) and T regulatory (Treg) cells will be 
discussed (Figure 1.11).  
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Figure 1.11: T cell differentiation. During the inflammatory phase innate cells secret 
cytokines that influence the T cell response generated.  In addition to antigen presentation, 
the co-stimulatory cytokine present drives naïve CD4+ T cell differentiation to either Th1, Th2, 
Th17 or T regulatory cells.  
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 1.4.3.1: T cell sub-populations 
CD4+ T-helper 1 (Th1) cells secrete cytokine such as IFN-γ and IL-12 which 
drive inflammation via recruitment of more T-helper and Natural Killer (NK) 
cells, which is necessary during the acute phase of healing to facilitate the 
clearance of necrotic debris and reduced microbial load in order to prepare 
the wound for re-epithelialisation [101-103].  
CD4+ T helper 2 (Th2) cells secrete IL-4, IL-5 and IL-13, which are modulatory 
cytokines that control and cease the pro-inflammatory phase [101]. Induction 
of Th2 cells is facilitated by the presence of IL-4 and the down regulation of 
IL-12 (that is associated with a Th1 type response). Further to this, IL-5 
production increases which induces terminal differentiation, proliferation and 
increases survival of eosinophils’, which also play a role in the Th2 response 
via their secretion of Th2 chemokines and cytokines [85, 88].  
A balance between the CD4+ Th1 and Th2 response is required to provide the 
optimum basis for appropriate clearance of debris/microbes (during the pro-
inflammatory response) and wound healing that is accomplished following 
induction of the anti-inflammatory response. Should this balance between Th1 
and Th2 be disrupted, the patient may be susceptible to potential morbidity as 
a consequence of either a prolonged Th1 pro-inflammatory phase that can 
result in additional host injury secondary to over exposure to inflammatory 
cells such as neutrophils resulting in SIRS and chronic wound formation. 
Alternatively, an early or prolonged Th2 anti-inflammatory phase pushes the 
immune response to a state of suppression where the patient becomes more 
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vulnerable to wound infection or sepsis. This state of immune suppression 
known as CARS is preceded by SIRS suggesting that this would not occur in 
isolation and requires an initial abnormal Th1 inflammatory response. 
The differentiation of naïve T cells to Th17 T cells occurs under the control of 
both TGF-β and IL-6. In the absence of IL-6, TGF-β alone aids in the 
differentiation of Tregs from naïve CD4+ T cells [104]. Th17 T cells are a type 
of CD4+ T cell that produce effector cytokines, including IL-17, IL-6, IL-21 and 
IL-22, which are pro-inflammatory and lead to the recruitment of neutrophils. 
These primed neutrophils secrete chemokines such as MCP-1 that recruits 
further Th17 T cells, thus forming a positive feedback loop [105]. These Th17 
T cells have been identified as protective against a variety of microbes, 
including klebsiella and candida albicans, both are uncommon but problematic 
wound infections in the immunocompromised patient [101].  
T regulatory cells (Tregs) make up to 5-10% of CD4+ T cells [106]. They are 
classified into 2 groups, natural (nTregs) and induced (iTregs). Natural Tregs 
are produced in the thymus and are present in the circulation where they are 
capable of expansion following exposure to danger signals and APCs. These 
cells appear to exert their suppressive/regulatory effect via a cell-to-cell-
contact manner without the need for cytokine secretion or antigen, the 
process of which is not wholly understood [106]. Induced Tregs are converted 
in the periphery from naïve CD4+ T cells that acquire a regulatory function 
following exposure to a pathogen or damaged autologous cells which is 
antigen specific in relation to the nature of the insult [107]. The iTregs exert 
their regulatory effect via the secretion of cytokines such as IL-10 and TGF-β 
[106]. Tregs are commonly identified by the markers CD4+CD25+FoxP3+, 
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where CD25+ enables the regulatory function via the IL-2R and FoxP3+ 
represent the functional marker Forkhead/winged helix family of 
transcriptional regulators, which at present is specific to Treg cells [108]. 
  
CD8+ T cells are referred to as cytotoxic T lymphocytes and make up 20-25% 
of T cells in the peripheral blood pool [109]. These cells play an important role 
during viral infection and cancer cell eradication [96].  Once activated CD8+ T 
cells (CD8+CD25+) act via a perforin-dependent pathway on virally infected 
and foreign cells. They are activated by an APC binding via MHC class I to 
their T cell receptors (TCR) [96]. The cytotoxic CD8+ T cells are able to 
apoptose the APC via cell lysis following antigen recognition, in addition they 
also act by secreting IFN-γ [85]. 
  
The skin itself contains T cell populations, including gamma-delta (γδ) T cells, 
natural killer (NK) T cells, and alpha-beta T cells which make up a third of the 
skins T cells [47]. Gamma-delta T cells are the predominant type of T cells in 
murine skin. When activated they express Macrophage inflammatory protein 
1α (MIP1-α), Macrophage inflammatory protein 1a (MIP1-β), RANTES 
(Regulated on Activation, Normal T Expressed and Secreted), KC, IFN-γ, IL-2 
and IL-13 which contribute to the recruitment of innate and adaptive cells 
during the inflammatory phase following cutaneous injury [49]. 
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1.5: The Immune Response to Injury 
In response to cutaneous injury, an immune response is triggered. The 
immune response orchestrates a complex cascade of events that aims to 
reduce microbial infection, clear necrotic cellular debris and coordinate repair, 
ultimately striving to restore function. It is broadly divided into the innate and 
the adaptive responses that have been discussed (section 1.4.1 – 1.4.3). The 
innate cells are rapidly recruited, which provides a generic and board 
response to injury. If required the innate system engages cells of the more 
specific adaptive system via APCs [85].  
1.5.1: DAMPS, chemokines and inflammatory cytokine induction 
Cells of the innate immune system are recruited by the release of cytokines 
and chemokines at the injury site. Damaged keratinocytes in the epidermis 
release a number of cytokines from pre-formed pools including IL-1α, MCP-1, 
GM-CSF and TNF-α [91, 110, 111]. Interleukin-1α attracts circulating 
neutrophils and monocytes to the wound, it facilitates in the induction of T 
cells via increasing IL-2 production and induces the production of other pro-
inflammatory cytokines such as IL-6, TNF-α and GM-CSF [73, 85, 112]. 
In consequence to tissue injury and cell damage there is release of 
mitochondrial DNA fragments and adenosine triphosphate (ATP) from the 
nucleus that can activate the Toll Like Receptor (TLR) pathways and thus 
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recruit the innate system in the form of neutrophils. These signals are known 
as Danger Associated Molecular Patterns (DAMPs) and also include the 
alarmins and the Pathogen Associated Molecular Patterns (PAMPs) (Figure 
1.12) [113-115]. The alarmins are danger signals released secondary to tissue 
injury, they include the heat shock proteins (HSPs), annexins, defensins S100 
and high mobility group box 1 protein (HMGB-1) [114]. PAMPs are microbial 
molecules that form recognisable profiles, which can be commensal or 
pathogenic microbes that have traversed the skin barrier [114]. These 
molecular patterns are recognised by pattern recognition receptors (PRRs) 
which are expressed by innate cells including neutrophils, macrophages and 
dendritic cells to initiate the inflammatory immune response [116]. The Pattern 
recognition receptors (PRRs) include the Toll Like Receptors (TLR), mannose 
receptor (MR), RIG-I-like receptors (RLRs) and NOD-like receptors (NLRs) 
[113, 116]. TLRs are the dominant PRR for microbes; with 10 TLR having 
being described in the literature with each recognising various patterns and 
associations. Some are expressed on the cell surface and recognise bacteria, 
fungi and protozoa, and others lie within endocytic compartments and 
recognise viral nucleic acid self-damaged DNA fragments [116].  
In addition to activation of various PRRs the inflammasome is simultaneously 
activated. The inflammasome is a large multi-protein complex that detects 
aggregated PAMPs and DAMPs on cell surfaces or within endosomes [115, 
117]. Following activation of the inflammasome, pro-IL-1β, -IL-18 and -IL-3 are 
converted to their active cytokine profiles and are released to further stimulate 
an inflammatory response [118].  
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Figure 1.12:  DAMPs engaging with immature DCs. Engagement of the DCs PRRs 
with co-stimulatory signals allows maturation of the DCs and subsequent recruitment of 
appropriate CD4+ or CD8+ T cells via antigen presentation. 
Chemokines are a subset of cytokines that aid the recruitment of cells by 
stimulating chemotaxis as well as the extravasation of leukocytes from the 
peripheral blood. Chemokines are produced in response to inflammatory 
cytokines such as IL-1 and TNF-α  [85]. There are 4 described subtypes of 
chemokines, the CXC, CC, CX3C and C-chemokines. Of these 4 subtypes, 
the CXC and CC chemokines have a prominent role in wound healing, 
specifically the recruitment of neutrophils, re-epithelialisation and 
angiogenesis [69, 91]. The CXC cytokines are more specific for neutrophils 
and lymphocytes, whereas the CC chemokines for monocytes, basophils, 
eosinophils and NK cells [85]. 
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Macrophage Chemo-Attractant Protein (MCP-1), also known as CCL2, is 
released by damaged keratinocytes following injury and serves to attract 
macrophages, T cells, natural killer cells (NK) and dendritic cells (DCs) to the 
site of injury [73, 91, 120].  
Macrophage inflammatory protein 1a (MIP1-α) is also known as CCL3 is 
released from damaged endothelial cells and aids in recruitment and 
differentiation of monocytes to macrophages [121]. Levels of MIP1-α peak in 
wounds around day 1 post injury, correlating with maximal macrophage 
infiltration [91].  
Macrophage inflammatory protein 1b (MIP1-β) also known as CCL4 attracts 
NK cells and monocytes to the wound site and increases following extensive 
cutaneous injury [122]. 
Granulocyte-macrophage colony stimulating factor (GM-CSF) is secreted 
predominately by eosinophils [73]. GM-CSF plays an important role in the 
inflammatory phase following injury as it increases the number of neutrophils 
recruited to the wound site and eosinophil survival. In addition it increase 
keratinocyte proliferation via direct action & indirectly via up-regulating IL-6 
and therefore aids in the process of re-epithelialisation [73]. 
Granulocyte colony-stimulating factor (G-CSF) is a modulatory cytokine, 
which is able to increase leukocyte count (predominately neutrophils) via 
increasing proliferation, cell survival and mobilisation [123]. In monocytes it 
has been reported to decrease the rate of deactivation following surgical 
injury, thus further encouraging a pro-inflammatory Th1 type (stimulatory) 
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response [42]. In contrast to these pro-inflammatory effects, G-CSF is 
associated with antagonising some pro-inflammatory cytokines such as IL-1 
and TNF-α.  
RANTES (Regulated on Activation, Normal T Expressed and Secreted) is also 
know as CCL5, its release (from eosinophils) is stimulated by INFγ and its 
acts to attracts T cells, eosinophils and basophils to the site of tissue damage 
thus levels increase following significant cutaneous injury [88, 124].  
EOTAXIN, also known as CCL11 is a chemokine highly specific for eosinophil 
chemotaxis to the peripheral tissues, its release is stimulated by eosinophils 
as well as epithelial cells. Elevated levels are associated with allergy and 
chronic inflammation [88, 125].  
KC is also known as CXCL1 is secreted by damaged epithelial cells and 
attracts neutrophils to the area of tissue injury, it is raised acutely in injury, 
both cutaneous and visceral [125]. 
 1.5.2: Innate cell response to injury 
Neutrophils develop in the bone marrow and following differentiation they are 
released into the circulation where they are able to extravasate into the 
tissues [123]. They are the first nucleated cell to arrive at the wound site 
following skin injury which can be achieved within minutes following injury, 
peaks at 24hrs post and levels can be sustained for several days [126]. 
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Neutrophils are recruited to the area of injury following the actions of IL-1β 
and TNF-α that are released on keratinocyte damage. These cytokines play a 
role in increasing in the permeability of endothelial cells and expression of 
adhesion molecules such as β2-Integrins. These changes to the endothelium 
allows trafficking of innate cells from the circulation to the area of injury, a 
process that can be observed clinically as tissue oedema and erythema [111]. 
In addition, the release of IL-1β and TNF-α from damaged keratinocytes 
facilitates in the recruitment of neutrophils from the bone marrow, aids in 
neutrophil migration and activation, enhances phagocytosis and reduces 
neutrophil apoptosis.  Further to this, these cytokines play a role in 
macrophage activation & production of other inflammatory cytokines such as 
IL-1 and IL-6 [110, 127, 128].  
Priming of neutrophils following injury is a two-step process, which includes 
the presence of pro-inflammatory cytokines (TNFα, IL-1β and GM-CSF) and 
engagement of their TLR (DAMPs/PAMPs) [105]. The primed neutrophils 
release reactive oxygen species and tissue toxic enzymes, which are able to 
debride the necrotic tissue and microbes that is found in wounded tissue. 
However, if neutrophils are excessively primed, these mechanism that aim to 
cleanse the wound can result in host tissue injury via cleavage of the 
extracellular matrix, elastin and collagen. This leads to further damage 
resulting in a self-perpetuating cycle and ultimately an altered inflammatory 
process and non-healing wounds [66, 129].  
Neutrophil apoptosis is regulated by macrophages via reduction of IL-23, 
IL-17 and G-CSF [130]. Where neutrophil apoptosis is delayed post injury 
there is accumulation of primed neutrophils in the tissues, which if substantial 
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can lead to Systemic Inflammatory Reponses Syndrome (SIRS) and 
eventually Multi-Organ Dysfunction Syndrome (MODS) secondary to vascular 
occlusion, ischaemia and subsequent necrosis [105]. In the absence of injury, 
impaired neutrophil apoptosis is associated with autoimmune disease [105].  
Monocytes are present in two forms, circulating (CD1c+CD16-) and tissue 
resident (CD14-CD16+) [130]. Monocytes are recruited from the circulation to 
the wound under the influence of IL-1α, TNF-α and IFN-γ. Here they 
differentiate into macrophages or dendritic cells. Despite the differing lineage, 
they retain many similar features including; phagocytosis; secretion of various 
cytokines/chemokines; and antigen presentation to T cells [24].  
Following differentiation, tissue macrophages are present in wounds from 12 
hours, peaking between day 2 to 4 and remain in the wound until 
approximately day 6 [126]. Here they phagocytose and cleanse the wound of 
debris and bacteria in preparation for wound healing. The adherence of 
monocytes and macrophages to the extracellular matrix in the wound bed 
induces the expression of TNF-α, TGF-β and growth factors such as colony 
stimulating factor 1 (CSF1) and platelet derived growth factor (PDGF) [64]. 
These growth factors and cytokines aid in promoting angiogenesis, 
keratinocyte activity stimulators (re-epithelialisation) and the process of 
collagen synthesis [64, 131]. These cells therefore facilitate in the transition 
from the inflammatory phase through to wound closure. 
Three populations of tissue macrophages have been described related to their 
response to cytokines; classic, wound healing, and regulatory macrophages. 
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Classic macrophages are activated in response to INFγ and TNFα secreted 
from Th1 T cells resulting in production of IL-12 and IL-10 by the macrophage. 
Wound healing macrophages are activated in response to IL-4 from Th2 T 
cells resulting in reduced secretion of IL-12 and IL-10. Regulatory 
macrophages are activated in response to prostaglandin 2 (PGE2) and IL-10 
resulting in increased secretion of IL-10 and reduced secretion of IL-12, and 
TGFβ. In combination, this cytokine milieu suppresses the immune response 
[105].  
Tissue macrophages sample their surrounding by phagocytosis, engulfing 
antigens. After engagement with a pattern recognition receptor (PRR), 
activation occurs amplifying their phagocytic ability and enabling them to 
secrete cytokines and chemokines [85]. These are both pro-inflammatory 
(IL-1, IL-6 and TNF-α) and modulatory cytokines (IL-10, IL-12 and TGF-β) 
enabling macrophages to influence the immune response in both a pro-
inflammatory or suppressive manner [102, 111, 125]. In contrast to DCs, 
tissue macrophages in the skin do not drain to the lymph nodes and have 
weak antigen presenting capacity, thus do not play as significant role in T cell 
activation compared to DCs [98]. 
1.5.3: Dendritic cells and injury 
When cutaneous injury occurs, Langerhans cells (LC) and dendritic cells 
(DCs) capture antigens and migrate via the lymphatic channels to the draining 
lymph node where they encounter naïve T cells. This occurs within the first 24 
 43
hours and peaks at 72 hours post injury [132]. Dendritic cells are primed via 
the engagement of a damage associate molecular pattern (DAMP) that binds 
to its toll like receptor (TLR) in the presence of inflammatory cytokines such 
as IFN-γ, GM-CSF and IL-4 (Figure 1.11) [121, 133].  
Dendritic cells acquire a mobile state that allows their translocation from the 
site of antigen uptake (i.e. the skin) to the site of antigen presentation (i.e. the 
draining lymph node) where they engage with T cells. Both IL-1 and TNF-α 
produced by DCs, keratinocyte and fibroblast are involved in this process of 
antigen presentation and translocation [47]. Following injury to the skin, the 
dermal DCs are responsible for the initial T cell recruitment, thus mobilisation 
occurs swiftly with a substantial number of DCs found in the draining lymph 
node by 24 hours post injury which peaks at day 2 [134]. The T cell response 
generated following engagement with the DC is dependent on the cytokine 
milieu at the time of presentation. In the presence of IL-12, a Th1 (pro-
inflammatory) response ensues, whereas when IL-10 is secreted a Th2 type 
response is generated [121] [135] [102].  
With extensive injury a SIRS state is generated which can alter the normal 
differentiation of DC precursors due to the level of the pro-inflammatory 
cytokine present. As a result, they do not acquire their full antigen 
presentation functions and are unable to mature appropriately resulting in low 
or no antigen capture and thus altered presentation to T cells. In this 
environment a state of immunosuppression ensues (CARS) as a T cell 
response cannot be generated thus compromising the adaptive response 
(Figure 1.13) [127].  
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Figure 1.13: DC response and SIRS. During the steady state, DC traverses through 
their cell cycle from pre DCs maturing to DCs under the influence of steady state cytokines 
and then apoptosis. When a systemic inflammatory response occurs secondary to injury cells 
of the innate and adaptive systems are exhausted. Further recruitment of myeloid precursors 
occurs. However the cells, such as the pre DCs are unable to mature and upregulate their 
MHC Class II expression. Consequently, antigen presentation is limited to T cells. 
Concurrently, Treg and M2 macrophages are activated and produce an anti-inflammatory 
milieu. In this environment immunosuppression ensues, as an effector T cell response cannot 
be generated. 
The conventional dendritic cells (cDCs) are predominately circulatory and are 
identified by their surface marker CD11c+ in conjunction with MHC class II 
high expression [49, 94, 98]. To classify DCs further, those that are resident to 
the lymph nodes express CD8a+, whereas the migratory dermal DCs express 
CD8a-.   
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These migratory dermal CD8a- DCs traffic from the skin to the draining lymph 
node during inflammation and surveillance. Here they present antigen 
specifically to the CD4+ or CD8+ T cells and can either engage the adaptive 
response or contribute to immune tolerance (Section 1.4.3).  
The dermal DCs can be further subdivided based on their surface markers 
and function. Three subsets of interest have been identified which include; 
CD103+CD11blo (CD103+ DCs), CD11bhiCD103- (CD11bhi DCs) and 
CD11bloCD103- (CD11blo DCs).  
The CD103+ DCs play a role in CD8+ T cell activation during viral immunity as 
these cells capture necrotic material and cross present to MHC class I thus 
engaging with CD8+ T cells [49, 94, 137, 138]. They behave in a similar 
manner to the CD8α+ DCs that are found in the lymph nodes [98]. 
During infectious challenges, both viral and fungal, these CD103+DCs are the 
dominant migratory DCs that present to CD8+ T cells which is associated with 
concurrent increased production of IL-12, IFN-γ, IL-2 and TNF-α thus 
promoting both Th1 and Th17 T cell responses which is required to manage 
the microbial challenge [139-141]. In addition to recruiting T helper cells, the 
CD103+ DCs have been implicated in the production of Treg cells in the lymph 
nodes via a retinoic acid dependent mechanism [141]. 
The CD11bhi (the most abundant dermal DC) and CD11blo populations can 
stimulate a Th1, Th2 or Th17 immune response on presentation of antigen to 
CD4+ T cells which is dependent on both the DC maturation status and 
simultaneous cytokine production [98]. In similarity to the CD103+ DCs, these 
CD11bhi dermal DCs also produce retinoic acid (RA), which is necessary for 
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the conversion of naïve CD4+ T cells to Treg cells in the presence of TGF-β. 
Implying that these CD11bhi dermal DCs also induce the generation of Tregs 
[49, 110]. 
The lymphoid tissue resident CD8a+ DCs captures circulating antigen that 
leech into the systemic circulation following injury. In the setting of injury and 
the presence of cytokines such as IFN-γ, GM-CSF and IL-4, a priming signal 
is received via their TLR following exposure to antigen [121, 133]. In response 
to this these cells are able to produce high levels of IL-12p70 which amplifies 
their ability to present to naïve lymphoid CD4+ T cells [142]. In addition, these 
lymphoid resident DCs are also able to accept antigen from migratory dermal 
CD8a- DCs via antigen cross-dressing, as well as cross-presenting to CD8+ T 
cells [143, 144]. These cells therefore play a vital role generating a Th1-type 
response during viral exposure/infection [49, 138]. In the steady state, the 
CD8a+ resident DCs are necessary in the induction of tolerance to cell 
associated antigens present during apoptosis as the CD8a+ DCs internalise 
dead cells [144, 145].  
1.5.4: T Lymphocytes and injury  
As previously discussed (section 1.4.3), Th1 T cells are pro-inflammatory thus 
enhance the clearance of intracellular pathogens via production of IFN-γ and 
support the inflammatory response via the production of IL-2, IL-12 and IFN-γ 
[42, 146].  The Th2 response is not suppressive, but modulatory via the 
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secretion of cytokines IL-3, IL-4 and IL-5.  These allow for cell proliferation 
and remodeling which does not occur in the presence of inflammation. 
In the injured state T cells are recruited once a their threshold for activation is 
reached via their interaction with APCs whilst in the context of inflammatory 
co-stimulators & cytokines in order to initiate the adaptive response [47]. The 
response of the T cells appears to be specific to the injury itself with 
significant alterations in gene expression (both up and down-regulation) 
between two murine injury models has been observed [22, 28]. However the 
details of the mechanisms leading to this have not been confirmed. 
On activation, CD4+ T cells up-regulate their CD25 expression. The marker 
CD25 is the IL-2 receptor that allows for IL-2 stimulation of T cells to induce 
further proliferation and increase T cell survival [147, 148].  
T cells can be recruited from the skin itself, the draining lymph nodes and 
from the circulation. The T cells which are resident to the skin can interact 
locally with skin resident DCs to induce a local T cell response [98].  Whilst 
those activated and released from the draining lymph node migrate to the site 
of injury via the actions of cytokine and chemokines. In brief, IFN-γ induces a 
cytokine cascade that recruits Th1 cells, whereas Th2 cells are recruited via 
IL-4 and Il-13 promoting chemokines such as MCP-1 and EOTAXIN [149]  
The literature suggests that the T cell response pivots on the innate 
inflammatory response i.e. should this be inappropriate it will be reflected in 
the adaptive response mounted. For example, in cases of major injury where 
there is excessive innate inflammation the major lymphocyte populations 
including the CD4+, CD8+ and NK T cells can be altered resulting in a state of 
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subsequent immunocompromise [150]. Using cytokine profiles as a measure 
of activity, it appears that the Th1 CD4+ T cell populations are reduced 
following major trauma (ISS >20) [41, 101, 102, 151]. It has been proposed 
that this is secondary to an increase in Th1 T cell apoptosis whilst the Th2-
type T cells are preserved (Figure 1.14) [41]. As a result there is a relative 
increase towards the Th2-type cell response and subsequent dampening of 
the inflammatory phase, evident by the paucity of Th1 inflammatory cytokine 
IFN-γ and the increase in modulatory cytokines IL-3, IL-4 and IL-5 [42, 101, 
151]. As a consequence pro-inflammatory cytokines and innate cells are 
reduced in the wound site, thus reducing the microbial defensives. Clinically, 
in both surgical and trauma patients, this can allow the development of sepsis 
secondary to CARS where T cells fail to proliferate, produce IL-2 and IFN-γ, 
thus levels of IL-10 and IL-4 rise (Figure 1.12) [41, 152]. 
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Figure 1.14: The Th1 to Th2 shift. Following trauma there is an initial Th1-type 
response, which generates copious pro-inflammatory cytokines, is clinically apparent as 
SIRS. Subsequently, a shift towards the Th2 type response occurs. A Th2 type response is 
less efficient with regards to microbial challenges that can clinically manifests as 
immunosuppression with infection and subsequent multi-organ dysfunction. 
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In combination with the shift towards a Th2-type response, the CD8+ T cells 
have been shown to increase their proliferation in response to apoptosis of 
CD4+ T cells following significant cutaneous injury [154]. This may be a 
protective mechanism to allow for some active defence against pathogens. 
Following injury Tregs exert their regulatory effect by secreting IL-10. This 
results in reduced antigen presentation by DCs secondary to trapping of the 
MHC class II molecules and reduction of co-stimulatory molecules that DCs 
express and/or secrete. Antigen presentation to T cells is therefore disrupted 
thus ceasing engagement of T helper cells via the reduced production of IL-2 
[107, 127]. Additionally, the Treg secreted IL-10 conditions CD4+ T cells to 
become unresponsive to antigens and thus lose capacity to produce 
cytokines, resulting in further suppression [107]. Aside from their manipulation 
of the cytokine milieu, Tregs can also act via a direct T cell to T cell 
interaction, resulting in the suppression of the proliferation of T cells via a 
reduction in the production of IFN-γ by both CD4+ and CD8+ T cells [20]. 
To prevent systemic immunosuppression, a negative feedback loop for Tregs 
occurs which is IL-2 dependant. During the inflammatory phase post 
wounding IL-2 is released and stimulates the activated Tregs transiently. As a 
consequence to the Treg proliferation the inflammatory response is dampened 
and the drive for Treg proliferation is subsequently terminated due to reduced 
IL-2 levels [155]. This aims to prevent negative sequelae of Treg cells such as 
autoimmunity. 
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1.6: Summary  
Following cutaneous injury there is a cascade of events, involving the release 
of cytokines, chemokines and recruitment of the innate cells that activates the 
adaptive immune response. Where there is excessive inflammation SIRS 
ensues followed by CARS that can lead to sepsis and MODS. In addition, 
excessive inflammation at the wound site can perpetuate delayed healing and 
a chronic wound which increases the risk of hypertrophic or keloid scarring 
[156]. It is well documented that this imbalance in the immune response 
occurs in severe burns, which can have devastating consequence to the 
patient with regards to infectious complications, however other cutaneous 
injury models have been poorly explored. 
The literature suggests that injury aetiologies have a similar immunological 
trend initially, however these later diverge and result in differences in the 
inflammatory response between the different injury models [22, 28]. These 
immunological differences are observed clinically following burn and non-burn 
injury. Specifically a gender dimorphism exists which is highly suggestive that 
there is recognition of injury type rather than injury result [5, 23, 29, 30, 34, 
35]. To date there has been little focus on comparing two cutaneous models of 
injury to establish if there is a difference in the immune response to different 
injuries in addition to establishing what this difference may be. 
The majority of work has focused on outcome in severe injury, however recent 
research has shown that even non-severe burn injuries of less than 10% 
TBSA are associated with long term sequelae including increased risk of 
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malignancy and cardiovascular disease [5, 38], suggesting that there are 
sustained impacts of burn trauma. However it is not clear what underpins this 
association. There is some indication that a measurable long-term impact can 
be seen in non-burn cutaneous injury though the extent of the long-term 
consequences remains to be explored. 
Thus, understanding the immune response to specific cutaneous injury is 
essential in order to predict response and manage patients appropriately to 
limit a potentially avoidable negative outcome. This difference may underlie 
the clinically apparent compensatory anti-inflammatory response syndrome 
and associated long-term sequelae of burn injury, which is not seen to the 
same extent in other trauma.  
1.7: Hypothesis 
The immune response to burn injury differs from the immune response to non-
burn injury (excisional injury).  
1.7.1: Aims 
Aim 1: To test the hypothesis that aetiology of injury (burn and non-burn, non-
severe cutaneous models) impacts the immune response.   
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Aim 2: To compare immune status long after non-severe burn and non-burn 
(excisional) injury. 
1.8: Experimental Design 
There are several models used to reproduce consistent burn injuries with 
respect to TBSA and depth [124, 157, 158]. In this laboratory a standard 
model of burn injury is used to produce a moderate size burn injury, 
comprising of 8% TBSA [157]. Where TBSA is calculated using the Meeh 
equation (S=kW(2/3)), where k = 9.82 (for C57BL/6J mice [87]), and W = the 
average weight at the time of injury (19.3g) [87].  
This injury model is used as it creates a full thickness contact burn injury that 
extends to the fascia (including the panniculus carnosus). It is reproducible, 
consistent in its size and depth, and represents the extent of injury found in 
the vast majority of burn patients presenting to hospital in developed countries 
and in Western Australia [10, 12]. 
In this study a comparable cutaneous injury model was used where a full 
thickness skin excision was performed using a described method to the same 
depth as the burn injury model and was matched in location and TBSA [159]. 
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1.9: Significance 
It is well known that the immune response to skin injury is a critical regulator 
of the subsequent healing response. Not only is it crucial for preventing 
infection subsequent to trauma but it also plays an important role in scar 
formation and repair. This study will compare the impact of aetiologies of 
cutaneous injury on the immune response. This information will help guide 
further research aiming to optimise treatment with respect to modulating the 
immune response to injury to improve clinical outcome with regards to limiting 
infectious complications, optimising scarring and improving function in both 
burn and trauma patients. Furthermore this study may partially elucidate some 
of the immune changes relevant to the evolving association with long-term 
consequences that occurs in burn injury survivors. This may have significant 
clinical impact as it may represent a large patient population group at risk of 
potentially preventable sequelae.  
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Chapter 2 
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Materials and Methods 
2.1: Injury Procedure 
All experiments were approved by the University of Western Australia Animal 
Ethics Committee (Perth, Western Australia; Animal Ethics Approval Number 
RA/3/100/1155) (Appendix A) and all experiments conducted in accordance 
with the National Health and Medical Research Council (NHMRC) Australian 
Code of Practice for the Care and Use of Animals for Scientific Purposes. 
2.1.1: Animals 
Nine week old, female C57BL/6J mice (Animal Resource Centre, Perth, 
Western Australia) were used for all studies. All mice were received aged 8 
weeks and kept for one week prior to the experiment to acclimatise. The mice 
were housed in the Pre-Clinical Facility at the University of Western Australia 
in standard housing with food (dry), water (acidified) and enrichment 
2.1.2: Time points, groups and experiment overview  
Experiments were divided into 6 time points with respect to the day of sample 
collection; Day 1, 3, 7, 14, 28 and 84 (Table 2.1). Within each of these time 
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points were three groups; burn, excision and control. The mice were randomly 
selected for both time point and group and each group housed in group 
specific cages of 4 to provide companionship. 
!  
Table 2.1: Experimental groups, time points and corresponding numbers for each 
experiment; Total numbers within each injury and time point group is shown in addition to the 
subsequent number in each of the specific experiments. Numbers differ from the total number 
in the group due to inadequate sample/experimental error. Note, day 14 required greater 
numbers as data was lost during the FACS analysis due to non-viable cells, as such the 
experiment required repeating. 
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Figure 2.1: Schematic overview of methods; Mice were allocated into burn, excision 
or control groups. Under anaesthetic burn, excisional or sham injury was performed. All injury 
groups received post operative IM burprenorphine at time 0 and 12hrs post. All groups 
received paracetamol in their drinking water for 5 days post operatively. On day 1,3,7,14,28 or 
84 cardiac puncture was performed and blood collected was separated into whole blood and 
sera with subsequent haematology or cytokine profiling. Euthanasia followed cardiac 
puncture & lymph nodes were harvested and processed for FACS analysis of dendritic or T 
cell profiles. Skin samples were taken and stained with H&E. 
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2.1.3: Anaesthetic and analgesia 
Mice were anaesthetised in a closed chamber with continuous flow of 
Isoflurane 2.5%. Following induction, anaesthetic was maintained via a 
facemask. In burn and excision groups Temgesic ® (Buprenorphine 
Hydrochloride 0.3mg/ml) was used for post-operative analgesia. A dose 
equivalent of 0.1mg/kg (0.001mg) was administered intramuscularly (I.M) 
following anaesthesia and prior to the injury, in addition a further injection was 
administered at 12 hours post injury. Soluble paracetamol was dissolved in 
drinking water for the administration of oral analgesia at a dose of 1mg/ml for 
a maximum of five days in all groups with the expected amount of 
consumption of 20ml/day/mouse based on their required fluid intake. The 
Buprenorphine was not administered to the sham group to prevent to 
unnecessary respiratory depression or apnoea that may occur in the absence 
of hyper-stimulation that occurs during pain/noxious stimulation. The 
implications of this are considered in the discussion (Section 4.7.1) 
2.1.4: Burn injury procedure 
A full thickness burn injury was performed using a previously described 
method which produces a full thickness burn to the level of the fascia 
(including the panniculus carnosus layer (PC)) [157]. For each time point the 
mice were anaesthetised as described above. The dorsal surface was shaved 
using clippers and prepped with Inadine® solution. A cylindrical brass rod 
weighing 65g with a circular diameter of 19mm was used to generate a full 
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thickness burn to the mid-lower dorsal area. The brass rod was heated to 
95⁰C in a thermometer controlled water bath and applied with equal pressure 
for 10 seconds. Using the Meeh formula (S = kW(2/3)) to calculate to surface 
area, with K = 9.82 (for C57BL/6J mice [87]), and the average weight (W) at 
the time of injury as 19.3g  therefore the sum equates to approximately 8% 
(7.7%) of the total body surface area. The wounds were left undressed to 
prevent agitation to the mice in attempts to remove while grooming. There 
were no cases of wound infection. One mouse died in the day 28 burn group 
at day 8-post injury. A post mortem was conducted to investigate for infection 
and concluded autolysis as the cause of death (see Appendix B).  
2.1.5: Excisional injury procedure 
A full thickness skin excision was performed using a described method [159]. 
For each time point the mice were anaesthetised as described above. The 
dorsal surface was shaved and prepped as per the burn group. The area to 
be excised was marked with ink from a circular stencil with a matching 
diameter to the brass rod (19mm) generating an equivalent TBSA of 8% 
(7.7%) as the injury group average weight prior to injury was also 19.3g. 
Under loupe magnification, the skin was incised using tenotomy scissors 
along the inked marking to the mid-lower dorsal. The incision was dissected 
down to the level deep to the panniculus carnosus and superficial to the fascia 
thus matching the depth of the burn model. The area marked was excised en 
bloc. There was minimal or no bleeding on excision of the tissue. The wounds 
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were left undressed to prevent agitation to the mice in attempts to remove 
while grooming. There were no cases of wound infection. One mouse from 
the day 84 excision group was culled at day 36 post injury due to an elevated 
animal monitoring score in excess of 2 (see section 2.1.7). Following 
examination by the approved personnel they suspected ulcerative dermatitis 
as the cause for the distress that was thought to be secondary to excessive 
grooming (see Appendix C). 
    2.1.6: Control procedure 
Control mice were anaesthetised as previously described and anaesthetic 
was maintained for the approximate duration of the injury groups (5 minutes). 
Soluble paracetamol (1mg/ml) was provided in their drinking water for 5 days.  
2.1.7: Recovery and monitoring 
All mice were observed during recovery from anaesthetic and/or injury in 
housing with foam bedding. All mice were monitored and scored twice daily 
(B.D) for five days post injury and once daily thereafter up to day 14. Mice 
monitoring was inclusive of signs of dehydration, distress, pain and infection 
(See  ). As per the conditions of the Animal Ethics Committee, a score of 1 
resulted in increased monitoring to three times daily (T.D.S) until score returns 
to normal (0). Should the animal score ≥ 2 the Chief Investigator and Acting 
Technician in Charge would consider euthanasia (see below procedure). 
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2.2: Whole Blood and Serum Collection 
Blood was collected from each group for all time points. The sample was 
obtained via cardiac puncture as this maximised amount of blood collection, 
approximately 500-800µL each mouse that was required for both whole blood 
and serum collection. A previously described protocol for cardiac puncture 
was used [160], in brief, the mouse was anaesthetised as previously 
described and positioned supine. Percutaneous cardiac puncture was 
performed; Maximal blood volume obtainable was aspirated using a 1ml 
syringe and dispensed between two tubes; Microvette® 500 EDTA and 
Microvette® 500 Serum tubes for whole blood and serum samples 
respectively.  
2.2.1: Euthanasia 
The anaesthetic was continued following blood collection (see above method) 
and animals euthanised via a Lethabarb© (Pentobarbitone Sodium) cardiac 
injection of a dose equivalent of 150mg/kg (2.7mg). Following injection, 
anaesthesia was ceased and the mice were observed until the toe pinch 
reflex was absent. 
2.2.2: Sample preparation  
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Whole blood samples (collected in Microvette® 500 EDTA tubes) were 
analysed for haematology using ADVIA® 2120i Haematology System at 
Murdoch University Veterinary Hospital Clinical Pathology Department. All 
samples were kept at 4⁰C until processed. 
Serum samples (collected in Microvette® 500 Serum tubes) were processed 
as per manufacturer’s instructions. In brief, the samples were allowed to clot 
at room temperature for 30 minutes, followed by centrifugation at 13,000rpm 
to separate the clot. Serum was aspirated immediately and stored at -20⁰C. 
2.2.3: Whole blood data analysis 
Descriptive analysis completed for whole blood results using Excel. Statistical 
analysis was performed using Excel Program and GraphPad Prism 7.0e® 
2.3: Cytokine Analysis 
Cytokine profiling assays were performed on a selection of the sera collected 
using a Bio-Plex Pro™ Mouse Cytokine 23-plex assay kits as per the 
manufacturer’s instructions. The plate holds 78 wells for sampling, thus just 
over half of the data was analysed. The well allocation was evenly distributed 
across the groups and time points (see table 2.1). 
2.3.1: Bio-Plex assay preparation 
 64
!  
Table 2.2: Cytokine assay 96 well plate layout. A 96 well plate was used. This 
encompassed 16 wells for standards (S) and blanks (B); 78 wells were used for the burn (B), 
excision (E) and controls (C). Numeration represents the animal number and time point, i.e. 
B501 is burn specimen 5 day 1. 
The cytokine plate was organised including 16 wells with predetermined 
locations for the standards and blank wells (Table 2.2). The assay reagents 
were equilibrated to room temperature. Bio-plex standard diluent was 
reconstituted and diluted to form the standards. The 8-point standard dilution 
series and blanks were prepared (Figure 2.1). Briefly, 72ul of diluent was 
added to tube S1, 150ul was added to tubes S2 through S8 and the blank. 
128ul of reconstituted diluent was transferred to S1; serial dilution of 50ul 
between tubes S1 to S8 was performed, with vortexing. 
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Figure 2.2:  Standards and blanks preparation. The standards and blanks were 
reconstituted to 8 standards (S1-S8) and a blank (B). 
The serum samples were thawed from -20°C at room temperature and kept at 
4°C. Once the serum samples were thawed, they were diluted in the Bio-Plex 
sample diluent using a 1:4 ratio (1 volume of sample for 3 volumes of sample 
diluent) in this case 50ul of serum sample to 150ul diluent sample.  
The coupled beads were prepared in assay buffer; this was performed 
protected from light due to fluorescence sensitivity. The beads were allowed 
to equilibrate at room temperature for 20 minutes prior to use. For this assay, 
x1 couple beads were required. Prior to dilution, the beads were vortexed for 
30 seconds. Each well requires 50µl of coupled beads (x1), therefore 575ul of 
x10 couple beads were added to 5175ul of buffer solution, total volume of 
5750ul (this calculation includes a 20% excess to account for transfer loss).  
The detection antibodies were prepared during the primary incubation, as they 
require preparation 15 minutes prior to use. The detection antibodies were 
vortexed for 20 seconds, followed by a further 30 second vortex, 300µl was 
then transferred into 2700µl of detection antibody diluent was added to a 15ml 
tube.  
The Streptavidin-PE is prepared during the detection antibody secondary 
incubation. In brief, 5940µl of assay buffer is added to a 15ml tube, the 
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Streptavidin-PE is vortexed for 20 seconds then spun for 30 seconds, 60µl of 
Streptavidin-PE is pipetted in to the 15ml tube containing the assay buffer, 
diluting the Streptavidin to a x1 concentration. Calculations used include a 
25% excess to compensate for transfer losses. 
The Bio-Plex® MAGPIX™ Multiplex Reader system (Bio Rad®) was warmed 
up for 30 minutes prior to use.  
2.3.2: Running the assay 
The filter plate was pre-wet with 100µl of assay buffer and the liquid was 
removed using vacuum filtration. The diluted coupled beads were vortexed for 
30 seconds and 50µl of x1 beads were added to each well of the assay plate. 
The wells were washed twice by adding 100µl of wash buffer that was then 
removed via vacuum filtration. 
The diluted standards, blanks and samples were vortexed gently for 3 
seconds, 50µl added to each applicable well. The plate was incubated at 
room temperature on a shaker for 30 minutes. 
Following the primary incubation of the samples, wells were washed three 
times with 100µl of assay buffer and liquid removal by vacuum manifold.  
The detection antibody mix was then gently vortexed for 3 seconds and 25µl 
added to each well. The plate was then incubated with shaking at room 
temperature for 30 minutes. 
Following the secondary incubation with detection antibody, the wells were 
washed three times, using the previously described method. The Streptavidin-
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PE was vortexed for 5 seconds, and then 50µl added to each well, and the 
plate incubated at room temperature with shaking for 10 minutes. 
Following the tertiary incubation with streptavidin-PE the plates are washed 
three times, using the previously described method.  
Finally, Assay buffer, 125ul was added to each well, and the plate was shaken 
at 1100rpm for 30 seconds prior to being placed on the Bio-plex analyser 
(Perkin Elmer CS 1000 Autoplex Analyzer with Sheath Delivery 
System301-3913-BSIINV with Luminex xMAP® Technology). 
2.4: Lymph Node Preparations and Analysis  
To assess migration of dendritic cells and nature of T cell responses to the 
injury, the wound skin draining lymph nodes were harvested from all groups at 
all time points. Both inguinal nodes were harvested as the draining lymph 
nodes due to the size and location of the injury. 
Following blood collection and euthanasia as described above, the lymph 
nodes were stored at 4⁰C in PBS until processed. Processing commenced 
within an hour of collection of all samples in order to capture live cells for 
analysis.  
2.4.1: Preparation of lymph node single cell suspension 
Lymph node digest was performed cold at 4 degrees using a described 
protocol [161], in brief the lymph nodes were chopped with a scalpel for 1 
minute then digested with a solution of Collagenase D (1.5mg/ml; 
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Worthington® Biochemical, Lakewood, NJ) and Pancreatic type I DNase 
(0.1mg/ml; Sigmal-Aldrich® St. Louis, MO) in 10% FBS-GKN (Fetal Bovine 
Serum- Glucose Potassium Sodium solution D-glucose, 5.5mM KCl, 137mM 
NaCl, 25mM Na2HPO4, 5.5mM NaH2PO4.2H2O solution) using 5ml per lymph 
node pair. The solution was incubated at 37⁰C in an agitated incubator for 30 
minutes. Digested samples were further aggravated (using manual pipetting) 
before filtering through a 100 µm yellow cell strainer and washed with 10% 
FBS-GKN to reach a total volume of 25ml. The suspension was centrifuged at 
1700rpm for 5 minutes, after which all samples were placed on ice.  
The supernatant was aspirated and cells resuspended in 200µl of 0.5% BSA/
GKN solution and incubated with 1.0µl anti-Fc block (anti-mouse CD16/CD32 
purified eBioscience®) for 15 min on ice. Cells were centrifuged as previously 
before the addition of phenotyping mABs to prevent any nonspecific binding 
prior to the addition of the anti-mouse antibodies. 
Cells from the suspension were counted using Trypan Blue at a 1:9 ratio 
(10µl: 90µl).  
2.4.2: Lymph node cell staining  
2-5 x 10⁶ cells were added to each FACS tube (BD Pharmigen®) for both the 
dendritic cell stain and the T cell stain. Cell suspensions were centrifuged at 
1800rpm for 5 minutes, and the supernatant was discarded. Cells were re-
suspended in a 200µl GKN/BSA with primary anti-mouse antibody conjugates 
for determination of DC and T cell populations. 
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All antibodies were used as direct conjugates to FITC, Phycoerythrin (PE), 
PE-Cy7, allophycocyanin (APC), APC-Cy7, or biotin and Streptavidin 
conjugated PE-Cy5 (BD Biosciences, San Jose, CA) as required. 
Appropriately matched IgG isotype controls (BD Pharmingen, Western 
Australia) and cytometer compensation settings adjusted using single-stained 
controls were used for each experiment 
2.4.3: Dendritic cell antibody staining  
DC populations were identified using combinations of fluorochrome-labeled 
mAbs including; anti-CD4 APC (BioLegend®), anti-CD11cPE (N418), anti-
CD11bAPC Cy7 (M1/70), anti-CD8a FE Cy7 (53-6.7), anti-CD103bio (M290 
BD Pharmigen®), anti-I-A/I-E FITC (2G9 eBioscience®) primary antibody 
stain. All labeling was performed in glucose sodium potassium buffer 
containing 0.2% BSA for 30 minutes on ice.  Following incubation 2mls of 
GKN/BSA 0.1% was added and re-centrifuged at 1800rpm for 5 minutes.  
The supernatant was aspirated and resuspended in 200µl of PE-Cy5 
Streptavidin conjugated antibodies and incubated for 15minutes at 4⁰C. After 
which 2mls GKN/BSA 0.1% solution was added to each and repeat centrifuge 
at 1800rpm for 5 minutes. The supernatant was aspirated and resuspended in 
250µl GKN/BSA 0.1% solution. Samples were stored at 4⁰C over night then 
processed on the Flow cytometer. 
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2.4.4: T Cell antibody staining 
T-cell populations were identified in ILN digests using the fluorochromes anti-
CD4 APC Cy7, anti-CD25 APC, anti-CD8 PECy7 to identify the T cell 
subtypes (BD Pharmigen®).  Anti-Ki67 (BD Pharmigen®) was used to identify 
proliferating T cells and a FOXP3 intracellular staining kit (eBiosciences, San 
Diego, CA) was use to determine FOXP3 intracellular staining. All Abs were 
used as direct conjugates to FITC, Phycoerythrin (PE), PE-Cy7, 
allophycocyanin (APC), APC-Cy7, or biotin and Streptavidin conjugated PE-
Cy5 (BD Biosciences) as required. 
The cells were incubated at 4⁰C for 30 minutes.  Following incubation 2mls of 
GKN/BSA 0.1% was added and re-centrifuged at 1800rpm for 5 minutes.  
Following the primary staining, cells were washed with 2mls of GKN/BSA 
0.1% and centrifuged at 1800rpm for 5 minutes. The supernatant was 
discarded and cells were resuspended in 250µl GKN/BSA 0.1% solution. 
Samples were stored at 4⁰C over night. The following day cells were 
processed using the FoxP3 Transcription Factor Staining Buffer Set 
(eBioscience®), as per manufacturer’s instructions. In brief, cells were fixed 
using 700 µl of Fix/Perm Solution and incubated in the dark for 30 minutes at 
4⁰C. Cells were washed with 1ml x1 Fix/Perm Buffer Solution and centrifuged 
at 1800rpm for 5 minutes. The supernatant was discarded and cells were 
resuspended in 100µl fix/perm buffer solution with 1.5 µl of Fc block added. 
Cells were incubated at 4⁰C for 15 minutes. Without washing, 1.5µl of Foxp3-
PE and Ki67-FITC antibodies (eBioscience®) were added. Cells were 
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incubated at 4⁰C for 30 minutes. Following incubation cells were washed in 
2ml of x1 fix/perm buffer solution, and then centrifuged at 1800rpm for 5 
minutes. The supernatant was discarded and the cells were resuspended in 
250µl GKN/BSA 0.1% solution.  
Both the DC and T cell samples were stored at 4⁰C and transferred to the 
Telethon Institute of Child Health Research for processing. 
Samples were run using LSRII flow cytometer (BD Biosciences) and analysed 
using FlowJo software (TreeStar, Ashland, OR). 
Staining for surface molecules was reported as the frequency of cells within a 
population expressing the marker of interest.  
2.4.5: Splenic cytokine assays 
At the indicated time points, spleens were collected and digested to 
single-cell suspensions as described previously. Cells were prepared 
in RPMI 1,640 with glutamine (Invitrogen Life Technologies, Australia) 
supplemented with 10% fetal calf serum, 20 µgml− 1 gentamycin, 
and 20 µM 2-ME and plated at 3 Å~ 105 cells per well in 96-well plates 
(Nunclon, Nunc, Denmark) with Concavalin A at 10 ngml−1 in 
triplicate. At 48 hours of culture, triplicate supernatants were pooled 
and stored at −20 °C prior to cytokine analysis. 
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2.5: Statistical Analysis 
Microsoft Excel Program was used for data collection and GraphPad 
Prism7.0e® was used for statistical analysis. As our sample size was small, 
normal distribution was not assumed and a non-parametric ANOVA test 
(Kruskal-Wallis) with Dunns multiple comparison test was used. A p-value of 
<0.05 was considered statistically significant. 
 73
Chapter 3 
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Results  
3.1: Summary of Results 
!  
Table 3.1; Summary of significant results throughout all time points. Where (B) 
represents the burn group and (E) represents excision group. Results summarised included: 
C - cytokines; H – haematology; DCs – Dendritic cells; TC – T cells; # - Cell number; % - Cell 
Frequency; ! - Increased significantly; " Decreased significantly 
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3.2: Injury Impact on Growth 
The weight of the mouse was used to assess clinical dehydration and general 
recovery post operatively. There were no significant changes observed in 
weight between the burn & excision groups within the specified days. There 
was increased weight observed in both groups throughout the time points 
(day 1 -84) as the mice increased in maturity and reached adult size (Figure 
3.1). 
  !  
Figure 3.1 Weight changes in mice post burn and excision injury. Weights were 
measured twice daily in each group from day 1 – 7 post injury/sham. Weights were once daily 
in each group from day 14 – 28, then once weekly from day 28-84 post injury/sham. Graphs 
represent mean + range. Significance is indicated by *(p=0.05) and **(p=<0.01) compared to 
control; # (p<0.05) compared to burn injury group. N=3-14 mice/group 
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3.3: Burn Injury Induces a Rapid Systemic Cytokine and Chemokine 
Response 
Significant trauma induces an early inflammatory cytokine responses 
including IL-1α, IL-1β, tumour necrosis factor-α (TNF-α), and IL-6 [162]. This 
response facilitates the coordination of removal of cellular debris, defends 
against pathogen exposure and initiates tissue repair.  
Sera was isolated from all groups (burn, excision and control) on day 1, 3, 7, 
14, 28 & 84 post injury/control. The serum was examined for inflammatory 
cytokines (Figure 3.2), chemokines (Figure 3.3) and T cell cytokines (Figure 
3.4). 
At day 1 post-burn injury, IL-6 levels were significantly increased (Figure 3.2). 
Excision injury also induced a significant increase in IL-6 production at day 1, 
however its peak level was not until day 3, compared with both control and 
burn injury (Figure 3.2). TNF-α sera concentrations were significantly elevated 
at day 1 post burn compared with the excisional injury. However, in the 
excision group TNF-α levels did not significantly increase.  
Interleukin 10 was also significantly elevated in the burn group at day 1 
compared to the control, in addition there was a later peak at day 84 
compared to the excision. Whereas in the excision group IL-10 trended 
towards an increase at day 3 with significant elevation at day 7 compared to 
the control (Figure 3.2).  
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There was no significant difference in sera concentrations of IFN-ɣ in either 
injury group at any time. Due to data loss in some of the IL-α groups resulting 
in an n=1 statistical significance could not be drawn (data not shown). 
!  
Figure 3.2 Inflammatory cytokines following burn and excision injury: 
Inflammatory cytokines were assessed from the sera of each group; control, burn and 
excision on day 1 - 84 post injury/sham. Graphs show prominent cytokines involved in the 
inflammatory phase, including: IL-6 (a), TNF-a (b), IL-10 (c) and IFN-ɣ  (d).Graphs represent 
mean + range. Significance is indicated by *(p=0.05) and ** (p=<0.01) compared to control; # 
(p<0.05) compared to burn injury group. n=2-5 mice/group, for at least two independent 
experiments. 
Chemokines are responsible for the recruitment of innate inflammatory cells 
that are required during the inflammatory response. Levels were assessed in 
each of the groups and all time points (Figure 3.3).  
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monocyte chemoattractant protein 1 (MCP1) is a monocyte, immature DC, 
and memory T-cell attractant. At day 1, burn injury induced elevated levels in 
the sera when compared with the excision injury and control (Figure 3.3a). 
Macrophage inflammatory protein 1α (MIP1α/CCL3) and macrophage 
inflammatory protein 1β (MIP1β/CCL4) attract monocytes, T cells, and 
polymorphonuclear leukocytes. Their sera levels were also significantly 
elevated at day 1 post burn compared with excision (Figure 3.3b & c). No 
significant change in MCP1, MIP1α, and MIP1β was observed after excision. 
KC (CXCL1) is a neutrophil attractant that also induces angiogenesis. 
Elevated levels of KC were detected at day 1 both post excision and burn 
compared with control (Figure 3.3d). 
Serum granulocyte colony stimulating factor (G-CSF) was next examined as 
its secretion stimulates the release of granulocytes from bone marrow in 
addition to increasing neutrophil proliferation and mobilisation [42]. A 
significant increase in G-CSF levels after burn injury was detected at day 1 
through to 7 when compared to control levels (Figure 3.3e). Following 
excisional injury a 7-fold increase in G-CSF at day 1 occurred compared to 
both the burn and control groups. This significant elevation persisted to day 3.  
EOTAXIN (CCL11) is an eosinophil, basophil, mast cell, T-helper 2 cell, and 
platelet attractant [125]. This chemokine was significantly elevated at day 1 
above the control in burn injury alone (Figure 3.3f). GM-CSF showed a trend 
towards elevation in the burn injury at day 1 and excision at day 3, however 
neither were found to be significant. RANTES showed no significant change in 
either burn of injury group at any time point, thus data not shown. 
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Figure 3.3 Chemokine changes in burn and excision injury. Chemokines were 
assessed from the sera of each group; control, burn and excision on day 1 - 84 post injury/
sham. Graphs show prominent chemokines involved in the innate and adaptive systems, 
including: MCP-1/CCL2(a), MIP1-a/CCL3 (b), MIP1-b/CCL4 (c) KC/CXCL1 (d) GCSF  as an 
overview from day 1-88 and expanded views day 1-7 and day 14-84 (e), EOTAXIN (f) and 
GM-CSF (g). Graphs represent mean + range. Significance is indicated by *(p=0.05) and 
**(p=<0.01) compared to control; # (p<0.05) compared to burn injury group. n=2-5 mice/
group, for at least two independent experiments. 
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T cell–modulating cytokines were next examined (Figure 3.4). Both IL-3 and 
IL-4 showed a trend towards elevation in both injury groups at day 1 in the 
burn and day 3 in the excision, however results here were not found to be 
significant (Figure 3.4a & 3.4c).  
Levels of IL-12p-70 were significantly increased in the burn injury at day 1 
compared to the excision which showed increasing levels from day 3 which 
reached significant elevation above the control at day 7 (Figure 3.4b). 
The burn injury group had elevated IL-5 levels compared to the excision at 
day 1 alone. The excision group showed an apparent increase at day 3, 
however this was not found to be significant.   
When looking at IL-13, the burn group had significantly raised levels at day 1 
against the control and the excision group rose later at day 3 (Figure 3.4e). 
IL-2 and IL-17 are both Th2 associated cytokines. These were also examined 
in the sera with IL-2 found to be increased significantly in the burn injury alone 
at day 14 only.  
Levels of sera IL-17 could not be assessed due to an n=2 in some of the 
control sample time points, thus significance could not be accurately 
established and the data is not shown. 
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Figure 3.4: T cell modulating cytokine changes in burn and excision injury; 
Cytokines that modulate the T cell response were assessed from the sera of each group: 
control, burn and excision on day 1 - 84 post injury/sham. Graphs represent the cytokines 
IL-3 (a), IL-12p70 (b), IL-4 (c), IL-2 (d), IL-5 (e) and IL-13 (f). 
Graphs represent mean + range. Significance is indicated by *(p=0.05) and **(p=<0.01) 
compared to control; # (p<0.05) compared to burn injury group. n=2-5 mice/group, for at least 
two independent experiments. 
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The data thus far indicates a difference in both the timing and profile of the 
cytokine and chemokine production between burn and excision injury. The 
burn induced an earlier release of inflammatory cytokines and a different 
chemokine response consisting of those that promote monocyte/macrophage 
recruitment & differentiation (MCP1, MIP1α, MIP1β, and EOTAXIN). Whereas, 
the excision group showed a later and less amplified inflammatory cytokine 
levels with a chemokine response that predominantly recruits neutrophils (KC 
and GCSF). 
3.4: Burn Injury Induces Changes in Systemic Monocyte and Neutrophil 
Levels 
Whole-blood counts were obtained at days 1, 3, 7, 14, 28 and 84 post injury. 
There were no significant acute alterations to the total white cell count (WCC) 
in either injury group (Figure 3.5a). The total WCC was divided to examine the 
cell numbers for neutrophils, lymphocytes, monocytes, eosinophils, and 
basophils. The lymphocyte cell count reflects circulating T and B cells and 
specific sub-types were not examined in the systemic compartment. 
Neutrophil cell counts were elevated post burn (<0.05) and excision (<0.01) at 
day 7 compared to the control. In the burn injury group this significant 
elevation was sustained until day 14 when compared with the excision group 
(Figure 3.5b).  A significantly increased monocyte count was observed at day 
3 post burn when compared with control with no changes observed in the 
excision group (Figure 3.5c). However, later at day 84 the burn group showed 
reduced total WCC levels compared to the control, which appears to be 
secondary to a significant reduction in lymphocyte and eosinophil populations 
in the burn injury (Figure 3.5a,d & e).  
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Figure 3.5: Innate cell numbers in burn and excision injury. Whole blood was 
collected from control, burn and excisional injury groups on days 1 - 84 and analysed 
for basic haematology and innate cell profiles. Graphs represent white cell 
populations including; total white cell count (a) neutrophils, (b) monocytes (c) 
lymphocytes (d) and eosinophils (e). Graphs represent mean + range. Significance is 
indicated by *(p=0.05) and **(p=<0.01) compared to control; # (p<0.05) compared to 
burn injury group. n=3-13 mice/group, for at least two independent experiments. 
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3.5: Changes in Dendritic Cell Population and Maturation are Different 
Following Burn and Excision Injury 
The draining inguinal lymph nodes (ILNs) were harvested at all time points 
post injury and assessed using flow cytometry. Dendritic cells (DCs) and their 
subsets were examined for cell number, frequency and maturation status. 
Dendritic cell populations were identified as major histocompatibility complex 
(MHC) class II high and CD11c+ [49, 94] . This cell population was 
subsequently gated on CD8a+ and CD8a- representing DCs resident to the 
lymph node and those that have migrated from the skin, respectively.  The 
latter CD8a− DC that circulate from the dermis during surveillance and 
inflammation were further gated into CD103+CD11blo (CD103+ DC), 
CD11bhiCD103- (CD11bhi DC), and CD11bloCD103- (CD11blo DC) subsets 
(Figure 3.6a). This gating strategy provides information on resident DC 
filtering blood antigens and migratory DC presenting antigen from the 
periphery, which modulate adaptive T-cell responses via induction of CD4+ 
and/or CD8+ T–cell populations. 
Inguinal lymph node (ILN) total cell number was significantly increased after 
burn and excision injury at day 3 compared with controls (Figure 3.6b). Total 
DC cell number, resident CD8a+ DC number, and CD8a- DC number were all 
significantly increased at day 3 in both injury groups when compared with the 
control. In the burn injury total DC number had a trend towards elevation at 
day 7 and was significantly elevated above the control at day 14 (Figure 3.6c). 
In the  CD8a- population, the burn also had significant elevation at day 7 and 
14 which was not seen in the excisional model (Figure 3.6e).  
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The CD8a- DC subpopulation cell numbers were further analyzed. There was 
no increase in the CD103+ DCs in either the burn or excision groups. In the 
CD11bhi DC populations numbers were significantly increased compared with 
controls at day 3,7 and 14 in the burn injury group only (Figure 3.6f). In the 
CD11blo DC populations, both burn and excisional injuries had significantly 
elevated levels above the control at day 3 (Figure 3.6g).  
In the later time points when healing was complete a significantly reduced 
number of CD11blo DCs were seen after burn injury compared with the 
control. In addition to this, the excision group also showed some persistent 
changes in the DC populations with significantly elevated total DCs at day 84 
compared with control (Figure 3.6c). 
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Figure 3.6:  Dendritic cell following burn and excision injury. Inguinal lymph nodes were 
harvested from each group day 1 - 84 post injury/sham. Inguinal lymph nodes were digested 
to a single cell suspension. Cells were gated at CD11c+ MHC class IIhi & further gated using 
CD8a, then CD11b and CD103 to establish resident lymph node and migratory skin 
populations (a). The CD8α- DC were subsequently delineated according to CD11b and 
CD103 expression, as indicated. The graphs represent the total cell numbers in the paired 
inguinal lymph nodes (ILN) (b), total DC number (c), CD8α+ DC (d) and CD8α- DC (e). The 
CD8α- DC subpopulations numbers are represented next; CD103+ DC (e), CD11b- DC (f) and 
CD11b+ DC (g). Graphs represent mean + range. Significance is indicated by *(p=0.05) and 
**(p=<0.01) compared to control; # (p<0.05) compared to burn injury group. n=3-11 mice/
group, for at least two independent experiments. 
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In addition to the dendritic cell number data, the burn injury group had a 
significant decrease in the percentage of DC cells in the draining ILN that (DC 
% frequency) at day compared with control (Figure 3.7a). No changes were 
observed in the excision group. 
There were no significant changes in either of the injury groups when looking 
at the different populations of DCs (CD8a+ or the CD8a-). However, within the 
CD8a- DC subpopulations, there was a significant decrease in the CD103+ DC 
percentage frequency post burn when compared with control at day 3 (Figure 
3.7d). There were no other significant changes in the CD103+, CD11bhi, or 
CD11blo percentage frequencies in the burn or excision groups (Figure 3.7e & 
f). 
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Figure 3.7: Dendritic cell frequency following burn and excision injury. Inguinal 
lymph nodes were harvested from each group day 1 - 84 post injury/sham. Inguinal lymph 
nodes were digested to a single cell suspension. Cells were gated at CD11c+ MHC class IIhi 
to establish DC populations were gated using CD8a, then CD11b and CD103 to establish 
resident lymph node and migratory skin populations (Figure 3.6a). The CD8α- DCs were 
subsequently delineated according to CD11b and CD103 expression, as indicated. The 
graphs represent the total DC frequency (a), CD8α+ DC frequency (b) and CD8α- DC 
frequency (c). The CD8α- DC subpopulations frequencies are represented next; CD103+ DC 
(d), CD11b- DC (e) and CD11b+ DC (f). Graphs represent mean + range. Significance is 
indicated by *(p=0.05) and **(p=<0.01) compared to control; # (p<0.05) compared to burn 
injury group. n=3-11 mice/group, for at least two independent experiments. 
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The activation status of the DC populations was also determined by analysing 
the up regulation of Mean Fluorescence Intensity (MFI) of MHC II expression 
(Figures 3.8).  Reduced MHC II expression on DCs compromises their ability 
to prime T-cell responses and may potentiate a tolerant response. 
The total DC MFI was significantly decreased at day 3 in the burn injury alone 
when compared with control. Furthermore, there were significant reductions in 
the MHC II MFI in the CD8α+ DC and CD8α- DC subsets after burn injury 
compared with the control (Figure 3.8b & c).  
Within the migratory CD8α- DC the subsets also showed significant reductions 
the MCH II MFI in the burn injury group, specifically the CD103+ DC subset at 
day 1 and day 3 compared with control (Figure 3.8d).  
Interestingly these changes in activation of the migratory CD8α- DCs was 
found to have significantly reduced MHC II MFI at the later time points of day 
28 and 84. The CD11bhi were found to be significantly reduced compared to 
the control post burn on day 28 and 84, whereas the CD11blo DCs at day 14 
and 28 (Figure 3.8e & f). 
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Figure 3.8: Dendritic cell MHC class II surface expression following burn and 
excision injury. Inguinal lymph nodes were harvested from each group day 1 - 84 post 
injury/sham. Inguinal lymph nodes were digested to a single cell suspension and gated at 
CD11c+ MHC class IIhi to establish DC populations. This was further gated using CD8a, 
CD11b and CD103 to establish resident lymph node and migratory skin populations (Figure 
3.6a). The CD8α- DCs were subsequently delineated according to CD11b and CD103 
expression, as indicated. Cell surface expression of MHC II as determined by MFI is 
presented in the graphs for each of the cell populations. The graphs represent total DC MFI 
(a), CD8α+ DC MFI (b) and CD8α- DC MFI (c). The CD8α- DC subpopulations CD103+ DC (d), 
CD11b- DC (e), and CD11b+ DC (f).Graphs represent mean + range. Significance is indicated 
by *(p=0.05) and **(p=<0.01) compared to control; # (p<0.05) compared to burn injury group. 
n=3-11 mice/group, for at least two independent experiments.l 
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3.6: CD4+ and CD4+ T Regulatory Cell Responses Differ Between Burn 
and Excision Injury 
Inguinal lymph node (ILN) cells were examined for T populations including 
CD4+ T cells, CD8+ T cells, and T regulatory (Treg) cells by flow cytometry. 
Subsequently CD4+ T-cell number, proliferation, activation, and Treg cell 
induction was determined (Figures 3.9a).  
The CD4+ T cell number was significantly increased at day 1 in the excision 
compared to the control and both the burn and excision at day 3 compared to 
the control (Figure 3.9b). In the dividing CD4+ cells (Ki67hi) there was an 
earlier increase in the excision group at day 7 post injury compared to the 
control. Whereas in the burn group, there was significant increase compared 
to the control from day 14 which continued and was elevated above the 
excision group at day 28 (Figure 3.9e).  
In the CD4+CD25+ (activated) T cells there was a significant elevation at day 3 
in the excision group compared to the control. In contrast the burn group 
showed depressed levels in both cell number and frequency later at day 28 
(Figure 3.9c & f). 
No significant acute changes were observed in CD4+ Treg cell numbers in 
either injury group, however there was an observed upward trend in both until 
day 14 where the burn group reached significant elevation above the control 
group in both number and compared to the excision group in frequency 
(Figure 3.9d & g). 
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Figure 3.9: CD4+ T cell number changes following burn and excision injury. 
Inguinal lymph nodes were harvested from each of the groups at day 1 - 84 post injury/sham, 
and digested to a single cell suspension.  Cells were gated as CD4+, the CD4+ population 
was further gated for expression of CD25, Ki67 and FoxP3 (a). The graphs represent the 
number of the total CD4+ T cells (b). The subsequent graphs represent the cell count of the 
subpopulations of CD4+cells including CD4+CD25+ T Cells (c), CD4+ Tregs cells 
(CD4+CD25+FoxP3+) (d), in addition to the percentage frequency of CD4+Ki67hi (e), 
CD4+CD25+ (f)  and CD4+ Tregs cells (CD4+CD25+FoxP3+) (g).  Graphs represent mean + 
range. Significance is indicated by *(p=0.05) and **(p=<0.01) compared to control; # (p<0.05) 
compared to burn injury group. n=3-11 mice/group, for at least two independent experiments. 
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3.7: CD8+ T Cell Response Differ Between Burn and Excision Injury 
The CD8+ T cell number, proliferation, and activation were also determined by 
flow cytometry (Figures 3.10a). The CD8+ T cell number was significantly 
increased at day 1 post burn compared to the control and day 3 in both the 
burn and excision groups compared to the control (Figure 3.10b). when 
looking at the dividing status (Ki67hi) of the CD8+ there was a significant 
decrease in the frequency in the burn group compared to the control at 3 
(figure 3.10d).  
In the CD8+CD25+ (activated) T cells, there was a significant elevation in the 
number in both the burn and excision groups at day 1 compared to control 
which persisted in the burn group until day 3 post injury (Figure 3.10c). There 
was no significance found in the percentage frequency in these cells (Figure 
3.10e) 
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Figure 3.10: CD8+ T cell changes following burn and excision injury. Inguinal 
lymph nodes were harvested from each of the groups at day 1 - 84 post injury/sham, and 
digested to a single cell suspension.  Cells were gated as CD8+, the CD8+ population was 
further gated for expression of CD25 and Ki67 (a). The graphs represent the number of the 
total CD8+ T cells (b). The subsequent graphs represent the cell count of the subpopulations 
of CD8+cells including, CD8+CD25+ T cells (c), in addition to the percentage frequency of 
CD8+Ki67hi (d) and CD8+CD25+ (e) 
Graphs represent mean + range. Significance is indicated by *(p=0.05) and **(p=<0.01) 
compared to control; # (p<0.05) compared to burn injury group. n=3-11 mice/group, for at 
least two independent experiments. 
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3.8: Burn Injury Leads to Suppressed Acute Splenic T-cell Cytokine 
Responses 
Stimulation of T cells isolated from the spleen was conducted in cell culture 
using Concavalin A to assess T-cell function after burn injury. At day 7 post 
burn, the T-cell response was reduced compared with control animals (Figure 
3.11). There was significantly reduced production of IL-1β in the splenic T 
cells at day 7 that was not reflected in the sera (Figure 3.11a & b).  IL-17 was 
also significantly reduced in splenic T cells following burn injury at day 7, 
(Figure 3.11i ). The systemic reflection of this cytokine could not be assessed 
due to an n=2 in some of the control sample time points, thus significance 
could not be accurately established. Both IL-6 and IL-2 showed a trend to 
reduced production (P=0.06) at day 7 in the splenic T cells (Figure 3.11c & e). 
In the systemic system the IL-6 (which has previously be discussed) was 
significantly elevated the burn group from day 1-7(Figure 3.11e). In the sera, 
systemic IL-2 levels were found to be significantly elevated in the burn group 
at day 14 only (Figure 3.11f). There were no significant changes to the 
IL-12p40 levels either in the splenic T cells or sera (Figure 3.11g & h). 
By Day 14, T-cell cytokine production in response to Concavalin A had 
returned to normal levels (data not shown). 
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Figure 3.11: Burn injury leads to suppressed acute splenic T cell cytokine 
responses. Spleen cells (3 x 105cells/mL) were stimulated with 10µM concavalin A and 
cytokine levels determined in supernatant at 48 h. At Day 14 there was no significant 
difference between burn injury and control spleen cultures stimulated with concavalin A (data 
not shown). The subsequent grafts represent the functional T cell response in splenic T cells 
with the comparable serum value, including;  IL-1β (a & b);  IL-6 (c & d); IL-2 (e & f); IL-12p40 
(g & h); IL-17 (i). 
Graphs represent mean + range. Significance is indicated by *(p=0.05) and **(p=<0.01) 
compared to control; # (p<0.05) compared to burn injury group. n=3-11 mice/group, for at 
least two independent experiments. 
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Chapter 4  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Discussion 
4.1: Injury and the Impact of Immune Dysfunction  
The word ‘injury’ is defined as a stress that exceeds physiological tolerance 
resulting in physical harm or damage [163]. Worldwide, injury is a leading 
cause of morbidity and as such has huge implications medically and 
economically. To date there has been little focus on non-severe burn injury 
despite this accounting for almost 90% of admissions in burn units in the 
developed countries [10]. As such, non-severe models of injury have been 
used in this thesis to facilitate translation of this work to what we frequently 
see clinically. 
Immunological dysfunction is apparent in several clinical forms following 
injury. In the acute setting this is observed clinically as Systemic Inflammatory 
Response Syndrome (SIRS), characterised by hypo/hyperthermia, 
tachycardia, tachypnoea and leucocytosis. This can progress to Multi Organ 
Dysfunction Syndrome (MODS) where there is a failure to maintain 
homeostasis and subsequent circulatory collapse. In trauma, this process can 
be primary occurring in consequence to the initial insult or secondary to an 
abnormal host response [24]. In the intermediate phase, Compensation Anti-
Inflammatory Response Syndrome (CARS) can occur in consequence to 
SIRS and is characterised by leukopenia, infection susceptibility and failure to 
clear infection [24-27]. This clinical status observed is a reflection of the Th1/
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Th2 paradigm where there is an imbalance in T helper 1 (Th1) and T-Helper 2 
(Th2) cells [164]. In burn injury this can result in infectious challenges, poor 
wound healing and chronic wound formation resulting in increased scar-
associated morbidity with poor functional outcome [164]. In addition to these 
early and intermediate sequelae recent studies have demonstrated a long-
term impact following burn injury that includes an increased risk of 
malignancy, infectious susceptibility as well as cardiac dysfunction [3, 7, 
38-43]. It has been proposed the latter is a sequalae of the documented 
prolonged and complex metabolic changes that occur post burn injury and 
work in this area is on-going [7, 39]. With respect to the increased risk of 
malignant change and infectious susceptibility, the mechanism is at present 
unknown but it is believed it is related to immunological changes. The role of 
stress at the cellular level or indeed changes in the immune system and its 
subsequent function require further investigation.  
Burn injury in isolation is already a global burden due to scarring and loss of 
function [165]. With the developing association of long term consequences 
post burn injury, the impact these injuries have clinically and economically is 
set to rise. The knowledge of the mechanisms involved provides potential 
future therapeutic opportunities to reduce the acute consequences and limit 
the global burden of burn injury.  
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4.2: Neither Non-severe Burn nor Excision Injury Disrupted Growth 
Potential in Mice 
Adolescent mice were used for the experimental model and therefore reached 
maturity and adult size during the course of the experiment. The weight of the 
mice was measured throughout the duration of the experiments and was 
documented in all groups at all time points. The data showed no significant 
disruption to the terminal growth in either the burn or the excision injury as 
demonstrated by the final time point weight on day 84 (Figure 3.1).  In 
contrast to this data other published work looking at the long term outcome in 
paediatric burns growth has been reported to be impacted in consequence to 
the metabolic and hormonal disturbances [7, 166]. Metabolic and hormonal 
data was not collected in this experimental model, however in other murine 
non-severe burn injury models the consequence of metabolic dysfunction has 
shown significant impact to both distant skeletal and cardiac muscle 
dysfunction [38, 167].  To better establish the details of the relationship 
between metabolic dysfunction and immunological changes in burns of this 
size warrants further investigation.  
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4.3: Non-severe Burn Injury Generates a Different Cytokine Response 
Compared to Excisional Injury 
Cutaneous injury results in damage to multiple structures and cell types; 
denaturation of proteins occurs, there is disruption of plasma membrane 
integrity and subsequent secretion of mediators such as nitric oxide (NO) and 
reactive oxygen species (ROS) [125]. In response to this soup-pot of cells and 
cellular debris, pro-inflammatory cytokines such as TNF-α, IL-6 and IL-10 in 
addition to chemokines are released to recruit inflammatory cells to the area 
of injury and initiate the innate immune response [149, 168, 169]. 
Despite the non-severe model used in this thesis an inflammatory response in 
both models was observed, however the nature and temporal release of these 
cytokines and chemokines were different. 
In this thesis, Interleukin 6 (IL-6) was elevated early at day 1 in the burn injury 
with a secondary peak occurring later at day 7. Whereas, in the excisional 
injury a modest elevation occurred at day 1 reaching significance at day 3.  
In the context of injury and in support of the data observed in this study, IL-6 
has been shown to be released early following both burn and non-burn injury 
and positively correlates with the size of the burn or extent of the trauma as 
assessed by the injury severity score (ISS) [170-174].  In similarity, different 
IL-6 profiles have previously been observed where levels of IL-6 were found 
to be higher in burn injury comparison to injury secondary to elective surgery 
[170].  
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Production of IL-6 is induced by the presence of pathogen associated 
molecular patterns (PAMPs) as well as other inflammatory cytokines such as 
IL-1α and TNF-α [111]. IL-6 is produced by a number of cell types, including 
neutrophils, monocytes and lymphocytes [111]. In the context of the model 
used in this thesis, the IL-6 data suggests the burn injury resulted in an earlier 
and more prolonged exposure to PAMPs and other inflammatory cytokines. 
The source of the IL-6 release may be from recruited neutrophils, monocytes 
and lymphocytes in the wound as systemic levels of these cells showed a 
trend towards depression signifying egress to the wound bed.  
High levels of IL-6 are associated with increased morbidity and mortality 
following both burn and non-burn injury and as such, it is regarded as a 
marker of severity [158, 171]. The data presented here demonstrates that 
similar changes occur in a non-severe injury model and as such may have 
clinical implications.  The IL-6 data demonstrates differing profiles and 
temporal release of IL-6 in the two injury models showing support towards an 
aetiology specific immune response.   
A significant elevation in sera TNF-α levels was observed at day 1 following 
burn injury compared to control levels. In similarity to the IL-6 data, the 
excisional injury trended towards a peak at day 3, however was not found to 
be significant.  
TNF-α is produced by monocytes, macrophages and T cells in response to 
high levels of other inflammatory cytokines such as IL-1, IL-2, IL-12 and IFN-γ 
following injury [111, 152, 175, 176].  Together with IL-1β, TNF-α promotes 
further pro-inflammatory cytokine release specifically IL-6 in addition to 
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increasing the local concentration of neutrophils [85, 110, 127], both of which 
were apparent in the burn injury group. Should this become uncontrolled a 
state of SIRS will arise which may result in concurrent tissue damage [177]. In 
relation to this sustained or abnormally elevated levels of TNF-α are 
associated with poor clinical outcome [164]. The production of TNF-α requires 
modulation via the influence of other cytokines to limit adverse outcome. 
Modulatory cytokines such as IL-10 and IL-13 as well as Th2 cytokines IL-4 
and IL-13 act to reduced levels of TNF-α [111, 152, 175, 176].  In this data, 
both IL-10 and IL-13 were found to be significantly elevated in the burn group 
at day 1. The Th2 cytokines IL-4 and IL-3 also demonstrated a trend towards 
elevation at this same time point in the burn group, however it was not found 
to be significant. These concurrent levels of modulatory Th2 cytokines may 
represent measures to control the elevated TNF-α following the burn injury 
and minimise host tissue damage. 
Significantly raised IL-12p70 levels were also observed at day 1 post burn 
injury in comparison to the excision model. The excision group had increasing 
levels from day 3, which reached significance later at day 7 when compared 
with the control. IL-12 is a Th1 cytokine and is associated with the 
development of an inflammatory CD4+ Th1 type response in addition to the 
induction and proliferation of cytotoxic CD8+ T cells in burn injury [96, 154]. 
This early rise of IL-12p70 in the burn injury group correlates with the 
presence of other inflammatory CD4+ Th1 cytokines which include IL-6 and 
TNF-α [178]. The elevated levels of IL-12p70 may be responsible for the 
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significant elevation seen in the following days in the CD8+ T cell populations 
in the lymph nodes. 
The IL-10 data in this thesis showed an earlier rise after burn injury at day 1 
when compared to the excision model which showed a trend towards 
elevation at day 3 and significantly elevated at day 7 when compared to the 
control. In addition, IL-10 was the only cytokine significantly elevated at the 
latest time point of day 84 in the burn group compared to the excision group. 
IL-10 is a modulating cytokine that is synthesized by a number of cells 
including monocytes, dendritic cells and CD4+ Th2 T cells [168].  As a 
modulatory cytokine, IL-10 acts to inhibit IFN-γ, TNF-α and IL-1β therefore 
inhibiting Th1 T cell proliferation thus dampening the inflammatory response 
[85, 125, 178, 179].  
Early elevation in Th2 cytokines occurs in consequence to a hyper-acute 
elevation of inflammatory Th1 type cytokines following burn injury [122]. Given 
the previous literature findings, the elevation of IL-10 seen in the burn injury at 
day 1 may have been released by local or recruited Th2 T cells in 
consequence to the elevated Th1 cytokines IL-6 and TNF-α. Unlike the burn, 
the excision model had significantly elevated IL-10 at day 7 only. This may be 
due to the later and less amplified inflammatory response found in this group 
at day 3 and as such the requirement to reduce the Th1 cytokine as promptly 
was not warranted. 
The T cell data from this thesis was from cells harvested from the wound 
draining lymph node that are activated in response to dendritic cell (DC) 
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interaction and presentation of antigen. As such, this may explain why 
elevation of the CD4+ T cells was not evident until day 3 in the burn group. 
Considering this, it is possible that the T cells responsible for this cytokine 
profile are local cutaneous T cells such as the gamma-delta (γδ) T cells which 
when activated secrete IL-13 in addition to a host of chemokines which were 
also found to be significantly elevated in the burn group at day 1, including 
Macrophage inflammatory protein 1α (MIP1-α) and Macrophage inflammatory 
protein 1a (MIP1-β) [47, 49]. It was out of the scope of this work to investigate 
the functional cells in the wound bed and surrounding tissues, however further 
work in this area could clarify the results with respect to the source of cytokine 
release. Despite the ambiguity, the IL-10 profile in context of the cytokine 
profile gives further evidence that in this burn injury model there was an 
earlier drive towards a Th2 cell type response when compared to the excision.  
EOTAXIN attracts eosinophils, basophils, mast cells and Th2 cells that are all 
involved in the acute phase following burn injury [125]. In compliment to the 
IL-10 data, EOTAXIN levels were also significantly elevated at day 1 post burn 
that was not seen in the excision injury. Although not significant, the 
haematology data observed relatively low circulating eosinophils at day one in 
comparison to the later time points which would correlate with the EOTAXIN 
data and indicate migration of these cells from the systemic circulation and to 
the wound site. 
These findings suggest that this burn injury model has a similar picture to that 
which occurs in clinical studies where there is a correlation between early 
increased levels of IL-10 in association with reduced production of pro-
inflammatory cytokines and down-regulation of MHC class II expression on 
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antigen presenting cells [91, 125, 152, 176]. These actions aim to reduce the 
inflammatory phase to make way for wound healing & resolution of 
inflammation, however if the Th2 response is inappropriately high 
immunosuppression occurs and recognised clinically as CARS [146, 158, 
164]. Furthermore, the IL-10 profile seen here in the burn injury may also play 
a role in the differences observed in the dendritic cell data as IL-10 influences 
dendritic cell differentiation, maturation and function when presenting to T 
cells [102, 121, 135]. The details of the dendritic cell data will be discussed 
later in this chapter (Section 4.4).  
The data from the cytokine profiles show that the non-severe burn injury 
model in this thesis caused early elevation of both pro-inflammatory Th1 and 
modulatory Th2 cytokine in the acute phase post injury. When compared to 
the excision injury of the same size and depth the same response was not 
observed. It is possible in the burn injury group the Th1 cytokines are 
released earlier than the Th2 cytokines rather than concurrently. However this 
may not have been captured by the cytokine assessment at day 1. The Th2 
cytokine levels appear to represent a counter response to dampen an 
unfavorably high pro-inflammatory response. As such, the data shows 
concurrent elevation of both Th1 and Th2 cytokines at day 1. This process 
has been observed before in other studies where raised Th2 cytokines 
increase in response to elevated Th1 cytokines following burn injury [7, 39, 
122, 180]. Interestingly, this cytokine profile was not observed in the excision 
injury. The data strongly suggests that there is an acute ‘inflammatory storm’ 
response to burn injury that is absent after an excisional injury of equivalent 
extent.  
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It is possible that the excision model represents an appropriate inflammatory 
response where there is first a modest increase in inflammatory cytokines 
followed by later resolution as represented by th2 cytokines.  
The cytokine data in the burn injury appears to fit with the cytokine profiling in 
previous murine and clinical studies [7, 21, 39, 118, 122, 124]. The magnitude 
of this initial innate inflammatory response directly corresponds to the 
deregulation of the adaptive response and therefore may explain the 
persistent changes seen in the later time points in the burn injury group [20, 
158]. The known clinical consequences of this cytokine profile in the early 
phase post burn injury correlate positively with the extent of tissue damage, 
development of post injury complications (such as sepsis and ICU 
admissions) and a higher mortality rate [172, 181-184].  The relationship of 
the initial immune response and the subsequent immunocompromise offer 
supporting evidence to the evolving association with long term consequences 
(such as malignancy and infection vulnerability) seen following burn injury [5, 
14, 36].   
To gage a more accurate timing of release and the specifics of the profile 
further studies could be done looking at interval time points within the first 
24hrs to assess which cytokine type (Th1 or Th2) rose first in the burn injury. 
Cytokines analysed but not shown/discussed include; IL-9, RANTES, IL-1α. 
This is due to an n=1 in some of the groups/time points due to inaccurate 
plate readings. As such, values had to be omitted and the n value was too low 
to draw significance.  
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4.4: Injury Aetiology Induces Different Chemokine Profiles  
Chemokines are a subset of cytokines that aid the recruitment of cells by 
stimulating chemotaxis, including the extravasation of leukocytes from the 
peripheral blood  [85]. Neutrophils are the first nucleated cell to arrive at the 
wound site following skin injury [126]. Monocytes are next to be recruited, 
where they promptly differentiate into macrophages or dendritic cells in the 
wound which phagocytose and secrete cytokines and chemokines to 
manipulate the immune response to the injury via their engagement with the 
adaptive system [24]. 
4.4.1: Excision injury promotes chemokine expression that drives 
neutrophil recruitment   
KC (CXCL1) levels were significantly elevated in both the burn and excision 
models at day 1 against the control, however the excision group had a more 
pronounced elevation with a p value of <0.01. KC is secreted by damaged 
epithelial cells and attracts neutrophils and lymphocytes to the area of tissue 
injury [85, 125].  
The Granulocyte Colony-Stimulating Factor (G-CSF) data demonstrates a 
different profile between the two injury models with the excision group 
inducing an earlier and greater (10-fold) increase at day 1 which remained 
elevated until day 3 against the control. Whereas, in the burn injury levels 
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were elevated moderately from day 1 to 7 compared to the control. G-CSF is 
a modulatory cytokine that promotes neutrophil function, antagonises pro-
inflammatory cytokines such as IL-1, INF-γ and TNF-α, as well as reducing 
monocyte deactivation thus promoting a Th2 type response [42, 185].  
The circulating neutrophil levels trended towards low levels in the early time 
points of day 1 and 3, followed by a significant elevation in both the burn and 
excision models at day 7 which persisted in the burn to day 14. In the burn 
group the neutrophilia and raised G-CSF were prolonged in comparison to the 
excision group (day 14 and 7 respectively). Further to the chemokine data, 
IL-6 was also elevated at day 7 in the burn group. IL-6 modulates the growth 
and differentiation of neutrophil progenitors in the bone marrow and also 
attracts neutrophils to the site of injury [42, 73, 85, 169].  
Both injury models had elevated KC and G-CSF; however the profile of these 
chemokines differed in the two injury groups. The excision model appeared to 
induce an earlier and greater response in these chemokines compared to the 
burn which is suggestive of a greater requirement of neutrophils in the 
excisional wound.  The burn injury model demonstrated elevation in both KC 
and G-CSF which has previously been observed in other burns literature [85, 
118, 124, 125]. However, when compared to the excision profile and taken in 
context with the neutrophil data, this profile observed in the burn injury group 
may represent neutrophil dysfunction.  This has previously been reported in 
burn injury and G-CSF has been used to facilitate restoration of neutrophil 
balance [185, 186]. Clinically, high activation or prolonged peripheral 
neutrophils are associated with burn wound progression and the development 
of SIRS, whereas low activation is related to sepsis [56] [187] [130]. Implying 
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that neutrophils are required during the inflammatory phase but in a balanced 
manner. In burn injury neutrophilia has been observed to occur in association 
with dysfunctional chemotaxis to the wound site [187]. This may explain the 
relationship in burns with the development of SIRS due to the increased levels 
of circulating neutrophils and delayed infiltration into the wound site. 
Alternatively, the data presented may suggest that burn injury generates a 
prolonged neutrophil requirement at the wound site compared to the 
excisional model. 
4.4.2: Burn injury promotes chemokine expression that drives 
monocyte to macrophage differentiation 
Monocyte chemotactic protein (MCP-1), Macrophage inflammatory protein 1a 
(MIP1-α) and Macrophage inflammatory protein 1b (MIP1-β)  are chemokines 
that are all involved during pro-inflammatory response to promote monocyte 
recruitment to the wound bed, release of progenitors from the bone marrow 
and facilitate in monocyte to macrophage differentiation (Section 1.5.1) [49, 
121] [91, 188]. In addition to this, MIP-1α is released by damaged epithelial 
cells and activated γδ T cells [49, 121]. MIP-1β attracts natural killer (NK) T 
cells and monocytes to the wound site [122]. 
The data showed MCP1, MIP-1α and MIP-1β were all elevated at day 1 in 
burn injury when compared to the control with no significant elevation being 
observed in the excision model.  This suggests a high influx of monocytes to 
the wound tissues.  The haematology data shows a trend towards monocyte 
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depletion at day 1 in the burn. Although this was not found to be significant it 
is suggestive of an egress of these cells to the wound site in response to the 
chemotractive nature of these chemokines. There was significant elevation of 
systemic monocytes in the burn group at day 3 which indicated the response 
to the haematological roles of these chemokines in repopulating the 
peripheral pools. In keeping with this, similar chemokine findings have been 
reported in other burns literature [71, 122, 125, 189]. Alternatively, the 
monocyte elevation at day 3 in the burn injury may indicate a loss of 
monocyte egress from the circulatory system secondary to immaturity which 
has previously been reported following trauma [190].  
Other cytokines including IL-4, IL-10 and GM-CSF play a role in promoting 
monocyte to macrophage differentiation [92]. IL-10 it is considered modulatory 
as it is not only capable of suppressing the inflammatory response but also 
complements IL-6 and its actions when released during the inflammatory 
phase by facilitating the drive of monocyte towards macrophage differentiation 
[42, 73, 85, 168, 169]. As previously discussed, both IL-10 and IL-6 were 
significantly elevated at day 1 in the burn group with IL-6 levels remaining 
elevated until day 7.  Although not significant, both IL-4 and GM-CSF showed 
a trend towards elevation in the burn group at day 1. Collectively, the 
chemokine and cytokine data is suggestive that the burn injury demonstrates 
a promotion towards monocyte to macrophage differentiation. 
The chemokine data in the context of the haematology profiles indicate that 
the burn and excision injury behave differently with regards to the innate cells 
they require. The excision injury appeared to recruit neutrophils, whereas the 
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burn injury showed preference to monocytes. Furthermore, the burn injury 
demonstrated a drive towards monocyte to macrophage differentiation.   
Analysis of differences in wound infiltrates from both injury types was out of 
the scope of this research. However, this work would be beneficial to correlate 
these chemokine findings and compare the systemic innate cells to those that 
have infiltrated into the wound or scar and have a greater understanding of 
the immune response on the pathophysiological process. 
4.5: Cutaneous Injury Alters Dendritic Cell Profiles  
Dendritic cells are specialised antigen presenting cells (APC) that bridge the 
gap between the innate and the adaptive systems. During homeostasis a 
tolerogenic T cell response is induced. In the presence of inflammation and/or 
infection DCs up-regulate their MHC class II expression and become capable 
of engaging with the adaptive system and inducing a T cell response. The DC 
activation/maturation status of the DCs impacts the ensuing T cell response. 
Skin migratory DC subsets are able to differentially stimulate CD4+ and CD8+ 
T cell responses in the lymph node in order to tailor the response required 
[191].  
The lymph node populations were examined via FACS. The total inguinal 
lymph node (ILN) count data show a trend towards elevation in both injury 
models by day 1 post injury, which reached significance when compared to 
the control at day 3. Despite the injury model being non-severe this data 
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confirms engagement of the adaptive system as there has been an increase 
in the cellular populations in the regional draining lymph node basins.  
Expanding on the lymph node populations, cells were stained and gated for 
migratory and lymph node resident dendritic cell (DC) populations. 
A significant increase in the total number of DCs in the draining inguinal lymph 
node (ILN) after both burn and excision occurred when compared with the 
control at day 3. In addition, the burn had a mid-point significant elevation 
above the control at day 14 and the excision had a later elevation at day 84.  
Considering the analysis of the  DC sub-populations the early elevation of 
total DCs in the two injury models was secondary to an increase in both the 
resident lymph node CD8a+ and migratory CD8a- populations above the 
control. The burn group appeared to generate a greater response compared 
to the excision, however this was not found to be significant. This data implies 
expansion of the resident DC populations as well as adequate migration of the 
DCs from the skin to the draining lymph node in response to the non-severe 
cutaneous injury. This data appears to correlate with other authors who 
reporting similar findings with an increased number of DCs in the draining 
lymph nodes during the acute phase post burn injury (day 1 – 3) [192].  
Despite the resident CD8a+ DCs being elevated at day 3 in both injury 
models, further study of these DCs demonstrated a reduced activation status 
as indicated by MFI in the burn group when compared to the control, no 
changes to the activation status were observed in the excision group. The 
lymph node resident CD8a+ cells play an essential role in the development of 
tolerance to cell-associated antigens presented during apoptosis [145, 193]. 
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Therefore following burn injury and subsequent reduction in CD8a+ DC 
activation may result in reduced tolerance to self and pave the way towards 
the development of long-term immune consequences.  
The migratory CD8a- DCs were also elevated in both injury models at day 3, 
which persisted in the burn injury until day 14. Similarly to the resident CD8a+ 
DCs there was an associated reduced activation status in the burn injury 
alone at day 3. Activation of dendritic cells is a complex multi-staged process 
that involves the engagement of Toll Like Receptors (TLRs) in the presence of 
inflammatory cytokines such as interferon type 1, GM-CSF and IL-4 [121, 133, 
194, 195]. Neither TLRs nor IFN-1 were examined in this thesis thus the 
influence of these in the immune response following injury cannot be 
establish. However, both GM-CSF and IL-4 were examined, both showing a 
trend towards depression at day 3 in the burn group only, however neither 
were found to be significant. Given the context of literature surrounding DC 
maturation, these cytokine/chemokine changes may be responsible or the 
reduced activation status seen in the burn injury. 
In further support, high circulating IL-10 leves are also known to suppress DC 
maturation and antigen presentation [127]. As discussed previously (section 
4.3), IL-10 was significantly elevated at day 1 compared to the excision that 
showed a later and less pronounced elevation at day 7. This early elevation in 
IL-10 may have further contributed to the suppression and reduced maturation 
status in this DC population that we see only in the burn. 
The migratory CD8a+ cells were further sub-categorised into CD103+, 
CD11bhi, and CD11blo as they differentially stimulate CD4+ and CD8+ T cells in 
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the lymph node, thus altering the adaptive response generated [98, 191, 196, 
197]. Presentation to CD4+ T cells is preference in the presence of IL-12 at 
the time of antigen presentation, and as such a Th1 (pro-inflammatory) 
response ensues [121] [135]. Whereas in the presence of IL-10 a Th2 type 
response is generated which ultimately results in dampening of the Th1 
response [102]. With regards to cross presentation to CD8+ T cells concurrent 
high levels of IL-12 and TNF-α have been found to promote a Th1 T cell 
response [139-141]. 
The CD103+ DCs showed no significant change to their number following 
either injury; however a reduced maturation status at day 1 and 3 in 
association with depressed frequency at day 3 occurred after burn injury 
alone. Altered maturation status would result in poor T cell activation in burn 
injury. As these migratory DCs are able to stimulate both CD4+ and CD8+ T 
cells, a process known as cross presentation they play a prominent role 
during infectious challenge, particularly in viral and fungal immunity [98, 138, 
139, 196, 198, 199] [139-141]. The consequence of immaturity in these DC 
populations may explain the high infectious rates observed in burn patients 
[15, 16]. In addition to maturation disruption that was observed here, these 
cutaneous CD103+ DCs have previously been found to be dysfunctional 
following burn injury where unregulated IL-10 and reduced IL-12 levels 
resulted in reduced co-stimulatory signals and subsequent poor stimulation of 
T cells [200].  
The most pronounced changes post burn injury were in the migratory CD11bhi 
DCs subsets which showed significantly elevated levels above the control 
from day 3 to 14 with normal activation status. There were no significant 
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changes seen in the excision injury model. In the later time points (day 28 and 
84) despite no significant alteration to their numbers in the lymph nodes these 
cells were found to have suppressed activation, again this was not observed 
in the excision group. These migratory DCs are the most abundant subtype in 
murine skin and predominantly present to CD4+ T cells to preferentially 
stimulate a Th2 response. However, a Th1 or Th17 response can be 
generated depending on the DCs maturation status and chemokine milieu 
present [98, 199]. In this data there was no significant corresponding cytokine 
changes that support the changes seen in this DC population from day 3 - 14. 
The CD11bhi and the CD103+ DCs behave similarly and are implicated in the 
development of tolerance to antigen via retinoic acid that enables these DCs 
to induce T regulatory cells [198, 201]. Interestingly, the Tregs were 
significantly elevated (number and frequency) in the burn group alone at day 
14 echoing the CD11bhi data. Tregs are known to release IL-10 as part of their 
modulatory function [107, 127]. The raised IL-10 at day 84 may represent a 
remaining reflection of the earlier Treg activation. Additionally, the late 
changes to the CD11bhi DC activation may be in response to this later IL-10 
elevation as it is known to suppress DC maturation and antigen presentation 
[127]. This data indicates that the burn injury model in this thesis showed 
changes associated with tolerance induction at day 14 as well as long term 
disrupted activation of these cell types. This DC data shows further supportive 
evidence that the immunological changes post burn injury are long term. 
Furthermore, these changes are not successfully demonstrated in the size 
matched excision model indicating a difference between the two aetiologies.  
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In the migratory CD11blo DCs both injury groups had significantly elevated 
levels with normal activation status at day 3 when compared with the control. 
Later at day 28, the burn injury developed significantly suppressed levels that 
corresponded with a preceding reduced activation status at day 14 that 
continued day 28. The CD11blo act in a similar manner to the CD11bhi and 
activate CD4+ T cells [98]. The early change in this DC population appears to 
correspond with the CD4+ T cell data where both injury groups had elevated 
levels above the control at day 3. This data may demonstrate the expected 
course following a cutaneous injury (both burn and excision) where there has 
been migration of cutaneous DCs to the draining lymph node with an 
associated elevation in T cell numbers to generate the required adaptive 
response. In the later data, there is suppressed CD11blo DCs in the burn 
injury demonstrating further differences between the injury models as there 
were no long-term changes seen in the excision injury. These migratory 
CD11blo DCs are found in the draining lymph node in both the steady state as 
well as during inflammatory conditions [98]. As such, suppression of these 
DCs indicates persistent immune compromise following burn injury that may 
explain the long-term morbidity observed following burn injury [3, 5, 7, 37]. 
The DC changes in migration and activation of the skin resident DCs to the 
draining lymph nodes post injury may be sufficient enough to impact antigen 
presentation to T cells and induce a different adaptive immune response that 
is aetiology dependent. The cause of late depletion in DCs may be related to 
the significant elevation of IL-10, however the source of this cytokine remains 
uncertain and warrants further investigation. Interestingly, recent evidence in 
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burn injury has indicated the reduction in DCs may be secondary to bone 
marrow monocyte progenitors lacking DC differential potential secondary to a 
high MafB expression which exerts an inhibitory role in monocyte-derived DC 
differentiation with a preference towards monocyte to macrophage 
differentiation [202, 203].  The data presented in this thesis shows support of 
this literature, with evidence of monocyte to macrophage differentiation 
(Section 4.3.2) in the context of reduced DC populations. 
4.6: Injury aetiology induces different T cells responses 
T cells are recruited to the site of injury following antigen presentation in the 
presence of co-stimulatory molecules in the draining lymph node [47]. There 
are various types of T cells depending on the required action and the 
concurrent cytokine secretion including CD4+ T helper cells, CD8+ cytotoxic T 
cells and CD4+ T regulatory cells [150]. T cells engage with antigen presenting 
cells such as dendritic cells in the draining lymph node as well as in the 
primary lymphoid tissues (the spleen). During the steady state, this is a 
tolerogenic process to maintain homeostasis. However during inflammatory 
states, the T cells migrate to the site of injury and the response is determined 
by the activation and maturation status of the DCs [200, 204-206]. In both 
burn and non-burn trauma, findings have suggested that the Treg cells can 
induce an anti-inflammatory state observed clinically as delayed 
immunosuppression thus rendering the patient more susceptible to infection 
and sepsis [20, 40, 158, 180, 207].  To date, there has been little work that 
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demonstrates the long term impact this early immune-compromise has post 
injury. 
4.6.1: Injury aetiology impacts activated CD4+ T cell function  
The excision injury showed a significant increase in CD4+ T cell number from 
day 1 to 3 when compared to the control, whereas the burn group showed a 
later response at day 3. As discussed previously (section 4.4), these 
elevations appear to been in keeping with the expected response to injury 
where a T cell response is induced [49, 208]. Based on the DC data, it may be 
in consequence to elevated migratory CD11blo DCs at day 3.  
CD4+ activation was determined via CD25+ expression and was increased in 
the excision injury at day 3. The data from the activated T cells corresponds 
appropriately when considering time matched cytokine profiles (section 4.2) 
where the excision injury had elevated levels of IL-6 suggesting activation of 
the Th1 type response. This was followed by significant elevation of 
modulatory and Th2 cytokines (IL-10 and IL-12p70 respectively) at day 7 
indicating resolution of the inflammatory phase. This data indicates the 
expected post injury response with demonstrated increased frequency of 
activated CD4+ T cells following trauma [180].  In complement to this data, 
proliferation as determined by Ki64 showed significant elevation at later time 
points of day 7 in excisional injury which may indicate repopulation of these 
cells following earlier elevation.  
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In the burn injury, there was a trend towards elevation later than in the 
excision at day 7, however this was not found to be significant. The delayed 
elevation in the activated CD4+ T cells in the burn injury group may be 
secondary to altered DC maturity (section 4.4) preventing successful 
presentation to T cells and thus stifling T cell activation. These changes in the 
burn demonstrate how an early immune challenge creates a domino effect 
with subsequent poor engagement of the adaptive system. This would be in 
keeping with the evolving picture of immune alteration following burn injury. 
Furthermore, the burn injury had depressed number of activated CD4+ T cells 
after healing at day 28. In the proliferating data (Ki64) there were increased 
levels at day 14 and 28 implying the CD4+ T cells are present and 
proliferating but not activated. Additionally, sera IL-2 shows elevation at day 
14 in the burn group suggesting attempts to increase population as IL-2 is 
known to promote induction of T cells, stimulate further proliferation and 
increase T cell survival [73, 85, 112] [147, 148].  This rebound effect has 
previously been observed following burn injury but in the cytotoxic CD8+ T 
cells population [209]. Other studies have similarly reported reduced activated 
CD4+ T cells during the acute phase post burn injury, however there is little 
data on the long term changes [210]. The alterations in T cell populations 
previously reported have occurred in substantial burn injury, however here it 
has been demonstrated that changes also occur in a non-severe model [158]. 
Without appropriate T cell response one would expect poor response to 
infective challenge (bacterial and viral), which in the intermediate term post 
injury would results in infectious susceptibility and poor clearance of sepsis. In 
relation to this, burn injury patients are known to have a higher rate of wound 
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infections and sepsis in comparison to other trauma and as such the T cell 
data presented here is highly suggestive of the underpinning process [15, 16]. 
In the long term, if T cell anergy or deletion tolerance persist the development 
of autoimmune disorders or malignant change can occur [148, 211]. Should 
this immune response observed in this murine burn model translate to 
patients following burn injury, both severe and non-severe injury, it may 
explain the findings relating to the increased incidence of malignancy and 
infectious sequalae in the clinical and population studies.  
4.6.2: T regulatory cells were activated following burn injury 
In this study, elevated T regulatory (Treg) numbers were observed in the 
draining lymph nodes of the burn group at day 14 post injury, with no changes 
seen in the excision group. This may be due to the DC response observed in 
the burn injury where the migratory CD11bhi DCs (which stimulate production 
of Tregs) was elevated. Following activation of the adaptive immune system 
the Treg cells orchestrate the T cell response in order to dampen the 
inflammatory state and make way for healing and remodelling to occur [151, 
212]. As such, this increase of Tregs in the burn injury may be responsible for 
the reduction in activated CD4+ T cells seen in the burn injury at day 28, as 
neither Treg elevation nor reduced CD4+ activation was seen in the excision 
injury. Tregs are induced or activated following engagement with DCs in 
consequence to an exaggerated inflammatory response. The activation of the 
Tregs in the burn injury and not in the excision implied that the burn induced a 
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greater but poorly controlled inflammatory response that required regulation. 
The Treg data consolidates the findings that burn and excision injury induce 
different immune responses.  
Other studies have also reported later increases in Tregs in association with 
low levels of IFN-γ and higher levels of IL-10 following burn injury [20]. These 
changes to the cytokine profile can inhibit the Th1 type response, thus making 
way for increased action of a Th2 type response and promoting the 
immunosuppressive state seen clinically in burn patients. Treg secretion of 
IL-10 renders CD4+ T cells unresponsive to antigens and therefore cease to 
produce cytokines, thus perpetuating the immunosuppressive state [107].  In 
further support of the data, the burn injury demonstrated increased IL-10 in 
the burn group at day 84 in association with activated CD4+ T cells 
suppression, implying that these changes may be secondary to Treg 
influence.  
These late differences in the CD4+ T cell and Treg populations profiles 
implicates the development of T cell anergy, exhaustion or deletion tolerance 
to self-antigens in this burn injury model in consequence to the innate 
cytokine profile, innate cell recruitment and altered DC maturation. 
4.6.3: Injury aetiology impacts the cytotoxic CD8+ T cell response  
With regards to the cytotoxic CD8+ T cells in the draining lymph nodes 
elevated levels compared to control were seen in the excision injury at day 1 
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in both the excision and burn injury models on day 3. Cytotoxic T cells are 
vital to the control of viral infection and malignant cell eradication and 
predominantly secrete Th2 type cytokines following injury [96, 109]. The 
markers of CD8+ T cell activation (CD25+) were also assessed and both burn 
and excisional injuries had significantly elevated levels compared to the 
control at day 1 which persisted to day 3 in the burn injury group. In the burn 
injury group these elevations in the CD8+ T cells were associated with a 
significant reduction in the proliferation of these cells as indicated by low Ki67 
which was not seen in the excisional injury. Demonstrating a different 
cytotoxic T cell response in the two aetiologies. In burn injury, altered CD8+ T 
cell function has similarly been observed with functional studies in the acute 
phase demonstrating that these cells take on more of a Th1 cytokine profile in 
addition to reduced activity [109]. This is further supportive data showing 
evidence of immune suppression following burn injury.  
4.7: Burn Injury Leads to Suppressed Acute Splenic T-cell Cytokine 
Responses 
Analysis of T-cell activation using cells isolated from the spleen after a burn 
injury showed that T cell cytokine production in response to stimulation was 
suppressed at day 7.  Levels of IL-1b and IL-17 were significantly reduced 
compared to the control, whereas IL-6, IL-12p40 and IL-2 were all reduced but 
significance was not reached. By day 14, levels had recovered. The functional 
T cell data from the splenic cells show transient suppression, which in time 
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returns to normal. T cell lymphoid tissue changes have been found to behave 
in a compartmentalised manner with the response primarily related to the 
zone of injury, i.e. within the draining lymphatic tissue [158]. This suggests 
that the effect on the function of the cells within the ‘compartment/lymph node’ 
would be greater than observed in the less affect the primary lymphoid tissue 
of the spleen.  The lymph node cell population changes more likely reflect 
alterations in dendritic cell presentation and maturity. This has previously 
been reported after UV exposure of the skin and may also occur after burn 
injury [213]. Therefore, characterisation of long-term changes in dendritic cell 
function after a non-severe burn, in particular the ability to prime T cells, is an 
important next step. In addition, comparison data from the secondary 
lymphoid tissues (inguinal lymph nodes) would be valuable to assess the 
functional impact to these cells. 
4.8: The Impact of Injury Aetiology on the Immune Response 
Altered immune response following injury is not a novel concept, with other 
literature similarly concluding that different injuries induced a different immune 
response [22, 28]. The collective work following the ‘Host Response to 
Inflammation’ collaborative produced some insightful work in this area and 
concluded that injuries of differing aetiology induced different gene up/down-
regulation which results in a tailored immune response to the injury [22, 28]. 
Other studies have similarly published findings that suggest injury aetiology 
influences the immune response generated and impacts clinical outcome [21]. 
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Specifically, burn patients had higher IL-6 and IL-8 compared to non-burn 
trauma which correlated with poorer outcome despite the same injury severity 
score (ISS) [21]. In addition to the acute cytokine/genetic differences early 
post injury, differences between injury aetiology and infectious risk has been 
acknowledged. The literature reports that the rate of infection is known to be 
higher in burn injury when compared to other trauma [15, 16]. This is seen in 
both this data as well as the wider literature in burn injury and is suspected to 
be related to adaptive dysfunction and early Th2 elevation [214].  
 Furthermore, there has been a body of literature looking into the gender 
dimorphism following injury. Although the model used in this thesis was 
gender matched, the consensus from these works provides supporting 
evidence towards the development of different immune responses specific to 
the aetiology of injury. In murine burn injury studies, male mice have higher 
pro-inflammatory cytokines levels such as IL-6, in association with decreased 
IL-2 and INF-γ during the acute phase post injury where consequentially 
reduced CD4+ T cell proliferation is observed [34, 35]. In the female mice the 
same process occurred but in a delayed manner (day 7) [34, 35]. Clinically, 
male burn injury patients have a lower morbidity and mortality in both the 
acute and long-term post injury, with female patients having greater morbidity 
and mortality, specifically an increased risk of malignancy has been observed 
[5, 29, 30]. In contrast, the opposite is seen in non-burn injury with females 
having a lower morbidity and mortality in both trauma and surgical injury [31, 
32]. These gender difference have also been observed in a large 
epidemiological study that combined burn survivor data from Western 
Australia and Scotland [5]. Although there were differences between the 
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cohorts with regards to gender and socioeconomic risk factors etc. the 
authors used well accepted methods to adjust for and correct the data. Their 
findings showed that female burn injury patients had an increased incidence 
of malignancy compared to expected (for age/gender match) which was not 
observed in the male burn population, suggesting a change post burn to the 
function of the immune response in females [5]. These findings collectively 
indicated that gender influences the immune response, and as such alters its 
function following exposure to different injury with subsequent long-term 
changes. The mechanisms of this have not been fully established, but it has 
been suggested it is secondary to the overlap that exist between the 
endocrine and immune systems as the differences reduced following 
menopause [29, 30, 34].  
There are some published reports that have not established a difference 
between injury responses. Of particular interest, a genomic study comparing 
the response of injury in patients and murine models reported that the 
aetiology of injury had minimal effect on the clinical response in humans, in 
addition to reporting a low correlation of murine models to human data [215]. 
Since publication the limitations of this study have been discussed openly as it 
presents a one-dimensional view of the genomic response to injury and the 
findings do not appear to correlate with many previously well described 
correlations between murine and human immune responses [21, 48]. 
Specifically, the analysis of the peripheral blood alone, the limited diversity in 
murine strain and inconsiderate statistical analysis of data [216]. It is also 
worth considering that despite minimal genomic difference observed by the 
authors there may still be a considerable variation in the immune response 
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generated by that different gene expression between different injury and 
aetiology.  
To date there is paucity in the literature with regards to the comparison of 
different aetiology on the same tissue type. The injury models used in the 
previously discussed literature are limited as they do not involve the same 
tissues (i.e. cutaneous, visceral, long bone, sepsis etc.) and as such it makes 
it difficult to draw conclusions on whether it is the aetiology of injury or the 
type of tissue injured that lead to their interesting findings. In consequence of 
this, it makes the findings of these studies difficult to translate into clinical 
practice. The data presented in this thesis compares injury to the same tissue 
type and demonstrates clearly a divergence in the immune response in the 
two cutaneous injury models. Specifically there was a greater inflammatory 
response with both Th1 and Th2 cytokines released early in addition to 
chemokine promotion of monocyte recruitment with macrophage (rather than 
DC) differentiation. There was engagement of Treg cells and subsequently 
reduced white cell populations and lymphocytes, in addition to reduced DC 
maturation and poor CD4 activation. Further to this, there is indication that in 
the burn injury the immunological changes are evident long after healing 
which may go some way to explaining the long-term morbidity that occurs 
post burn injury [5-7, 13, 36, 37, 124] 
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4.8.1: Injury model and eschar impact the immune response  
When interpreting the data from this thesis, consideration of the limitations of 
the injury models used (thermal verses sharp) must be acknowledged. The 
pathophysiology process of the tissue injury in each model differs. 
Specifically, in incised wounds the damage does not grossly extend beyond 
the boundary of the incision, which is not the case in thermal burn wounds 
where there are radiating zones of injury around the point of initial contact (a 
process originally described by Jackson) [79].  
Opiate analgesics in the form of buprenorphine were used at time 0 and 12 
hours post injury in keeping with accordance of the animal ethics issued (see 
Appendix A). Opiates were not issued in the control mice post sham 
procedure due to ethics committee guidance with regards to risk of respiratory 
depression in the absence of painful stimulation. The literature around the use 
of opiate analgesia and its immune consequences is well established and 
thus must be discussed. What appears to be consistent within the literature is 
the variance in the impact to the immune response based on the specific 
opioid used with the focus of work looking into fentanyl, morphine and 
buprenorphine [217-221]. From this work, buprenorphine appears to have the 
least impact on the immune response with minimal effect reported in animal 
studies [221]. As such, it is difficult to determine the impact the absence of 
buprenorphine administration in the control model made in the results in this 
thesis.  
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In addition the presence or absence of an eschar must also be explored. The 
excision model created a size and depth matched cutaneous wound with a 
parameter of damaged cells around the circumference and base, however it 
did not create a formal eschar that resulted following the burn injury (Figure 
4.1).  
!  !  
!  !  
Figure 4.1: A demonstration of wound size and phases of wound healing observed in 
this study. Note the presence of the burn eschar formation and progression and the eschar-
like wound in the excision model on days 1, 3 and 7 post injury. All wounds were healed 
between day 14 and day 28. 
The eschar is a dry cellular mass that forms in full thickness wounds over the 
area of necrosis [79]. The presence of this eschar and its role in burn wound 
healing has been well investigated with regards to the management and 
timing of excision [2, 19, 222-227]. Despite this, there appears to be variability 
in both the literature and in clinical practice. The disparity in practice may be 
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influenced by the complex nature of burn wound progression that is not yet 
wholly understood and as such requires clinical judgment to determine 
between adequate excision and skin salvage [84, 228]. In several older 
clinical studies, they concluded that early excision of the burn eschar and 
coverage with skin graft (between 48-72hrs) proved beneficial in reducing the 
hyperinflammatory (as determined by reduced IL-6, IL-1β, IL-10 and TNF-α) 
and hypermetabolic process (as determined by reduced growth factor levels 
and hormone production) as well as reducing mortality in severe burn injury 
[19, 223-226]. Whereas other studies suggested a later excision (4-10 days) 
was optimal to improve patient prognosis [2, 227].  
Subsequent work completed from this laboratory following the findings in this 
thesis concluded that early excision was preferable to late in a murine model, 
as early (day 1) excision of the burn wound was found to preserve a more 
appropriate innate and adaptive immune response to cutaneous injury when 
compared to late excision (day 8) [229].  
Collectively, the data from this thesis, the subsequent work from this 
laboratory and clinical studies where removal of the eschar has been shown 
improve outcome are highly suggestive of the burn eschar contributing further 
to the inflammatory response and subsequent influence on the direction of the 
immune response [222, 226]. It is possible the eschar act as a nidus of 
damaged self-antigen (DAMPS and PAMPS) that drive the initial hyper-
inflammatory response observed in the burn injury model. The findings from 
the gender studies shows supportive evidence that the immune response to 
injury is related to immune recognition of the aetiology of injury rather than the 
tissue damaged or the subsequent development of an eschar [34, 35] [31, 
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32]. However, there appears to be some role and contribution from the eschar 
presence [229]. To establish this and determine its level of contribution, an 
experimental model where two injury aetiologies, both of which result in the 
formation of an eschar would need to be developed and examined in both 
genders. Furthermore, it would be neglectful to not consider and investigate in 
future studies other complexities and compounding factors when assessing 
and analysing the immune response including; the mechanical force to the 
cells i.e. thermal vs sharp; the impact of the peripheral/surrounding zones of 
injury and the microbial exposure.  
4.9: The Immune Response to Burn Injury Has Long-term Implications 
To date, there have been many studies that have demonstrated long-term 
morbidity in burn patients [5-7, 13, 36, 37, 124]. With much of the focus 
having been on the metabolic changes that occur in consequence to the 
hypermetabolic state that is observe during the acute phase post burn [7, 39]. 
In compliment to this work, other burns studies have reported in non-severe 
models that burn patients have greater risk of developing both skeletal and 
cardiac complications, both in the intermediate and long-term [38, 167]. In 
parallel to the metabolic work, others have observed long-term changes in the 
cytokine profile post burn injury, which echoes the data in this thesis [7, 124]. 
The authors report changes in the cytokine profile as long as three years post 
major burn. From these studies it is clear there is change in the immune 
function that remains late post burn and that these changes correlate with 
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clinically observed hypermetabolic morbidity. However, what is not evident 
from these studies is how these changes link with other aspects of the 
immune system. The data from this thesis goes some way to indicating these 
associations and paves the way for further and more focused study. 
The data in this thesis was examined until day 84 post injury and was found to 
show long-term immune changes. All wounds were healed between day 14 
and 28 however, changes were still observed in the burn injury day 28 and 84 
that was not seen to the same extent in the excision model. At day 28 the 
migrating skin dendritic cells had depressed maturation and number in the 
CD11blo population. In the CD11bhi maturation was reduced from day 28 and 
continued until day 84. The DC changes were reflected in the T cell lymph 
node data at day 28 where the activated CD4+ T cells were reduced in the 
burn that was associated with a rebound elevation in the proliferating CD4+ T 
cells.  In addition, the burn injury had associated elevated IL-10 levels and 
depressed white cell populations, including neutrophils, eosinophils and 
lymphocytes at day 84. This immunological picture seen in the burn injury 
may represent a process of T cell anergy or deletion tolerance to self-antigens 
that is secondary to abnormal DC antigen presentation. In consideration of 
these findings, recent clinical and population based studies elude to altered 
immune function following burn by way of increased risk of subsequent 
infection (unrelated to the burn scars/wounds); increased incidence of 
gastrointestinal disease as well as increased malignant development [5, 6, 13, 
36, 37]. These later changes to the DC and subsequently the T cells observed 
in this thesis may contribute to a state of immune vulnerability which is 
observe clinically in the findings of these previous studies as increased 
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incidence of infection and cancers that is observed in burn patients. Further to 
this, this burn injury sustained was a non-severe injury model yet still 
demonstrated an immunological impact. This has great clinical and economic 
relevance as these non-severe burns represent a large proportion of clinical 
workload in burn units [1] [2] [10]. As such, the net is cast wider with regards 
to those patients that may be affected by the sequelae of their burn injury. 
4.10: Study Limitations 
The use of a murine model for human pathology and in particular immunology 
has long been established and well investigated with regards to its 
comparability to human biology [48, 51]. Although some literature may dispute 
its relevance, many others show support [48, 215]. The murine model has 
many advantages for immunological study, including immunological similarity 
to humans; age and gender consistency, in additional to practical advantages 
with regards to size and care of the animals. Despite this, it is necessary to 
acknowledge its limitations and differences. In the skin, structural differences 
are apparent with the presence of the panniculus carnosus, which is a 
contractile layer of tissue that facilitates greatly in wound contraction. In 
humans, this layer is mostly absent, with remnants remaining in layers such 
as the platysma [50]. In addition, mice have greater density of hair, which has 
implications in wound healing due to the presence of epithelial cells lining the 
follicles [50]. With regards to the immune system there are some differences 
in the type of DCs and T cells present in mice and the equivalent in humans 
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needs to be considered during translation to human pathology or in planning 
of clinical studies [51]. In this work, the murine model shows that there is a 
difference between aetiologies of injury in mice and as such it is necessary to 
verify these findings in patient based studies. 
The time points of data collection were from day 1 to day 84 post injury to 
establish a broad range of both acute and long-term immune profiles following 
burn and excisional injury. However, assessment of earlier and later time 
points would display a more complete comprehension of the changes 
following injury. In particular establishing whether the changes observed at 3 
months persist to 6 or 12 months will be important to determine the likely long-
term impact of the changes observed. 
Analysis of the cellular influx into the wound bed would be helpful to establish the 
dispersion of innate cells. Furthermore, functional studies to assess cytokine 
production of the innate cells at the wound site would also facilitate clarification 
source of the systemic cytokine profile observed. However this work was out of the 
scope of this research project.  
Functional studies of the dendritic cells were not performed in this study. In the 
context of microbial or malignant challenge this data would give a better insight as 
to how aetiology of injury alters cellular function of the immune response rather 
than cellular and cytokine profiling alone. 
Wound size at the different time points post injury was not measured. This 
information would have been helpful with the analysis as well as determine time to 
healing and the impact the immune response has on this. From our observation, 
all wounds healed between day 14 – 28. The wound sizes at day 1 were equal 
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and all wounds were healed by day 84, thus the data from these time points are 
reflective of the same wound/scar and differences in the immune responses are 
still observed. In order to quantify the impact of wound healing in the two models 
and correlate this with the immune system, growth factor analysis would also need 
to be considered.  
4.11: Future Work 
Future work would include the addition of extended time points for data 
collection, including prior to day 1 and post day 84 at up to 12 months post 
injury. Previous literature has observed earlier cytokine changes following 
injury which may have been missed in this study [124]. Furthermore, the data 
collection could be extended to beyond day 84 to assess the chronic 
implications following burn injury, which may facilitate explanation of the 
increased incidence of malignancy following burn injury [5]. 
To assess current clinical practice in full thickness burn injury, the addition of a 
further group to assess the impact of excision of the burn eschar. Since the 
completion of this thesis this work has been completed and published 
( Appendix E [229]). This data demonstrated that changes following burn 
injury can be reduced or eliminated with early excision of the burn, thus 
potentially reducing some of the clinically recognised morbidity associate with 
burn injury [5, 7].  
Increased malignancy is seen in ageing, where changes to the functioning of the 
immune system also occur, known as immune-senescence [230, 231]. Ageing is 
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associated with reduced DC antigen uptake and migration, and a reduced level of 
circulating DC that leads to diminished naïve T cell activation. CD4+ T cell function 
also declines with age, where Tregs increase, thus contributing to CD4+ and CD8+ 
T cell immunosuppression. Aged mice also have elevated levels of IL-10 which 
had been associated with cancer development as this modulatory cytokine may 
prime Treg cells and/or dampen immune responses [231]. It is therefore possible 
that burn injury prematurely ages the immune system, as in similarity to some of 
the aging studies this data showed a down-regulation of DC and T cell responses 
in addition to elevated IL-10 at the latest time point [5]. To assess this, functional 
studies would be beneficial to establish changes in the dendritic and T cells in 
response to the different aetiologies of injury. 
Finally, to establish the similarity between murine and human pathology, a clinical 
study will need to be conducted to assess immune system function in burn 
injury survivors to determine the proportion of T cells, B cells and DC subsets 
and their activation levels in peripheral blood mononuclear cells.  
4.12: Conclusion 
Severe burns have a profound hyper-inflammatory response followed by 
immunocompromise. Recent research has shown that even in non-severe 
burn injuries there are long term sequelae including increased risk of 
malignancy, infection, gastrointestinal and cardiovascular disease supporting 
that immunological changes observed in this study occur in humans and are 
sustained [5].  
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The literature suggests that burn and non-burn injury have similar 
immunological trends; however burn injury shows some key differences. Here, 
it has been shown that the immune response to different cutaneous injury 
(burn and excision) differs in the temporal cytokine response resulting in 
promotion of monocyte to macrophage differentiation in burn injury with 
subsequent alteration to the dendritic and T cell response. Despite the size of 
the injury model used, changes were still observed long after healing, 
suggesting alteration to the immune system post injury. 
Understanding the immune response to cutaneous injury is essential to 
understand the drivers of clinical outcome and assess consequence to 
surgical procedures in addition to injury. At present there is still need for 
further work in this area to generate the evidence necessary to tailor the 
clinical management, reduce patient morbidity and improve patient outcomes. 
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Flow Diagram/s Section 13A  
Monitoring Sheets  
Glossary of Terms  
 
 
1. SPONSORS - SOURCE OF FUND AND STATUS OF OUTCOME 
Source of Funding: Fiona Wood Foundation 
ID Number (if approved): N/A 
Approved?  Pending [ ] Yes [X]  No [ ]   
OTHER APPROVAL (if applicable) 
Does this project involve more than one AEC?  Yes [] No [ X] 
If Yes, an Inter-Institutional Agreement is required. Please arrange this with the Animal Ethics Office, complete 
the following details and attach a copy of the approved application. 
Name of the Institution and approval number and the Outcome: 
     Approved [ ] Not Approved [ ]  Under consideration [ ] 
  
PREVIOUS APPROVAL (if applicable) 
Protocol title: 
AEC Approval no: 
Unexpected deaths or adverse events:  
Please attach list of publications arising: 
 
 
2. CHIEF INVESTIGATOR 
Title, first name, middle, last name 
A/Prof Mark Fear 
Staff number (UWA) 
00058472 
Qualifications: PhD 
Work mailing address /school (include UWA MBDP): M318, Burn Injury Research Unit 
 
Email: mark@mccomb.org.au Phone:6488 8133 Mobile: 0411 355944 
Please detail the relevant experience you have (including the number of years) in the 
procedures/techniques to be used in this project. 
I have previously conducted burn procedures in mice, rat and pigs. I have also previously 
conducted rodent studies on dermal templates using the excision model that will be the basis of the 
experiments proposed in this application. 
Over the past six years I have been chief investigator on several projects involving burn injury and 
wound repair, and have experience of monitoring wounded animals, with both burn injury and 
excisional skin injury. I have been responsible for anesthesia, analgesia, euthanasia and monitoring 
of animals in these previous projects, which have resulted in published papers (selection of papers 
involving the rodent model are listed below) 
I am currently Chief Investigator on ongoing projects related to burn injury using rodent models 
(RA3/100/1032, RA3/100/899, RA3/100/951). 
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1. Morellini NM, Fear MW, Rea S, West AK, Wood FM, Dunlop SA. Burn injury has a systemic effect 
on reinnervation of skin and restoration of nociceptive function. Wound Repair Regen. 2012 May-
Jun;20(3):367-77.  
2. Anderson JR, Zorbas JS, Phillips JK, Harrison JL, Dawson LF, Bolt SE, Rea SM, Klatte JE, Paus R, 
Zhu B, Giles NL, Drummond PD, Wood FM, Fear MW. Systemic decreases in cutaneous innervation 
after burn injury. J Invest Dermatol. 2010 Jul;130(7):1948-51.  
3. Morellini NM, Giles NL, Rea S, Adcroft KF, Falder S, King CE, Dunlop SA, Beazley LD, West AK, 
Wood FM, Fear MW. Exogenous metallothionein-IIA promotes accelerated healing after a burn 
wound. Wound Repair Regen. 2008 Sep-Oct;16(5):682-90. 
 
 
Animal Competency and Experience  AEO checked  
Have you obtained UWA Permission to Use Animals (PUA) within the last 5 years?  Yes [X] No [ ] 
 
Please note: All personnel named on the protocol must apply for a PUA.  
 
If No, Please download a PUA form available from our website and attach to this application.   
http://www.research.uwa.edu.au/staff/forms  
 PUA application attached [  ] 
 
 
3. CO-INVESTIGATOR/S (copy and paste additional tables as required for each co- investigator) 
Title, first name, middle, last name 
Professor Suzanne Rea 
Staff /Student number (UWA) 
 
Qualifications: 
MBBS, FRACS 
Work mailing address /school(include UWA MBDP): M318, Burn Injury Research Unit 
 
Email: Suzanne.rea@health.wa.gov.au Phone: 9202 1145 Mobile: 0413 827186 
What is your Role in this project? 
Prof Rea is a Burns consultant with the Burns Service,WA. Prof Rea will conduct and/or monitor the 
surgical procedures (excisional and burn injury) and also assist with monitoring post-injury.  
 
Please detail the relevant experience you have (including the number of years) in the 
procedures/techniques to be used in this project. 
Prof Rea has worked together with the CI for the last 5 years on burn injury related projects on 
mouse, rat and pig models of injury. She has previously conducted the excisional injury model 
together with the CI on this proposal to investigate a novel dermal template for stability in vivo. Prof 
Rea has also been responsible, together with the CI, for anesthesia and euthanasia using the 
established protocols described here in the previous research. Prof Rea is a co-author on all papers 
listed above from recent rodent injury model research projects. 
 
Animal Competency and Experience  AEO checked 
Have you obtained UWA Permission to Use Animals (PUA) within the last 5 years?  Yes [X ] No [ ] 
 
Please note: All personnel named on the protocol must apply for a PUA.  
 
If No, Please download a PUA form available from our website and attach to this application.   
http://www.research.uwa.edu.au/staff/forms  
 PUA application attached [  ] 
3. CO-INVESTIGATOR/S(copy and 
paste additional tables as required for each co- investigator) 
Title, first name, middle, last name 
Emily O Halloran 
Staff /Student number (UWA) 
 
Qualifications: MBBS 
Work mailing address /school(include UWA MBDP): M318, Burn Injury Research Unit 
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Email: ohalloranemily@gmail.com Phone: 6488 8587 Mobile: 0424433839 
What is your Role in this project? 
 
Dr O Halloran is currently studying for her Masters of Surgery within our group and has been a key 
person working on the project RA3/100/1032 (impact of non-severe burn injury on skeletal muscle 
and role of the inflammatory response). Dr O Halloran is now very competent with mouse handling 
and monitoring techniques. Dr O Halloran will contribute to supervising Samantha Valvis with 
monitoring and euthanasia of the animals together with the CI Fear. 
Please detail the relevant experience you have (including the number of years) in the 
procedures/techniques to be used in this project. 
 
Dr O Halloran has completed the PAWES course and spent the past 8 months working on a project 
involving non-severe burn injury and the impact on skeletal muscle using the mouse animal model 
that will be used for this project. During this time she has gained considerable experience with the 
mouse model of skin injury and with monitoring the animals under the supervision of A/Prof Fear and 
Prof Rea, and she is now very competent with handling and monitoring animals with the types of 
protocols involved here. 
 
Animal Competency and Experience  AEO checked 
Have you obtained UWA Permission to Use Animals (PUA) within the last 5 years?  Yes [X] No [ ] 
 
Please note: All personnel named on the protocol must apply for a PUA.  
 
If No, Please download a PUA form available from our website and attach to this application.   
http://www.research.uwa.edu.au/staff/forms  
  
NB- PUA will be applied for on arrival and completion of PAWES course PUA application attached [  ] 
 
3. CO-INVESTIGATOR/S (copy and paste additional tables as required for each co- 
investigator) 
Title, first name, middle, last name 
Samantha Valvis 
Staff /Student number (UWA) 
 
Qualifications: MBBS 
Work mailing address /school(include UWA MBDP): M318, Burn Injury Research Unit 
 
Email: samantha_valvis@hotmail.com Phone: 6488 8597 Mobile:  
What is your Role in this project? 
 
Dr Valvis is currently a core surgical trainee who will be undertaking a Masters in Surgery as a 
research project within our team. Dr Valvis will be involved in assisting with the surgical procedures 
(together with Prof Rea) and in monitoring animals. Dr Valvis will join the group in August 2012 and is 
registered for the PAWES course. After this she will apply for permission to use animals (PUA).  Her role 
will also be in the analysis of samples collected after euthanasia of the animals. 
 
Please detail the relevant experience you have (including the number of years) in the 
procedures/techniques to be used in this project. 
 
Dr Valvis has no prior animal experience. However, she will complete the PAWES course and 
subsequently be supervised closely by CI Fear and CO-I Rea until she is demonstrably competent 
with monitoring and relevant procedures. The AEC will be notified once the CI deems that Dr Valvis 
is competent to conduct the experiments with limited supervision. No burn injury or excisional 
procedures will be carried out by Dr Valvis alone without either Prof Rea or A/Prof Fear assisting and 
supervising.  
 
Animal Competency and Experience  AEO checked 
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Have you obtained UWA Permission to Use Animals (PUA) within the last 5 years?  Yes [] No [ X] 
 
Please note: All personnel named on the protocol must apply for a PUA.  
 
If No, Please download a PUA form available from our website and attach to this application.   
http://www.research.uwa.edu.au/staff/forms  
  
NB- PUA will be applied for on arrival and completion of PAWES course PUA application attached [  ] 
4. EMERGENCY CONTACT PERSONNEL - DURING STUDY 
Name: Mark Fear, Emily O Halloran, Samantha Valvis (all details on monitoring sheets) 
What is their role in this project? Chief Investigator 
Email: mark@mccomb.org.au Phone: 6488 8133 Mobile: 0411 355944 
After hours/emergency contact number:0411 355944 
 
 
5. ANIMAL MONITOR - DURING STUDY - ANAESTHESIA, SURGERY & POST- OP RECOVERY PERIOD 
Name: Mark Fear, Emily O Halloran and Samantha Valvis 
Details of their relevant experience: A/Prof Fear has 6 years of experience with animal monitoring 
after skin injury. Dr Valvis will be a new student working on this project and will be closely supervised 
and assisted with monitoring by A/Prof Fear until deemed competent. 
Email: mark@mccomb.org.au Phone: 6488 8133 Mobile: 0411 355944 
After hours/emergency contact number: 0411 355 944 
 
 
6. PERSONNEL RESPONSIBLE FOR EUTHANASIA 
Name: Mark Fear, Emily O Halloran and Samantha Valvis 
Details of their relevant experience: As described above, A/Prof Fear has 6 years of experience with 
skin injury experiments in rodent models and the subsequent euthanasia and tissue collection 
procedures. Dr Valvis will be a new student working on this project and will be closely supervised 
and assisted with monitoring by A/Prof Fear and Emily until deemed competent. The animals are 
euthanased by lethal injection of pentobarbitone (IP) and this has been done for many animals 
previously (and is current procedure for approved related protocols). A/Prof Fear will be the person 
responsible for ensuring Samantha is adequately supervised until competent to carry out any 
procedures. 
Email: mark@mccomb.org.au Phone: 6488 8133 Mobile: 0411 355944 
After hours/emergency contact number:0411 355 944 
 
 
7. REVIEWER – INDEPENDENT EXTERNAL (non UWA staff)  
 Please note this person may be asked to review aspects of this application 
Title and name: Zee Upton 
Position /Business address / contact details: Assistant Dean (Research), Head of Tissue Repair and 
Regeneration Facility, Queensland University of Technology 
Email: z.upton@qut.edu.au Phone: 07 3138 9639  Mobile:  
 
 
8. OVERVIEW AND GENERAL AIM OF THE PROJECT 
Must be written in lay language (i.e. as if it was a press release) and must not exceed one A4 page. 
 
Burn injury causes a large immune response from the body. In particular, there is a lot of 
inflammation associated with burn injury. However, it is also thought that burn injury can cause 
suppression of the later immune response (the adaptive immune response), leading to susceptibility 
to infection. 
One key question is whether burn injury causes the same response as any other type of trauma, 
either to the skin or to other organs (such as in a road accident), or whether burn injury, because of 
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the type of damage to the skin, actually causes different changes in the body’s response to other 
injuries.  
From a clinical perspective, the currently used Injury Severity Score (ISS), which is used for trauma as 
a tool to help predict outcome, is thought to underestimate the impact of a burn injury. But whether 
this is because burn has unique impacts with the immune system, or is just due to the scoring system 
used, is not clear. 
It would be very useful for the accurate assessment of burn injury (and therefore to guide treatment 
options, which is critical to outcome for the patients) to understand whether burn injury causes 
different responses in the immune system than other injury types, or it causes the same response 
which is dependent on solely on the extent of injury. It is also necessary to further clarify whether 
burn injury really does suppress the longer term immune response, and if so how this occurs, as burn 
patients can often be susceptible to infection and this has significant consequences both for 
treatment and scar outcomes. 
This project will use the mouse model of burn injury, and also excisional injury (surgical skin removal) 
to look at whether injuries of the same extent BUT DIFFERENT ETIOLOGY (Surgical trauma or burn) to 
the skin cause the same or different immune responses. We will monitor the short term inflammatory 
response and also the longer term response (looking at cells at the injury site and in lymph nodes). 
We will also look at the response to the injury site as well as systemic (serum) changes. This data will 
be important in our design of studies in patients, as we can tightly control the injury size and monitor 
the immune response much more closely (for example using lymph node tissue samples as well as 
injury site tissue samples) using the mouse model than we can in patients.  
The outcome of this project will be that we can clearly understand the impact on the immune 
system of a burn injury compared to other types of trauma. This will be important in guiding 
clinicians’ assessment of burn injury severity and therefore how best to treat them. Also - currently, 
the use of the ISS score to assess burn injury severity and guide treatment does not appear to work 
well. This project will help to explain why. 
Finally, a clear understanding of the interaction between the immune system and a burn injury will 
be important in developing new treatments that limit systemic problems associated with burn injury. 
 
 
 
 
9. ANIMAL SUMMARY (add additional lines as required) 
Species scientific  
& Common name  
 
ONE SPECIES PER LINE 
Strain NHMRC  
Animal 
Species  
Code 
Dietary 
Modifications 
 
Yes/No 
Total 
 number required 
(over the life of the 
project) 
Vendor / Source  
 
(ARC/Jackson labs/ 
Wandalup/Murdoch) 
1.  Mouse C57BL/6  No 140 ARC 
2.        
3.        
4.        
 
Justification of Number of Animals Requested (ie number in each experimental group) 
This project will require 140 animals in total. This will provide n=10 for each group at each time point -
excision injury at day 1, day3, day7, day14, day28 and day84 (n=60 total) and burn injury at day 1, 
day3, day7, day14, day28 and day84 (n=60 total). There will also be a group of 10 baseline controls. 
Finally, there is an additional 10 animals requested in the ethics to provide for any potential post-
euthanasia sample or data loss. The analysis post-euthanasia will involve Flow cytometry, lymph 
node isolation and cell culture, wound tissue removal and serum collection. This provides a number 
of steps at which experimental errors may be encountered, so the additional 10 animals will be used 
if required due to problems with any individual samples. 
  
The numbers requested are based on our own experience of analysing the inflammatory response 
after skin injury. We have substantial preliminary data that demonstrates with the group size 
requested differences between the inflammatory response (as assayed by cytokine levels and cell 
counting) and the adaptive immune response (through lymph node cell isolation and flow 
cytometry) of clinical significance can be detected. These numbers will provide the ability to detect 
a difference (at p<0.05) in the extent of inflammation (level of response) of 10% between excisional 
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and burn injury. This is similar for other aspects of the immune response. Overall profiles of cytokines 
and cellular responses will be detected at much greater levels of sensitivity.  
NOTE – this is a greater level of sensitivity than for some previous experiments as this is to better 
understand the normal progression of two injury types, and it is expected the differences observed 
may be smaller than with our studies looking at wound healing intervention. 
If any experimental group size is less than 10, have you provided statistical justification or an 
example of an informative study of this type that used a similarly small sample size?  
Not applicable 
 
If your experimental group size varies across groups, have you provided justification for this 
variation? 
Not applicable 
 
Has a biostatistician been consulted? Yes [] No [X ] 
If Yes, please provide contact details below. 
Research Assistant Professor Hilary Wallace provides statistical support within the Burn Injury Research 
Unit. Dr Wallace has extensive statistical experience and knowledge in experimental design. 
 
 
 
 
DOES THE PROTOCOL INVOLVE ANY OF THE FOLLOWING?  Yes [ ] No [X] 
If Yes, please complete the details below 
 Species Strain Total number 
required 
Creation of hybridoma    
In vivo (ascites) production of monoclonal 
antibodies 
   
Genetically modified mice    
Other genetically modified animals    
Transplantation    
 autograft    
 allograft    
 xenograft    
 - cells    
 - tissue    
 - organs    
 
 
10. HOUSING AND LOCATION OF ANIMALS (SIGNATURES REQUIRED) 
UWA: (ACVS) OTHER UWA Facilities:  
 - QEII: M Block  - Fremantle Hospital – Z Block 
 - Shenton Park: BRF, NAF, SRF - Allandale Farm / Ridgefield Farm 
 - Crawley Campus: PCF, LAF - Animal Biology   
 - Royal Perth Hospital 
Facility  room 
number/ zone 
Species  
(and/or strain if 
applicable) 
Gender 
 
Age or 
initial 
weight 
Reproductive 
status 
Manager UWA (ACVS) Facilities / 
Curator Other UWA Facilities  
 
Signature and Date 
PCF Mouse 
C57BL/6J 
 F 9 weeks Non-
pregnant 
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* Locations not covered by a scientific licence require a Notification to the Department of 
Agriculture and Food, Government Western Australia.  The Proforma to be attached to this 
application is available from the website at http://www.research.uwa.edu.au/staff/forms/animals 
A. WHAT IS THE MAXIMUM LENGTH OF HOLDING IN WEEKS? 
13 weeks 
 
B. WHAT ADDITIONAL ENRICHMENT WILL BE PROVIDED FOR ANIMALS WHICH WILL BE HELD LONGER THAN 3 MONTHS? 
No animals will be held for LONGER than 3 months. However, 20 animals will be held for 13 
weeks (3 months duration). All animals, even those only held for a short duration, will be 
provided with additional enrichment. Enrichment materials will include soft paper tissue, coarse 
paper tissue, cotton nestlets, a wood gnawing block and a handful of rodent pellets in the 
cage for foraging. In addition, cardboard rolls (tunnels) will be provided. These types of 
enrichment will be alternated and/or mixed over time (changed weekly) to provide a more 
stimulating environment, which reduces anxiety. 
 
C. PLEASE DETAIL THE METHOD OF TRANSPORT AND ANY ANIMAL WELFARE IMPLICATIONS: 
Animals will not be transported after delivery to PCF by ARC. Animals will undergo surgery and 
euthanasia in PCF. 
[ ] I have attached copies of any necessary transport and acquisition permits/approvals. 
 
 
11. SAFETY AND HEALTH RISKS 
Does project involve use of: 
 
Y/N 
Approval 
Y/N/ 
Pending 
If YES, explain risks 
involved 
Precautions to protect staff 
and/or animals 
Teratogens or carcinogens N    
S7, 8 ,9 drugs  
(a copy of the permit will be required) 
Y  S8 drug used is 
buprenorphine which is 
used as an analgesic 
post-injury. The 
concentrations and 
quantities required for 
rodent work provide 
minimal risk since it is S8 
drug due to potential 
for abuse. 
S8 drugs are kept in a safe 
within PCF surgery and use 
of burprenorphine 
monitored and logged in 
accordance with 
requirements. 
Radioisotopes or x-rays N    
Other potentially infectious or 
hazardous (chemical/physical / 
biological) agents which may 
pose a health risk to staff or 
animals 
N    
IDENTIFY POTENTIAL RISKS TO STAFF AND HOW THEY WILL BE MANAGED AND MINIMISED 
We believe there are minimal risks for staff other than the possibility of bites and/or scratches from 
animal handling and needle stick injuries that could possibly occur during the administration of 
analgesic. All staff and students are trained in proper handling of hypodermic needles and animal 
restraint, and all investigators have extensive experience and have completed the PAWES course ( 
or potential students will undergo PAWES course, training and monitoring as required). If injury 
occurs, individuals will be directed to obtain a tetanus injection. 
 
[  ] I have attached a Risk Assessment  
 
 
12. GENE TECHNOLOGY / BIOLOGICAL SAFETY 
A. PLEASE PROVIDE DETAILS OF ANY BIOLOGICAL SAFETY CONCERNS TO STAFF, AND HOW THEY WILL BE MANAGED 
 
N/A 
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B. ARE YOU DEALING WITH GENETICALLY MODIFIED ORGANISMS? Yes [ ]  No [N ] 
 If Yes, please provide details of phenotypic expression. 
 
 
 
 
 [ ] Established Phenotype report attached? 
 
 [ ] I have attached copies of required permits/approvals. 
Dealing Type: EXEMPT DEALING[ ] NLRD [ ] DNIR [ ] DIR [ ] 
Exempt Dealings - Requires IBC assessment  
Notifiable Low Risk Dealings (NLRD) - requires IBC assessment and notification to OGTR  
Dealings Not involving an Intentional Release of a GMO into the Environment (DNIR) - Requires IBC Assessment & application to OGTR for a licence.  
Dealings involving an Intentional Release of a GMO into the Environment (DIR) - Requires IBC Assessment and application to OGTR for a licence.  
IBC Approval Number: 
(if approved) 
Approval Status:  Pending [ ] Yes [ ]  No [ ]  
IF USING GMOS, HAVE ALL INVESTIGATORS UNDERTAKEN THE (COMPULSORY) GENE TECHNOLOGY REGULATION TRAINING 
COURSE? Enrolled [ ] Yes [ ] NO [ ] 
If NO, or Enrolled, please specify which investigator/s have not completed the course: 
 
 
 
 
[ ]AQIS Permit is attached (please supply 1 photocopy) 
[ ] I have attached copies of all required permit/approvals. 
 
 
13. EXPERIMENTAL PROPOSAL – Cost Benefit Analysis 
A. FLOW DIAGRAM OUTLINING THE PROJECT AND THE PROCEDURES – Can be attached as separate 
sheet/s.  Must include a time line and list of procedures to clearly illustrate what will happen to 
each group of animals from acquisition to disposal. 
 
Day -7 – animals arrive at PCF (n=140) 
7 days acclimatization 
 
Day 0 – Control animals are euthanized (n=10) – normal skin, serum and inguinal lymph nodes 
collected for analysis 
 
Day 0 – 60 animals receive 19 mm diameter full-thickness skin excision under anesthesia. Wound is 
dressed using 3M Tegaderm absorbent clear acrylic dressing, a transparent sterile dressing 
commonly used for burn and surgical wound covering in patients. Animals are allowed to recover 
with buprenorphine analgesia. Paracetamol added to drinking water for 5 days post-injury 
 
Day 0 - 60 animals receive 19 mm diameter full-thickness burn injury under anesthesia. Wound is 
dressed using 3M Tegaderm absorbent clear acrylic dressing, a transparent sterile dressing 
commonly used for burn and surgical wound covering in patients. Animals are allowed to recover 
with buprenorphine analgesia. Paracetamol added to drinking water for 5 days post-injury 
 
Full thickness excisional injury is created using a skin punch biopsy to mark the skin for excision and 
then the skin is removed using surgical scissors by a plastic surgeon (Prof Rea). This creates an 
accurate reproducible injury size. 
 
The full-thickness burn injury is created using a brass rod of 19mm diameter heated to 95 C and 
applied to the skin for 10 seconds (as per the current approved protocol for RA3/100/899, 
RA3/100/1032 and RA3/100/951). 
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Day 1 – 10 excision and 10 burn injured animals euthanized (n=20 total). Serum, wound and normal 
skin samples and inguinal lymph nodes collected for analysis 
 
Day 3 – 10 excision and 10 burn injured animals euthanized (n=20 total). Serum, wound and normal 
skin samples and inguinal lymph nodes collected for analysis 
 
Day 7 – 10 excision and 10 burn injured animals euthanized (n=20 total). Serum, wound and normal 
skin samples and inguinal lymph nodes collected for analysis 
 
Day 14 – 10 excision and 10 burn injured animals euthanized (n=20 total). Serum, wound and 
normal skin samples and inguinal lymph nodes collected for analysis  
 
Day 28 - 10 excision and 10 burn injured animals euthanized (n=20 total). Serum, wound and normal 
skin samples and inguinal lymph nodes collected for analysis 
 
Day 84 - 10 excision and 10 burn injured animals euthanized (n=20 total). Serum, wound and normal 
skin samples and inguinal lymph nodes collected for analysis 
[ ] Attached is a separate flow diagram 
B. THE “COST” OF THE RESEARCH TO THE ANIMALS – Please describe any potential harms, pain, 
distress, that may arise from the procedures being performed. 
NOTE: IF YOU STATE THAT THERE IS NO LIKELY WLEFARE IMPACT, THIS MUST BE FULLY SUPPORTED BY APPROPRIATE EVIDENCE. 
      If using genetically modified animals or mutant, please attach phenotype reports. 
As the animal is under general anaesthetic, it will not experience any pain during the surgical 
excisional or burn injury procedure. Whilst under anesthesia, the animals receive buprenorphine 
analgesic, which will minimise any pain on recovery. The 19mm diameter wound is full-thickness, 
and has the potential to cause pain to the animals. However, full-thickness injuries are known to be 
much less painful than partial thickness injuries in patients (a key sign of a full-thickness injury is the 
absence of reported pain). The use of buprenorphine analgesia at time of injury and 12 hours post-
injury, together with paracetamol in the water, has been adequate to prevent any observable 
signs of pain in the animals.  The excision procedure (of similar size) in humans is conducted under 
local anesthetic and no additional pain relief is required.  The use of full thickness excision, as with 
the use of a full-thickness burn model, is to minimize pain and distress to the animals by creating a 
wound that has minimal active innervation and nociception. The wound surface area is 3 cm2 in 
total area, which equates in the age and strain of mice being used (9 week old female C57BL6/J 
weighing 20-22g) to approximately 7% of the total body surface area. 
All animals will have a dressing placed over the wound and this will be attached using tissue glue. 
The tissue glue will be used to adhere the dressing more permanently, so the dressing will cover the 
wound and overlap normal tissue, which is where glue will be applied and dressing adhered to the 
animal. The wounds will be on the back of the mouse away from the limbs, and should not impede 
movement or cause discomfort as animals move.  
After the biopsy is taken, animals are provided with paracetamol in drinking water as an additional 
precaution against pain. This is unlikely to be required in the case of excisional injury, but will be 
provided for all animals. 
At time of analysis, animals will be anesthetised and euthanized, and therefore the ultimate cost to 
the animals is death. No additional pain will be experienced by the animals as all analysis will be 
done on euthanized animals.  
Animals will be extensively monitored for any sign of stress indicated by lack of grooming, eating 
and drinking, general alertness, responsiveness and abnormal behaviour. Signs of skin infection will 
also be monitored. 
 
C. POTENTIAL “BENEFITS” OF THE RESEARCH – to humans, animals, or the environment.  
The potential benefits of this research are primarily for people that suffer skin injury, either through 
burn or other injury, and in particular those patients that do not heal well and therefore often need 
surgical procedures to try to improve the scar outcome. 
This work will add to our understanding of how the body’s immune system responds to burn injury 
and other skin trauma and how this differs between the two injury types. This will provide information 
on how best to change or moderate the immune response in these different injury types, and 
improve our understanding of the interaction between skin trauma and the individual. This 
information will be useful to design patient centred studies in the short term, and also in the design of 
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new tools to predict the severity of a burn injury similar to the widely used Injury Severity Score (ISS), 
which does not seem to work well for burn injury.  
 
 
14. ADDRESSING THE THREE R’S – ALL 3 SECTIONS MUST BE COMPLETED.  
If Genetically modified animals are to be used also provide justification for the strain  
A. REPLACEMENT – describe the alternatives to animal use that you have considered and/or 
adopted. See the Australian Code of Practice Section 1.8 
The healing of injuries involves a cascade of complex processes leading to the formation of new 
tissue. In vitro models are useful for isolating specific events or mechanisms of the process of 
wound healing, but fall short in modeling the complex in vivo situation during wound healing, 
where inflammation, nerve regrowth, revascularization and many other processes are all 
intertwined to repair the damage. Since this project is aimed at understanding the effect of skin 
trauma on the immune response, the animal model is necessary so that all the different factors 
which underlie changes associated with wound healing are active. In particular, to examine 
systemic and localized inflammation to the injury site requires the use of an animal model.   
B. REDUCTION – describe the ways that you propose to minimise the use of animals.  
See the Australian Code of Practice Section 1.9 – 1.13 
This study will analyse changes in the lymph nodes (inguinal, as the most proximal to the injury site), 
the wound site, normal uninjured skin and in the circulation (serum sampling). By conducting all 
these different analyses on each animal we can minimize the numbers required and also increase 
the power of the experiment by having matched data of all aspects of the immune response from 
each individual animal. Because this increases the complexity of the post-euthanasia experimental 
procedures, an additional 10 mice are requested to provide for potential sample loss or 
experimental problems. However, the intensive analysis means we do not need separate groups of 
animals to assess the cellular response, or the serum cytokines, or the wound changes, and so by 
analysing all aspects in each animal we substantially reduce the animal numbers required.  
The group numbers have been chosen to provide significance at a level that we believe is 
clinically relevant, rather than large group numbers that will identify even very small changes in the 
immune response which would not be important in terms of clinical and translational impact.  
Therefore the numbers have been reduced to the minimum required to progress this research and 
answer the proposed questions. 
C. REFINEMENT – Also complete the tables at Section 15 & 16. 
Step-by-step description of procedures. What will happen to animals and their tissues identifying 
the actions taken at each step to minimise suffering and distress 
See the Australia Code of Practice Section 1.14 – 1.28.  
Animal Welfare and Veterinary Advisors will be invited to observe initial surgeries and recovery of 
animals. The Animal Welfare Officer (AWO) and veterinary advisors have attended previous 
experiments involving both excisional injury (RA3/100/1067) and the burn injury (RA3/100/1032). As 
part of this process, the analgesia was changed to include a second burprenorphine injection at 12 
hours post-injury, as some animals exhibited signs of distress within this time period. Subsequently, 
with the addition of the 12 hour buprenorphine injection, recovery seems better and continued 
monitoring suggests this is a good analgesic regime for the injury types included here. 
As part of our refinements and in consultation with the AWO we have also investigated the use of 
carprofen, but this did not provide good analgesia and the optimal protocol is as included here. 
We also cannot use carprofen in the types of experiment detailed here as we are investigating the 
immune response which will be altered by the use of NSAID type analgesia. 
The technician in charge will also be requested to provide observations on animal behaviour and 
responses to treatment. Continual monitoring will allow refinements for this type of injury to be 
proposed and developed as part of a continual process to improve the research outcomes and 
the animal welfare in our experiments. 
The use of a transparent wound dressing allows close monitoring of the wound and potential 
infection status without interference in the wound healing process or unnecessary dressing 
changes. This reduces the impact on the animals of unnecessary handling.  
 
 
 
15. NON SURGICAL PROCEDURES 
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FULL DESCRIPTION OF ALL NON SURGICAL PROCEDURES.          Please also include details in the table below. 
 If substances are being administered to animals please include details of route, volumes, frequency, 
intervals and duration. 
Two non-surgical procedures are used – intramuscular injection of buprenorphine (for analgesia) 
and intraperitoneal injection of pentobarbitone for euthanasia. 
 
1. Buprenorphine injection-intramuscular injection using insulin syringe in the shoulder. Initial 
injection is given while animal is under anesthesia and therefore has no impact on the 
animal at the time. 
2. Second injection of burprenorphine at 12 hours post-injury animal is not under anesthesia 
and therefore animal is restrained briefly for im injection. 
3. IP injection of pentobarbitone requires restraint.  
 
All investigators have experience of animal handling and restraint for these injections (Samantha 
Valvis will be supervised and trained). 
 
Note: Only the title of the procedure should be listed in column one of table.  Full details of the procedures must 
be completed in the relevant space below each table. 
Type of non surgical 
procedure to be carried out 
Expected  impacts  of the 
procedure 
Expected frequency of 
adverse impacts 
Refinement taken to 
minimise impacts 
e.g. gavage Minor discomfort  
rarely substance enters 
airway or oesophagus is 
damaged 
Some discomfort on each 
occasion. Substance in 
airway or oesophageal 
damage in less than 1 in 
1000 administrations. 
Good handling to 
minimise discomfort and 
observation after dosing 
with humane killing of 
any animal showing 
signs of mis-dosing or 
damage. 
Analgesia – injection of 
buprenorphine im at time 
of injury 
None – animals under 
anesthesia at time of 
injection 
  
Analgesia – injection of 
buprenorphine im 12 
hours post-injury 
Minor discomfort from always  
Euthanasia – ip injection 
of pentobarbitone 
Minor discomfort from 
handling of animals 
and injection (and 
ultimately death of 
animal) 
always  
Which investigator as detailed in Section 3 or 4 will perform these procedures?   
 
A/Prof Mark Fear, Prof Suzanne Rea, Emily O Halloran and Samantha Valvis will conduct analgesia 
injections. Only A/Prof Fear, Emily and Samantha will conduct IP injections for euthanasia. 
 
 
 
16. SURGICAL PROCEDURES 
A. FULL DESCRIPTION OF ALL SURGICAL PROCEDURES.    Please also include details in the tables below. 
Methods 
Full thickness surgical excisional wound injury  
Mice aged 9 weeks will be obtained and given 7 days to acclimatise to handling and the PCF 
environment. On the day of surgery, they will be given a general anaesthesia using isoflurane 
administered by anaesthetic chamber and then maintained by face-mask. The surgery will be 
conducted in the small animal surgery room in PCF zone B. Prior to surgery, the surgeon will be 
wearing sterile gloves for the procedure duration. The equipment used is all single use sterile 
equipment except for clippers used to shave the animal which are washed in 80% Ethanol prior to 
use. 
Whilst under anaesthesia, the mouse will have the area to be wounded shaved and cleaned with 
Betadine. A sterile single use 19mm punch biopsy will be used to create an incision on the back of 
the mouse. The outline will then be removed by the surgeon using surgical scissors. The wound will 
 C:\Users\svalvis\Desktop\MD Project\Appendix\Animal Ethics Application.docx Updated May 2012 
13 
be on the back, away from all limbs, and on one side of the animals away from the spine.  The 
wound will be covered with Tegaderm using tissue adhesive to maintain in place. All animals will 
receive analgesia (buprenorphine 0.1 mg/kg intramuscular) immediately prior to surgery whilst 
under anesthesia with an additional injection of buprenorphine (0.1 mg/kg intramuscular) at 12 
hours post-surgery, with oral paracetamol for the 5-day post-surgery period (in drinking water 
1mg/ml).  
 
Full thickness burn injury  
Mice aged 9 weeks will be obtained and given 3 days to acclimatise to handling and the PCF 
environment. On the day of surgery, they will be given a general anaesthesia using isoflurane 
administered by anaesthetic chamber and then maintained by face-mask.  
Whilst under anesthetic, the mouse will have the area to be wounded shaved and cleaned with 
betadine. A 19mm diameter full-thickness burn injury will be created by an experienced burns 
surgeon (Prof Rea), using a brass rod heated to 95C in contact for 10 seconds. The wound will be 
on the back, away from all limbs, and on one side of the animals away from the spine.  The wound 
will be covered with Tegaderm using tissue adhesive to maintain in place. Animals will receive 
analgesia (buprenorphine 0.1 mg/kg intramuscular) immediately prior to burn injury whilst under 
anesthesia, with an additional injection of buprenorphine (0.1 mg/kg intramuscular) at 12 hours 
post-injury, with oral paracetamol for the 5-day post-surgery period (in drinking water 1mg/ml).  
 
ALL PROCEDURES 
Animals are recovered in the surgery in individual cages and are monitored until they are fully 
recovered from the anaesthesia. The procedure and duration of anaesthesia is less than 10 minutes 
in total, and the animals do not require a heatpad for surgery or warm recovery box, as recovery is 
very quick and normal ambient temperature is sufficient.  
Once recovered animals will be allowed feed and water ad libitum. At days 1, 3, 7, 14, 28 and 84 
post-surgery, animals will be euthanased and serum and tissue samples will be obtained.  
 
Analgesia protocol 
As stated above, we intend to use buprenorphine initially followed by oral paracetamol. Because 
the inflammatory response is critical to this investigation, we cannot use an anti-inflammatory type 
analgesic such as carprofen without substantially influencing the experimental results (we have 
also previously investigated the use of carprofen and this was not beneficial). From our experience, 
and currently approved protocols, we are confident the current analgesia provides good pain 
relief and minimizes discomfort for the animals. 
 
Monitoring 
Animals will be closely monitored (see attached sheets), and any animals that show signs of distress 
or infection will be euthanized. It should be noted that TEGADERM (the dressing to be used) is a 
transparent dressing that allows observation of the wound, and therefore monitoring for changes in 
colour or wound appearance to assess presence of localised infection is manageable. 
No prophylactic antibiotics will be used (as is standard clinical practice for burn patients), and they 
will not be used in the case of infection (which is an unlikely event not previously seen in our animal 
work) as the infection would have too large an impact on healing and inflammation and therefore 
impact on the data. However, as infection is an adverse event, the AWO and ACVS staff will be 
notified if infection does occur and the animal welfare implications and continuation of the 
procedures will be discussed. 
 
 
Type of surgical procedure 
to be carried out 
Expected  impacts  of the 
procedure 
Expected frequency of 
adverse impacts 
Refinement taken to 
minimise impacts 
e.g. insertion of catheter Pain Always Analgesia 
Induction of anesthesia Minor discomfort Always Optimised protocol 
Excisional injury Post-procedural pain always Appropriate 
analgesia 
Burn Injury Post-procedural pain always Appropriate 
analgesia 
Serum and tissue 
analysis 
Euthanasia always Careful handling and 
optimised protocol 
Which investigator as detailed in Section 3 or 4 will perform these procedures? 
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Prof Rea will perform surgical procedures listed above except for euthanasia will be A/Prof Mark 
Fear and Samantha Valvis 
 
B. ANAESTHETICS AND NEUROMUSCULAR BLOCKADE 
Species Agent (s) Dose Route Frequency Duration 
e.g. Rat  80 mg/kg 
 
Ip/ im Once only  Single injection  is sufficient for the 10 
minute procedure  
Mouse Isoflurane By 
induction 
Anesthetic 
chamber and 
mask 
Once only Maintained with face mask for 
duration of procedure 
Which investigator as detailed in Section 3 or 4 will perform these procedures? 
Prof Rea and A/Prof Fear will induce anesthesia. 
  
C. ANALGESICS - Analgesics to be used intra- and post-operatively 
Species Agent Dose Route Frequency & Duration 
e.g. Mouse buprenorphine 0.05-
0.1mg/kg 
Sub cut Initial dose given at induction of 
anaesthesia then continued every 
 8 hours for 3 days post-op 
Mouse Burprenorphine 0.1mg/kg intramuscular Initial dose at induction of 
anesthesia. Additional dose at 12 
hours post anesthesia. 
Mouse Paracetamol 1mg/ml  Drinking water Drinking water contains 1mg/ml for 5 
days post-surgery. Consumption per 
mouse approx. 20ml/day. 
Which investigator as detailed in Section 3 or 4 will perform these procedures? 
Prof Rea will administer buprenorphine at time of surgery. At 12 hours post-surgery, administration will 
be by A/Prof Fear and/or Samantha Valvis (once trained and competent). 
 
 
17. ANIMAL WELL-BEING 
A. POST-PROCEDURAL PAIN AND DISTRESS – How will pain and distress be monitored, scored and treated. 
All mice will be monitored continuously during anaesthesia and until fully recovered from 
anaesthesia.  To date, no mice have shown signs of distress in any experiments. Mice will be 
monitored for their behaviour, grooming and lack of activity. In previous experiments with the burn 
injury and excisional injury (eg RA3/100/899, or RA3/100/1067), mice have recovered and exhibit 
normal behaviour within minutes of recovery from the anaesthesia. No adverse events or unplanned 
euthanasia has been recorded as a result of the burn injury or excisional procedure to date. 
B. MONITORING SCHEDULE – provide a “Post-Procedural Monitoring Sheet” and /or “Long Term 
Monitoring Sheet” 
Monitoring sheets are attached. 
For the acute post-injury phase (5 days), animals are monitored twice daily, including weight of the 
animals and close monitoring of the wound site for signs of infection as well as hydration. After 5 
days post-injury, the wound healing is progressing and animals are monitored once per day until 14 
days post-injury, when wound will be completed healed and animal recovered from the 
surgery/injury procedure. For the period 5-14 days, wound site is still monitored as well as animal 
behaviour, but weight and hydration are no longer required as the animals are substantially 
recovered at this point. 
 
C. CRITERIA FOR EUTHANASIA - How will animals be assessed for euthanasia. 
If animals display a lack of activity or abnormal behaviour and signs of distress after the injury they 
will be euthanased. 
 
D. WHAT % OF ANIMALS DO YOU EXPECT TO DIE OR REQUIRE INTERVENTION EUTHANASIA DURING THIS PROJECT? 
 PLEASE EXPLAIN LIKELY REASONS FOR THE ANTICIPATED LOSS RATE. 
We expect that there will be less than 1% of animals requiring intervention euthanasia for this 
project. The anesthetic and surgical procedure does carry a level of risk, and this cannot be 
completely eliminated, but the protocols are well established and optimized and the team 
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involved very experienced, and we expect this to minimize any potential interventional euthanasia.  
 
Potential cause of 
death or euthanasia 
Impact on welfare   Steps taken to minimise impact Percentage of 
animals affected 
e.g. vessel rupture  irreversible haemorrhage haemorrhage apparent to surgeon, 
animal would be euthanased whilst still 
under general anaesthesia 
<1%  
Anesthesia  Death of animal under 
anesthesia – no 
additional impact 
Anesthesia protocol is optimised to 
minimize possibility of adverse 
reaction. 
<1% 
    
    
 
 
PLEASE NOTE THAT ALL UNEXPECTED /UNPLANNED DEATH/S MUST BE REPORTED PROMPTLY TO THE AEC. 
 
 
18. COMPLETION OF EXPERIMENT – Fate of the animals at the end of the experiment? 
Researchers are expected to share animal tissue where possible via Ethitex: www.ethitex.com.au 
To register please contact the Animal Ethics Office at aeo@admin.uwa.edu.au 
A. WHAT ARRANGEMENTS HAVE YOU USED TO SHARE TISSUE? 
Collaborators are made aware of any ongoing animal projects that may provide material for 
use after euthanasia for other projects, for example as a source of primary cells for culture. 
B. ARE ALL THE ANIMALS EUTHANASED AT THE END OF THE EXPERIMENT?  Yes [X] No [ ] 
If No, What is the fate of non-euthanased animals? 
 
 
 
If Yes, please complete the table below. 
METHOD OF EUTHANASIA – provide details of the generic constituents (not the trade name), the dose 
rate as mg/kg, and the route of administration. 
Species Agent Dose Route 
e.g. Rat  Pentobarbitone  >160mg/kg Intraperitoneal injection 
Mouse Pentobarbitone >160mg/kg Intraperitoneal injection 
    
    
C. DETAIL HOW DEATH WILL BE CONFIRMED: 
Lack of respiration for 2 minutes, permanent cessation of heartbeat, lack of reflexes 
D. METHOD OF DECONTAMINATION /DISPOSAL OF GMOS. 
N/A 
E. METHOD AND DETAILS OF CARCASS DISPOSAL 
Incineration 
 
 
   
CRICOS Provider Code: 00126G Updated May 2012 
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MONITORING SCHEDULE FOR MICE POST BURN AND/OR EXCISIONAL INJURY 
(up to 5 days) 
 
 
PROTOCOL NUMBER:  
 
CHIEF INVESTIGATOR:   MARK FEAR 
 
EMERGENCY CONTACTS:  Mark Fear    0411 355 944 
     Emily O Halloran  0424 433 839 
     Samantha Valvis  TBA 
     AWO    0428 021 529 
        
 
Objective: To monitor for signs of discomfort or infection post-injury 
 
Species    Mouse (C57BL/6) 
Procedure   Burn Injury 
  
DATE      
TIME AM PM AM PM AM PM AM PM AM PM 
Observations (Yes or No) YES YES YES YES YES YES YES YES YES YES 
Weight (actual, % loss)           
Active?           
Drinking/hydrated           
Normal gait/posture?           
Vocalization?           
Wound edges red?           
Swelling around injury site           
Exudate from injury site           
Pain score (1-4)           
Grooming           
Facial grimace           
Social behaviour           
OTHER (detail) 
 
 
          
Observers initials           
 
 
A score of 1 will result in additional monitoring of the affected animal to 3 times 
per day until score returns to 0 or increases (for euthanasia) 
 
A score of ≥ 2 will result in euthanasia 
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PAIN ASSESSMENT SCORING 
 
0 = normal behaviour and physiology 
1 = mild behaviour and physiological changes (decreased food/water consumption, slightly depressed, minor 
guarding of  incision site) 
2 = moderate pain (includes observation in group 1 plus swelling/redness/discharge at surgical site, 
reluctance to move, guarding with vocalization or aggression 
 
WEIGHT ASSESSMENT SCORING 
 
0 = Less than 5% weight loss 
1 =  Between 5%-10% weight loss 
2 =  >10% weight loss 
 
HYDRATION ASSESSMENT SCORING 
 
0= Skin instantly returns to normal after being pinched 
1= Skin slightly delayed in returning to normal 
2= Skin remains bunched after pinching and does not return to normal 
 
Water will be changed to normal water if score of 1.  
 
Signs of Infection - Exudate/swelling 
 
0 = no exudate/swelling 
1 = small amount of exudate/swelling infection unlikely 
2 = moderate exudate/swelling infection possible  
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MONITORING SCHEDULE FOR MICE POST BURN AND/OR EXCISIONAL INJURY (6 
to 14 days post-intervention) 
 
 
PROTOCOL NUMBER:  
 
CHIEF INVESTIGATOR:   MARK FEAR 
 
EMERGENCY CONTACTS:  Mark Fear    0411 355 944 
     Emily O Halloran  0424 433 839 
     Samantha Valvis  TBA 
     AWO    0428 021 529 
        
 
Objective: To monitor for signs of discomfort or infection post-injury 
 
Species    Mouse (C57BL/6) 
Procedure   Burn Injury 
  
DATE     
TIME Day 6 Day 7 Day 
8  
Day 9  Day 
10  
Day 
11 
Day 
12 
Day 
13 
Day 14 
 
Observations (Yes or 
No) 
YES YES YES YES YES YES YES YES YES 
Active?          
Normal gait/posture?          
Vocalization?          
Wound edges red?          
Swelling around injury 
site 
         
Exudate from injury 
site 
         
Pain score (1-4)          
Grooming          
Facial grimace          
Social behaviour          
OTHER (detail) 
 
 
         
Observers initials          
 
A score of 1 will result in additional monitoring of the affected animal to 3 times 
per day until score returns to 0 or increases (for euthanasia) 
 
A score of ≥ 2 will result in euthanasia 
 
 Dr Mark Fear
Surgery (School of)
MBDP: M318
 
Dear Doctor Fear
 
ANIMAL ETHICS RESEARCH APPLICATION - APPROVED 
 
Research Ethics and Biosafety Office
Research Services 
Phone: 
Fax: 
email: 
MBDP:
+61 8 6488 2516 / 3033 / 7887
+61 8 6488 8775
aeo@uwa.edu.au
M459 
Our Ref: RA/3/100/1155 25 September 2012 
Comparison of the effects of burn and non-burn skin trauma on the innate and adaptive immune response using a mouse 
model
On behalf of the Animal Ethics Committee (AEC), I am pleased to advise you that your modified application for the above research 
project has been approved from 01 October 2012 to 30 September 2015.
In approving this protocol, the AEC would like you to note the following items and conditions of approval:
l Your adherence to all provisions contained within the Australian Code of Practice for the Care and Use of Animals for 
Scientific Purposes (7th edition, 2004) 'the Code'.
l Submission of a satisfactory Annual Report and a State Government Animal Use Statistical Return to the AEC for each 
calender year (due each January).
l Compliance with the protocol including adhering to the specified procedural techniques and monitoring regimes.
l All unexpected deaths and unplanned euthanasia must be reported immediately to the Animal Ethics Office with a completed 
'Notification of Animal Death' form, available from http://www.research.uwa.edu.au/staff/forms. Please note that this also refers 
to all animal deaths in field research projects and wildlife projects.
The AEC would like to remind all investigators using animals that while animal technicians are responsible for the daily care of 
animals, and play a major role in alerting investigators should an emergency arise, the ultimate responsibility for animal welfare 
(including monitoring requirements) lies with the investigator. Investigators must maintain their own animal records in order to comply 
with the Animal Welfare Act 2002 (WA) and the Code of Practice, to enable accurate completion of the animal usage to be 
reported to the AEC.
It is a requirement of the Code § 3.3.24 that when an animal dies unexpectedly, or is euthanased due to unforseen complications, an 
autopsy should be performed by a person with appropriate qualifications and/or experience.
If you have any concerns with regard to animal wellbeing or animal welfare, one of the following persons must be notified 
immediately:
Animal Welfare Officer - awo@uwa.edu.au; T: (08) 6488 7882 M: 042 802 1529 
Animal Welfare and Veterinary Advisor - Vets-research@uwa.edu.au; T: (08) 6488 4549 / 4700 
Page 2.../
Doctor Mark Fear
25 September 2012
RA/3/100/1155: Comparison of the effects of burn and non-burn skin trauma on the innate and adaptive immune response 
using a mouse model
If you have any queries, please do not hesitate to contact the Animal Ethics Office as listed above.
Yours sincerely
 
Professor D'Arcy Holman 
Chair, Animal Ethics Committee 
 
Animal species and quantities approved for the above protocol from 01 October 2012 to 30 September 2015
.
Species Name Approved
C57BL/6 {220} 140
 
Gross Anatomical Report 
 
 
Date 20/2/2013 Facility PCF Zone B 
Animal found dead or culled  (method 
of euthanasia if applicable) 
Found Dead 
Species and strain C57bl/6j 
AEC# 100/1155 CI Fear 
Gender Female DOB 10wks  Genotype  
(e.g. +ve) 
 
ID/Pen # Tail Markings  
(V small 
white tip on 
end of tail) 
Parent ID # or 
Animal Facility 
Source 
 
ARC 
Biological Risk 
(compulsory) 
 
None  OGTR 
status  
and IBC # 
N/A 
History – phenotype – treatments 
Arrived in PCF on the 5/2/13 housed with 4 other mice.  All had burns surgery 7% to dorsum 
on 12/2/2013 all recovered well gaining weight were bright and alert, wounds healing well.  
Cage was changed on the 19/2/2013 and all were fine.  On 20/2/2013 one of the mice was 
found dead in cage, there was quite a bit of blood in cage so initially thought fighting was the 
cause but there are no obvious injuries on mouse other than the burns site.  All other mice are 
fine.  
 
External examination: 
Weight: 16.49 grams 
2cm x 1cm full thickness wound on the dorsal lumbosacral region. See image below.   
 
 
 
 
 
Internal Examination: 
Subcutis had a green discolouration and organs appeared to be liquefying,  
Final Comment: 
Inconclusive.  
Autolysis. 
  
 
 
Lauren Callahan  
ACS Veterinary Officer  
Animal Care Services 
Biomedical Researcher Facility 
 
  
School of Veterinary & Biomedical Sciences 
South St, Murdoch 
Western Australia 6150 
Telephone: (61-8) 9360 2356 
Facsimile: (61-8) 9310 4144 
Duty Pathologist: 04202 77743 
 
 
ANATOMIC PATHOLOGY NECROPSY REPORT 
FINAL 
          Pathology No: 13/223 
Date In: 17/4/2013   
Pathologist: Dr Ziyuan Lim and Dr 
 Nahiid Stephens 
Owner’s Details: 
Marilyn Davies  
University Of Western Australia 
Animal Care Unit 
35 Stirling Highway 
Nedlands WA 6009 
Ph:   6488 6661 
Fax: 6488 6677 
marilyn.davies@uwa.edu.au  
 
Consulting Veterinarian: Dr Marilyn Davies 
Date of Consult: 17/4/2013 
 
Patient’s Details:  
Clinic Number:                                                        Name: Anatomic Pathology 
Species Breed:     Mouse                                        Strain:   C57BL/6J     
Gender:   Female                                                   D.O.B:   8 weeks on 8-03-13                     
Current Age:  12 – 13 weeks 
 
History:  
AEC #   RA/3/100/1155 
 
Underwent burn surgery on 11-03-13 and mouse recovered well.  Burn injury appeared to be healing well up until 
the final 3 x 3mm area observed on 8-04-13 when barbering appeared on the mouse. She was singularly housed at 
this time. Further observations over the next week still showed excessive grooming and irritation of the hind area. 
 
Suspect ulcerative dermatitis. 
Request culture of the wound. 
  
Note: This is an OGTR Facility. Dispose of carcass and tissue by incineration 
 
Submission:  20.3g black mouse submitted in a transparent plastic bag contained within another transparent 
ziplock bag [Fig. 1 & 2]. 
Status:  Post euthanasia. 
Post mortem interval: Unknown; examined at 16.30pm on the 17/4/13. 
Post mortem decomposition:  Minimal. 
Identifying features:  Inner plastic bag had a white adhesive label [Fig. 1 & 3].  
  
   
[Figure 1 & 2: Submission; showing the front (left) and back (right) of the bag] 
 
 
[Figure 3: Close up of tag] 
  
□    External examination                                          □   Lymphoreticular system 
Not examined/ No visible lesions/ See Below Not examined/ No visible lesions/ See below  
□ Skin and subcutis □ Urogenital system 
Not examined/ No visible lesions/ See below Not examined/ No visible lesions/ See below  
□ Body cavities □ Endocrine system 
Not examined/ No visible lesions/ See below Not examined/ No visible lesions/ See below  
□ Respiratory system □ Musculoskeletal system 
Not examined/ No visible lesions/ See below Not examined/ No visible lesions/ See below  
□ Cardiovascular system □ Nervous system 
Not examined/ No visible lesions/ See below Not examined/ No visible lesions/ See below  
□ Alimentary system 
Not examined/ No visible lesions/ See below  
 
Visible lesions: 
Significant External Findings 
External examination, skin and Subcutis: 
An irregularly-shaped roughly 30 X 20 mm alopecic area was present on the dorsal caudal back; within this there 
were five to six 3-5mm ovoid, red, slightly depressed lesions (ulcers), the surfaces of which were covered with mild 
amounts of dried translucent yellow material (exudative crusts) [Fig. 4].  
 
 
[Figure 4: Dorsum of mouse; showing alopecic and ulcerative areas] 
 
Significant Internal Findings 
Body Cavities: 
There was a mild amount (about 0.1-0.2mls) of red fluid noted in the peritoneal cavity (sanguineous fluid ddx: post 
mortem changes, haemorrhage) and 2 irregularly-shaped 5mm long clumps of dark red gelatinous material located 
in the caudal pleural cavity (blood clots i.e. haemorrhage). 
 
Gross Summary:  
1. Skin and subcutis: 
Moderate, subacute, multifocal to coalescing, fibrinosuppurative, ulcerative and alopecic dermatitis. 
 
2. Body cavities: 
Pleural cavity: Moderate, acute haemothorax. 
 
 
  
Gross Comment: 
The loss of hair and presence of ulcerative and crusty wounds on the dorsal back is consistent with barbering with 
possible secondary bacterial infection. No obvious associated ectoparasites were noted on gross examination, 
however microscopic ectoparasites cannot be ruled out. Culture is underway and it is hoped that histology will 
further characterise the cause of the presumed barbering. 
 
The haemothorax is likely unrelated to the barbering and, as the mode of euthanasia is unknown, may be 
attributable to iatrogenic causes.  
 
Ancillary Tests: 
1. Anaerobic and aerobic culture was performed on an aseptically collected sample of affected skin: 
 
 
  
 
2. Gram Twort histochemistry was carried out on the skin section (H13-338A) and no bacteria were identified. 
  
Histopathological findings:  
H13-338 A Skin: 
There is focal epithelial loss (ulceration) and the adjacent epithelium displays decreased layers of cells with several 
of the cells appearing flattened (erosion). The rest of the epithelium is slightly thickened caused by increased layers 
within the stratum spinosum (hyperplasia; acanthosis). The dermis is diffusely infiltrated (more densely infiltrated 
superficially directly subjacent to the ulcer) by moderate numbers of neutrophils and macrophages, some mast 
cells as well as rare lymphocytes and plasma cells. A Gram Twort stain fails to identify any bacteria; likewise no 
ectoparasites or fungal organisms are seen.   
 
H13-338 A, B, C Lung, Heart, Liver, Kidney, Adrenal, Spleen, Brain, Stomach, Small intestines, Large intestines:  
There are no abnormalities detected. 
 
Final Diagnosis:  
1. Skin and subcutis: 
Moderate, chronic, multifocal to coalescing, neutrophilic and histiocytic, ulcerative and alopecic dermatitis 
with mild acanthosis. 
 
2. Body cavities: 
Pleural cavity: Moderate, acute haemothorax. 
 
Final Comment:  
Histopathological examination confirms the gross diagnosis of an ulcerative dermatitis however the inciting cause 
could not be identified. Although the changes (acanthosis, increased numbers of macrophages and mast cells) are 
consistent with ulcerative dermatitis of ectoparasitic origin (i.e. ascariasis) it is aetiologically non-specific and hence 
ectoparasitism cannot be definitively diagnosed on the basis of the section examined. There were no aetiological 
agents (e.g. ectoparasites, bacteria) identified either in culture or on histological examination of the tissue. Despite 
this, external parasites cannot be definitively ruled out based on the skin section examined; indeed in many cases 
of ectoparasitism there is a paucity of parasites, however they can nevertheless be clinically significant due to the 
secondary hypersensitivity-related dermal inflammation that ensues.  
 
The haemothorax is likely unrelated to the skin lesions and, as the mode of euthanasia is unknown, may be 
attributable to iatrogenic causes.  
 
Yours Sincerely, 
 
Dr Ziyuan Lim, BSc BVMS (Murdoch) 
Resident in Anatomic Pathology 
 
 
Nahiid Stephens BSc BVMS (Hons) MANZCVSc (Vet Path) 
Lecturer in Veterinary Pathology 
  
  
Checklist:   (√ = no gross lesions;  H = sample for histology;  C = culture;  P = photographed) 
 Eyes √H Lungs √H Stomach √H Adrenals  Other organs  
HC Skin  Bronch LN √H S. intestine  Testes  (list) 
 Head LN √H Heart  Caecum √H Ovaries   
√H Tongue √H Liver √H Colon  Meninges   
√H Oesophagus  Gall bladder  Mesent LN √H Brain   
 Thyroid √H Spleen √H Kidneys √H Bone Marrow   
 Parathyroid √H Pancreas √H Bladder     
 Thymus  Forestomachs       
Frozen samples:□  Liver □  Fat □  Kidney □  Brain □  Other (list) 
  
 
Disease Process 1 INC Disease Process 2  
System 1 SKI System 2  
General Cause 1 UNK General Cause 2  
Aetiology 1  Aetiology 2  
Common Name 1 Ulcerative dermatitis Common Name 2  
 
 
The Immune Response to Skin Trauma Is Dependent
on the Etiology of Injury in a Mouse Model of Burn
and Excision
Samantha M. Valvis1, Jason Waithman2, Fiona M. Wood1,3,4, Mark W. Fear1,3,5 and Vanessa S. Fear2,5
Skin trauma has many different causes including incision, blunt force, and burn. All of these traumas trigger an
immune response. However, it is currently unclear whether the immune response is speciﬁc to the etiology of
the injury. This study was established to determine whether the immune response to excision and burn injury of
equivalent extent was the same. Using a mouse model of a full-thickness 19mm diameter excision or 19mm
diameter full-thickness burn injury, we examined the innate immune response at the level of serum cytokine
induction, whole-blood lymphocyte populations, dendritic cell function/phenotype, and the ensuing adaptive
immune responses of CD4 and CD8 T-cell populations. Strikingly, both the innate and adaptive immune system
responses differed between the burn and excision injuries. Acute cytokine induction was faster and different in
proﬁle to that of excision injury, leading to changes in systemic monocyte and neutrophil levels. Differences in
the immune proﬁle between burn and excision were also noted up to day 84 post injury, suggesting that the
etiology of injury leads to sustained changes in the response. This may in part underlie clinical observations of
differences in patient morbidity and mortality in response to different skin injury types.
Journal of Investigative Dermatology (2015) 135, 2119–2128; doi:10.1038/jid.2015.123; published online 7 May 2015
INTRODUCTION
Injury to the skin initiates an immune response, which
is the key driver of repair (Gurtner et al., 2008). However,
it is not clear whether the immune response is etiology
dependent.
Patients with signiﬁcant skin injuries do appear to differ in
their responses dependent on etiology. This is evident in the
sexual dimorphism observed where female patients have a
lower incidence of sepsis and mortality after surgical or blunt
force trauma, whereas after burn injury male patients fare
better, with a 2-fold increase in mortality observed in females
with equivalent total body surface area burn injury (O’Keefe
et al., 2001; McGwin et al., 2002). Following burn injury, all
patients have a poorer outcome than predicted by the injury
severity scoring system (Cassidy et al., 2013), whereas recent
evidence shows an increased risk of cancer in burn injury
patients, in particular females (Duke et al., 2011, 2014). This
may be indicative of a unique impact of burn injury on the
immune system, leading to signiﬁcant acute and long-term
consequences.
Post injury there is increased prevalence of blood stream
infections and mortality (Sharma, 2007; Tran et al., 2012).
This is attributed to disturbances in the skin, including
changes in microﬂora (Wysocki, 2002; Barret and Herndon,
2003; Erol et al., 2004) and persistent innate pro-inﬂammatory
or the systemic inﬂammatory response syndrome (Ni
Choileain and Redmond, 2006). Finally, this increase in
morbidity and mortality is compounded by compensatory
anti-inﬂammatory responses and suppressed T-cell responses
(Ni Choileain and Redmond, 2006).
In burn patients, early investigations suggested that
increased susceptibility to infection is due to hyperactivity
of the monocyte/macrophage system on a backdrop of
insufﬁcient CD4 and C8 T cell responses (Murphy et al.,
2004; Samonte et al., 2004). The adaptive immune system
following burn injury adopts a suppressive phenotype with
reported reduced T-helper 1 and cytotoxic T-cell responses
(Hunt et al., 1998) and increased T-regulatory (Treg) cell
activity (Teodorczyk-Injeyan et al., 1988; Hultman et al.,
1995; Kelly et al., 1997, 1999; Lederer et al., 1999; Guo et al.,
2003; Hanschen et al., 2011; MacConmara et al., 2011).
Similarly, trauma injury immune responses include increased
Treg activity (Ni Choileain and Redmond, 2006) and a
reduced T-helper 1 response (Beilin et al., 2006).
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Research in burn patients with sepsis has revealed a signiﬁ-
cant decrease in circulating conventional dendritic cells (DCs)
and plasmacytoid DCs (D’Arpa et al., 2009). Burn injury has
been shown to decrease conventional DC (Patenaude et al.,
2010; Shen et al., 2012) and plasmacytoid DC (Shen et al.,
2012) number in both local draining lymph tissue and the
spleen, with DCs possessing an anti-inﬂammatory phenotype
and dysfunctional T-cell-priming ability in the acute post-injury
phase (Patenaude et al., 2010; Van den Berg et al., 2011).
Here, we have investigated the impact of burn and
excisional injury on the immune system. We examined the
innate immune response at the level of induction of cytokine,
chemokine, and DC function/phenotype, as well as the
ensuing adaptive immune responses in CD4 and CD8
T cell–populations. Strikingly, we observed different proﬁles
of innate and adaptive immune system changes, both acute
and in the longer term in response to the burn and excision
injury. This work suggests that etiology of injury is an
important determinant of the immune response.
RESULTS
Burn injury induces a rapid systemic cytokine and chemokine
responses, which differs from that of excision injury
Serum was isolated from control, burn, and excision groups on
days 1, 3, and 7 post injury and examined for inﬂam-
matory cytokine proﬁles (Figure 1). Severe trauma induces
inﬂammatory cytokine responses including IL-1α, IL-1β, tumor
necrosis factor-α, and IL-6 (Sheridan, 2001). Post-burn injury at
day 1, IL-6 was signiﬁcantly increased (Figure 1a). Excision
injury induced signiﬁcantly increased IL-6 production at day 1,
with a peak level at day 3, compared with control and burn
injury (Figure 1a). At day 1 post burn tumor necrosis factor-α
and IL-10 sera concentrations were signiﬁcantly elevated
compared with the excision injury. Following excision, tumor
necrosis factor-α does not signiﬁcantly increase, whereas IL-10
appears to be increasing at day 3 with a signiﬁcant increase
at day 7 (Figure 1a). There was no signiﬁcant difference in
production of IL-1α or IL-1β (data not shown).
Chemokine levels were also assessed (Figure 1b). Burn injury
induced elevated levels of serum monocyte chemoattractant
protein 1 (MCP1), a monocyte, immature DC, and memory
T-cell attractant at day 1 compared with the excision injury and
control (Figure 1b). macrophage inﬂammatory protein 1α
(MIP1α) (CCL3) and macrophage inﬂammatory protein 1β
(MIP1β) (CCL4) attract monocytes, T cells, and potentially
polymorphonuclear leukocytes. Their expression was also
signiﬁcantly elevated at day 1 post burn compared with
excision (Figure 1b). No signiﬁcant change in MCP1, MIP1α,
and MIP1β was observed after excision.
KC (CXCL1) is a neutrophil attractant that also induces
angiogenesis. Elevated levels of KC were detected at day 1
both post excision and burn compared with control.
Granulocyte colony–stimulating factor (GCSF) stimulates
granulocyte release from the bone marrow and increases
neutrophil proliferation and mobilization. A signiﬁcant increase
in GCSF levels after burn injury was detected at day 1 through
to 7 (compared with control (Figure 1b)). Excision injury
induced a 7-fold increase in GCSF at day 1, with signiﬁcant
increases in GCSF compared with the burn and control groups
persisting to day 3 (Figure 1b). The response appears greater but
for a shorter duration after excision injury. Eotaxin (CCL11) an
eosinophil, basophil, mast cell, T-helper 2 cell, and platelet
attractant was signiﬁcantly elevated above control at day 1
following burn injury only (Figure 1b).
T cell–modulating cytokines were examined (Figure 1c),
with burn injury showing a trend for the highest levels of
all ﬁve cytokines tested and signiﬁcantly increased IL-13
at day 1 (Figure 1c). This cytokine proﬁle is indicative of a
pro-T-helper 2 cell environment (Pulendran et al., 2010).
These data indicate signiﬁcant differences both in the
timing and proﬁle of inﬂammatory cytokine and chemokine
production between burn and excision. Burn induced
an acute inﬂammatory response consisting of MCP1, MIP1α,
MIP1β, and eotaxin on day 1. Alternately, the day 1 response
following excision injury consisted predominantly of elevated
KC and GCSF.
Burn injury induces changes in systemic monocyte and
neutrophil levels that are signiﬁcantly different to those induced
by excision
Whole-blood counts were obtained at days 1, 3, 7, and 14
post injury (Figure 1). A signiﬁcantly increased monocyte
count was observed at day 3 post burn compared with control
(Figure 1d). Neutrophil cell counts were elevated post burn
and excision at day 7, and this was sustained in the burn
injured group compared with the excision group at day 14
(Figure 1d). The differences in hematology in part mirror the
differences in cytokine and chemokine production observed.
Increases in MCP1, MIP1α, and MIP1β after burn injury
appear to lead to increases in monocyte production for
example. These data also support previous ﬁndings, indicat-
ing an important role for these chemokines in burn injury but
not excision (Heinrich et al., 2003; Low et al., 2001). In
contrast, the acute increase in GCSF is not mirrored by a
signiﬁcant increase in neutrophil number until day 7. This
may be due to egress of neutrophils from the blood to the
excision site. Analysis of differences in wound inﬁltrate from
both injury types will be important to assess this further. No
changes in whole-blood white cell count, eosinophil, or
lymphocyte levels were detected (data not shown).
Changes in dendritic cell population and maturation are
different following burn and excision injury
To compare DC responses in the lymph node, the inguinal
draining lymph nodes (ILNs) were harvested at days 1, 3, and
7 post injury. DC subset number, frequency, and maturation
status were assessed using FACS. Dendritic cells were
identiﬁed as the major histocompatibility complex (MHC) IIhi
and CD11c+ cell population, with subsequent gating on
CD8a+ (resident lymph node DC population) and CD8a−
expression (migratory DC population from the skin). The latter
CD8a− DC that circulate from the dermis during surveillance
and inﬂammation were further gated into CD103+CD11blo
(CD103+ DC), CD11bhiCD103- (CD11bhi DC), and
CD11bloCD103- (CD11blo DC; Figure 2a) as these subtypes
present differentially to CD4 and CD8 T cells. This gating
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strategy provides information on resident DC ﬁltering blood
antigens and migratory DC from the periphery, which
modulate adaptive T-cell responses via induction of CD4
and/or CD8 T–cell populations. In particular, CD8a-CD103+
DC are implicated in stimulation of viral immunity via cross-
presentation of antigen to CD8 T cells (Sung et al., 2006;
Malissen et al., 2014). Alternately, under steady state
conditions both CD11b and CD103 have been implicated
in the induction of Treg cells. However, this has been found to
be tissue dependent (Semmrich et al., 2012).
ILN total cell number was signiﬁcantly increased after
burn and excision injury at day 3 compared with controls
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Figure 1. Temporal cytokine, chemokine, and hematology changes in burn and excision injury. Mice received sham (control), burn, or excision injury, and sera or
whole blood were collected at the indicated time points for immune assay or hematology, respectively. Inﬂammatory cytokines IL-6, TNFα, and IL-10 (a), Chemokines
monocyte chemoattractant protein 1 (MCP1), macrophage inﬂammatory protein 1α (MIP1α), macrophage inﬂammatory protein 1β (MIP1β), KC/CXCL1, GCSF, and
Eotaxin (b), and T-cell-modulating cytokines IL-3, IL-12p70, IL-4, IL-5, and IL-13 (c). Bar graphs indicate control (white bars), burn injury (hatched bars), and excision-
injury (gray bars). Results are shown as mean+SEM. n=5–8 mice per group for at least two independent experiments. *Po0.05 compared with control; #Po0.05
compared with burn injury group; **Po0.01 compared with control; ##Po0.01 compared with burn injury. Hematology proﬁle for monocytes (d) and neutrophils (d).
Bars indicate control (white bars), burn injury (hatched bars), and excision injury (gray bars). Results are shown as median and range (0–100th percentile). n=6–8 mice
per group and at least two independent experiments. *Po0.05 compared with control; #Po0.05 compared with burn injury group; **Po0.01 compared with control;
##Po0.01 compared with burn injury. GCSF, granulocyte colony–stimulating factor; TNF-α, tumor necrosis factor-α.
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(Figure 2b). Total DC cell number, resident CD8a+ DC
number, and CD8a− DC number were all signiﬁcantly
increased at day 3 post injury compared with the control,
whereas after burn injury the increase in CD8a− cells was
sustained to day 7 (Figure 2c).
The CD8a− DC subpopulation cell numbers were further ana-
lyzed. There was no increase in CD103+ DC. However, CD11bhi
DC and CD11blo DC numbers were signiﬁcantly increased
compared with controls at day 3 (Figure 2d) with CD11bhi number
remaining elevated after burn injury at day 7 (Figure 2d).
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Figure 2. Dendritic cell responses in local draining lymph nodes after burn injury and excision injury. Mice received sham (control), burn, or excision injury,
and ILNs were harvested to single suspensions at the indicated time points. Dendritic cells were gated CD11c+ MHC II+ and further gated for subpopulations
using CD8α, then CD11b and CD103 (a). Graphs show ILN total cell number (b), total DCs, CD8a+DC, and CD8a− DC number (c), and the number of CD8a- DC
that was CD103+, CD11bhi, or CD11blo (d). Lymph node percentage frequency of total DCs, the percentage frequency of CD8a+ DC and CD8a− DC in total DCs
(e), and the percentage frequency of CD103+ DC, CD11bhi DC, and CD11blo DC in the CD8a− DC compartment (f) are as indicated. Expression of MHC II as
determined by MFI is presented for total DCs and DC gated CD8a+ and CD8a− (g). Data indicate MHC II MFI on CD8a− DC population further gated for CD103+
DC, CD11bhi DC, or CD11blo DC sub-populations (h). Bars indicate control (white bars), burn injury (hatched bars), and excision injury (gray bars). Results are
shown as median and range (0–100th percentile). n= 5–8 mice per group, for at least two independent experiments. *Po0.05 compared with control; #Po0.05
compared with burn injury group; **Po0.01 compared with control; ##Po0.01 compared with burn injury. ILN, inguinal lymph node; MFI, Mean Fluorescence
Intensity; MHC, major histocompatibility complex.
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There was a signiﬁcant decrease in the percentage of cells
that were DCs (DC % frequency) at day 3 post burn compared
with control (Figure 2e). Within the CD8a− DC populations,
we observed a signiﬁcant decrease in the CD103+ DC subset
percentage frequency compared with control at day 3 after
burn injury (Figure 3f), with no other signiﬁcant changes in the
CD103+, CD11bhi, or CD11blo percentage frequencies.
To determine the activation status of the DC populations,
we determined Mean Fluorescence Intensity (MFI) of MHC II
expression (Figures 2g and h). DC MHC II MFI was signiﬁ-
cantly decreased at day 3 in the burn injury only compared
with control. Furthermore, MHC II MFI was signiﬁcantly
reduced for CD8a+ DC and CD8a−y DC after burn injury
compared with control (Figure 2g). Within the CD8a− migra-
tory CD103+ DC subset, there was a signiﬁcant reduction in
MHC II MFI at day 1 and day 3 post burn compared with
control (Figure 2h).
CD4 and CD8 T–cell activation and Treg cell responses differ
between burn and excision injury
CD4 T-cell number, proliferation, activation, and Treg cell
induction in the ILN were determined by ﬂow cytometry
(Figures 3a and b). CD4 cell number was signiﬁcantly
increased at day 3 after burn injury and more acutely at days
1 and 3 after excision injury compared with controls. There
was a further signiﬁcantly increased frequency of dividing
CD4 cells (Ki67hi) in the excision injury group at day 7
compared with control. There was a signiﬁcant change in
the excision CD4+CD25+ cell number at day 3 compared
with the control; however, there was no change in the CD4+
CD25+ percentage frequency in either injury group
(Figure 3b). No changes were observed in CD4 Treg cell
numbers or the percentage frequency (Figure 3b).
CD8 T-cell number, proliferation, and activation were also
determined by ﬂow cytometry (Figures 3c and d). CD8 cell
number was signiﬁcantly increased at day 3 post burn
and days 1 and 3 post excision compared with control.
There was a decrease in the frequency of Ki67hi dividing
cells in this population at day 3 post burn compared with
control. An increase in CD8+CD25+ cell numbers, indicative
of cell activation, was observed at days 1 and 3 for burn injury
and day 1 alone for excision compared with control
(Figure 3d).
Long-term alterations in immune proﬁles following burn and
excision injury
Sera and whole blood were examined for cytokine and
hematology at 84 days post injury. At Day 84, there was a
signiﬁcant increase in IL-10 in the burn group compared with
the excision group (Figure 4a). In addition, there was a
signiﬁcantly decreased white cell count and lymphocyte cell
number for burn injury compared with controls (Figure 4a).
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There was also a signiﬁcantly reduced cell number for
eosinophils and neutrophils in the burn injury group only
(Figure 4a).
DC cell number was signiﬁcantly elevated at day 84 post
excision compared with control. At day 28, we observed a
signiﬁcantly reduced number of CD11blo DC in the ILN after
burn compared with the control (Figure 4b). Moreover, there
was reduced MHC II MFI on CD11bhi and CD11blo DC post
injury, and this extended to day 84 for the CD11bhi DC subset
(Figure 4c).
Reduced MHC II expression on DC compromises their
ability to prime T-cell responses and may potentiate a tolerant
response. Accordingly, although we observed an increase in
proliferating CD4 T-cell frequency and number, there was a
concomitant reduction in CD25 expression at day 28 after
burn injury (Figure 4d). This may indicate a downregulation of
the CD4 T-cell response. Indeed, CD4 Treg cell numbers
were signiﬁcantly increased at day 14 after burn compared
with the control, but there was no increase in the percentage
frequency of CD4 cells (Figure 4d).
CD8 T-cell number and proliferation were not changed at
day 14 through day 84 after burn or excision (Figure 4e).
However, a reduction in CD8 T-cell CD25 expression was
observed at day 28 for excision injury, which may indicate
less responsive CD8 cells at this time.
Burn injury leads to suppressed acute splenic T-cell cytokine
responses
Stimulation of T cells isolated from the spleen was conducted
in cell culture using Concavalin A to assess T-cell function
after burn injury. At day 7 post burn, the T-cell response was
reduced compared with control animals (Figure 5) with
signiﬁcantly reduced production of IL-1β and IL-17 and a
trend to reduced production of IL-2 and IL-6 (P=0.06). By
Day 14, T-cell cytokine production in response to Concavalin
A had returned to normal levels (data not shown).
DISCUSSION
Early following injury the innate immune response includes a
cytokine cascade with release of tumor necrosis factor-α and
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IL-1β to stimulate IL-6 production. IL-6 increases proliferation
of polymorphonuclear leukocytes and inhibits monocyte to
inﬂammatory DC differentiation, instead of promoting mono-
cyte to macrophage differentiation following injury (Chomarat
et al., 2000; De et al., 2003). In addition, IL-10 released after
trauma is monocyte to macrophage promoting (Vicari et al.,
2002). Indeed, high levels of innate cytokines have been
correlated with increased severity of tissue trauma (Shenkin
et al., 1989; Cruickshank et al., 1990; Mokart et al., 2002) and
development of post-operative complications (Baigrie et al.,
1992). Research indicates that the magnitude of the innate
inﬂammatory response directly corresponds to the subsequent
downregulation of ensuing immune response following
trauma (Tschoeke and Moldawer, 2005; Ni Choileain and
Redmond, 2006). Burn and excision injury, in this study, differ
in their temporal release and pattern of innate cytokine
production, with an acute innate cytokine response in burn
injury that could potentially mediate monocyte to macro-
phage development. Notably, excision induced an early
neutrophil chemoattractant response with no signiﬁcant
increase in macrophage inducing cytokines MCP/MIP1α/β,
delayed onset of IL-6 production, and lower IL-10 induction
when compared with the burn. These differences in acute
cytokine proﬁle after wounds of equivalent extent suggest that
the impact and subsequent changes in immune response are
related to the injury etiology.
Dendritic cells link the innate and adaptive arms of the
immune system. Resident ILN CD8a+ DCs are important for
tolerance induction to cell-associated antigens present during
apoptosis (Qiu et al., 2009). Here, we show a signiﬁcant
increase in the ILN resident CD8a+ DC population after burn
and excision with reduced activation status. This may assist
with dampening of an escalating immune response to tissue
necrosis/apoptosis antigen presentation during injury.
Skin migratory DC subsets are able to differentially
stimulate CD4 and CD8 T-cell responses (Sung et al., 2006;
Malissen et al., 2014) in the lymph node. The CD103+ DC
present antigen to both CD4 (Beaty et al., 2007; Jakubzik
et al., 2008; Semmrich et al., 2012) and CD8 T cells (Jakubzik
et al., 2008; Beauchamp et al., 2010; Semmrich et al., 2012),
whereas the CD11b+ DC predominantly present antigen to
CD4 T cells (Beaty et al., 2007). During homeostasis, a
tolerogenic T-cell response is induced, whereas during
inﬂammation and/or infection these DC subsets upregulate
MHC II expression and are capable of inducing a T-cell
response. The activation/maturation status determines the
development of a T-cell response. Our data indicate temporal
changes in DC populations following burn and excision injury
with notable differences in CD103+ frequency and maturity,
and CD11b DC cell number following burn compared with
excision. These temporal changes in resident and skin
migratory DC populations in the draining lymph node may
be sufﬁcient to induce differential trauma-dependent CD4
T-cell responses.
A CD4 T-cell increase was observed after both burn and
excision. However, only the excision group displaying an
increase in CD4 cell proliferation (day 7). Interestingly, there
was an increased CD4 T-cell proliferative response late (day
28) following initial burn-injury suppression in this popula-
tion. This rebound effect in burn injury has previously been
observed for a cytotoxic CD8 population (Hunt et al., 1998).
The effect of burn injury has been reported to stimulate a
more robust CD8 T–cell proliferative response compared with
their CD4 T-cell counterpart (Buchanan et al., 2006). In this
study, total CD8 T-cell number increased in the skin-draining
lymph node after burn and excision. However, in the
burn injury, there was a notable decrease in CD8 T cell–
proliferative response.
The changes in systemic cytokine and hematology proﬁles
as well as lymph node cell populations indicate that the
impact of the burn was substantially different to that of
excision. Additional work assessing wound inﬁltrate will be
important to shed light on localized changes as well. Of
particular note in this data, profound changes to the dendritic
cell populations were observed, indicating a loss of activation
and maturity after the burn injury that was not observed after
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excision. Importantly, these changes appeared to be sustained
until the ﬁnal time point analyzed. Analysis of T-cell
activation using cells isolated from the spleen after a burn
injury showed that T-cell cytokine production in response to
stimulation was suppressed acutely but had recovered to
normal levels by day 14 post injury. Together, this suggests
that functionally the T cells are normal after transient
suppression and that therefore the effects observed in cell
populations more likely reﬂect changes in dendritic cell
presentation and maturity. This has previously been reported
after UV exposure of the skin (Ng et al., 2013) and may also
occur after burn injury. Therefore, characterization of long-
term changes in dendritic cell function after a non-severe
burn, in particular the ability to prime T cells, is an important
next step.
In summary, these data show signiﬁcant differences
between the immune response to burn and excisional injury.
However, the injury model used is a non-severe injury (which
represents close to 90% of presentations in developed
countries), and it is possible responses converge as injury
severity increases. Here we observed an early acute inﬂam-
matory response to burn injury that is delayed following
excision. Interestingly, cytokine and chemokine proﬁles
indicate an early macrophage-promoting environment after
burn injury, whereas excisional injury has an acute neutrophil
attractant response with a delayed macrophage-promoting
environment. Furthermore, number and activation status in
resident and migratory DC subsets in the skin-draining lymph
nodes displayed temporal changes following burn or excision
injury. These changes may underpin the absence of a CD4 T
cell–proliferative response and decreased CD8 T-cell prolif-
eration following burn injury (day 7 and day 3, respectively).
Excision injury presented with a CD4 T cell–proliferative
response at day 7.
The immediate lack of adaptive immune responses after
burn injury likely contributes to increased infectious compli-
cations observed in patients including frequent Pseudomonas
aeruginosa infections, which hamper recovery (Guggenheim
et al., 2009; Singer and McClain, 2002) with reactivation of
latent viral infection potentially a further complication (Haik
et al., 2011). Although this period of suppression was
followed by a rebound effect in CD4 T–cell proliferation,
this was concomitant with a reduced CD25 expression
proﬁle, which may be potentiating a process of anergy or
deletion tolerance to self-antigens in this remodeling phase.
This may contribute to the increased incidence of cancer
observed in burn patients and requires further investigation.
MATERIALS AND METHODS
Mice
Adult 9-week-old female C57BL/6 mice were housed under
pathogen-free conditions with food and water provided ad libitum.
Approval was obtained by the University of Western Australia
Animal Ethics Committee, and all experiments performed in
accordance with the National Health and Medical Research Council
Australia Code of Practice for the Care and Use of Animals for
Scientiﬁc Purposes.
Full-thickness burn and excision trauma procedure
Nine-week-old C57BL6/J female mice (n= 140, n= 10 per group per
time-point) received either a full-thickness 19-mm diameter burn
wound following a previously described protocol (Giles et al., 2008)
or a full-thickness 19mm diameter excision by outlining the area
with a 19mm template and surgically removing the tissue under
anesthesia. This equates to ~ 8% total body surface area (a non-
severe injury model). Sham injury mice received no surgical
treatment but underwent anesthesia. Animals were administered
analgesic (buprenorphine, 0.1 mg kg− 1) intramuscularly immediately
post injury and at 12 hours. Water was instilled with paracetamol
(1 mgml− 1) for 5 days following surgery.
ILN tissue preparation
ILN preparations were performed as described previously (Fear et al.,
2011). In brief, ILN from individual mice were subjected to type IV
collagenase digestion (1.5 mgml− 1; Worthington Biochemical,
Lakewood, NJ) with type I DNase (0.1 mgml−1; Sigma-Aldrich,
St. Louis, MO) to prepare single-cell suspensions. All digestions and
washes were performed in glucose sodium potassium buffer (11 mM
D-glucose, 5.5 mM KCl, 137mM NaCl, 25mM Na2HPO4, 5.5 mM
NaH2PO4.2H2O).
FACS analysis and antibodies
Single-cell suspensions were FcR blocked (2.4G2; BD Biosciences, San
Jose, CA) prior to the addition of phenotyping antibodies. Airway and
draining lymph node DC populations were identiﬁed using combina-
tions of ﬂuorochrome-labeled mAbs (BD Pharmingen, Sydney, NSW,
Australia) to mouse I-A/I-E (2G9), CD11c (N418), CD11b (M1/70),
CD8a (53-6.7), or CD103bio (M290). All labeling was performed in
glucose sodium potassium buffer containing 0.2% BSA for 30 minutes
on ice. T-cell populations were identiﬁed in ILN digests using the
ﬂuorochromes CD4, CD8, CD25, and Ki67 (BD Biosciences). A FOXP3
intracellular staining kit (eBiosciences, San Diego, CA) was used to
determine intracellular FOXP3 staining. All Abs were used as direct
conjugates to FITC, Phycoerythrin (PE), PE-Cy7, allophycocyanin
(APC), APC-Cy7, or biotin and Streptavidin conjugated PE-Cy5 (BD
Biosciences) as required. Appropriately matched IgG isotype controls
(BD Pharmingen) and cytometer compensation settings adjusted
using single-stained controls were used for each experiment. Samples
were collected using an LSRII ﬂow cytometer (BD Biosciences) and
analyzed using FlowJo software (TreeStar, Ashland, OR).
Blood and sera collection
Mice were anaesthetized in a closed chamber with 2.5% isoﬂuorane,
placed under 2.5% isoﬂurane nose-cone and 1ml blood collected by
cardiac heart puncture. Bloods (0.5 ml) were placed in heparin
collection tubes for hematology whole-blood analysis at Clinical
Pathology, Murdoch University (Murdoch, WA, Australia). In addi-
tion, blood (0.5 ml) was collected in serum tubes, stored at 4 °C for
30 minutes, centrifuged at 13 000g for 30 minutes, and sera stored
at − 20 °C.
Cytokine analysis
Cytokine analysis on sera was performed using the Bioplex Pro
mouse Cytokine, 23-Plex Assay (Bio-Rad, Gladesville, NSW,
Australia) according to the manufacturer’s protocol. In brief,
premixed standards were reconstituted to 50 ng/ml and serially
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diluted for an 8-point standard curve. Premixed beads (50 μl) were
washed twice in a 96-well plate and 50 μl standard or sample added
to each well. The plate was incubated at room temperature for
30min with shaking. After washing, beads were suspended in 125 μl
of Bio-Plex assay buffer and read on a Bioplex System (Bio-Rad,
NSW, Australia).
Spleen cytokine assays
At the indicated time points, spleens were collected and digested to
single-cell suspensions as described previously. Cells were prepared
in RPMI 1,640 with glutamine (Invitrogen Life Technologies, Australia)
supplemented with 10% fetal calf serum, 20 μgml− 1 gentamycin,
and 20 μM 2-ME and plated at 3× 105 cells per well in 96-well plates
(Nunclon, Nunc, Denmark) with Concavalin A at 10 ngml−1 in
triplicate. At 48 hours of culture, triplicate supernatants were pooled
and stored at − 20 °C prior to cytokine analysis.
Statistical analyses
All results were analyzed using Prism 5 (Graphpad software, San
Diego, CA). Differences between groups were compared using the
Kruskal–Wallis test with Dunn’s test for multiple comparisons.
Correction for multiple testing was done using Bonferroni correction.
Values are presented as median and range (0–100th percentile).
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Timing of excision after a non-severe burn has
a significant impact on the subsequent immune
response in a murine model
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Background: Burn excision has emerged as the dominant clinical paradigm in treatment of
deep burns. Surgical intervention is common but the timing of wound excision is a balance
between wound depth assessment, avoidance of infection and unnecessary intervention.
However the physiological impact of timing of excision and consequences for the immune
response are not well understood.
Methods: Mice were subject to full-thickness burn (<8% TBSA) followed by early (day 1) or
late (day 8) surgical excision. Draining lymph nodes, wound tissue and sera were collected
longitudinally at day 2 and day 6 after excision and analyzed for cytokine, dendritic cell and
T cell profiles using FACS and multiplex ELISA assays.
Results: Delayed excision after injury initiated acute and severe inflammatory responses, with
high levels of inflammatory cytokines, increased chemokine responses, and elevated Th2
promoting cytokines compared to early excision. Cellular inflammation in the wound was
exacerbated with elevated neutrophils, eosinophil and monocytes. Wound cellular innate
immune response decreased after late excision with a loss of inflammatory dendritic cells
(DC), decreased NKT cells, and inhibition of NK cell activation. Systemically late excision
increased trafficking conventional CD8aDC to the lymph node, but there was no apparent DC
activation. This was reflected in the induction of CD4T regulatory (Treg) cells and suppression
of CD8T cell proliferation after late excision. No suppression was observed with early excision.
Conclusion: This data suggests early excision of the wound, during the phase of immune
down-regulation initiated by the burn, maintains an innate and adaptive immune cell
response. In contrast, late wound excision induced a severe inflammatory response, with
subsequent down-regulation of innate and adaptive immune cell responses. Therefore
timing of excision is critical in affecting the immune response to burn.
# 2016 Elsevier Ltd and ISBI. All rights reserved.
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1. Introduction
Early excision of burn in patients has in part decreased
mortality and reduced length of stay [1]. However, the optimal
timing of burn excision remains unknown. In clinical
practice, timing of excision has varied from less than 24 h
[2], to 4 days [3], to 4–8 weeks [4]. The nature of burn and
wound progression makes the decision to excise complex [5].
Clinicians must determine injury severity, forecasting the
degree of thermal injury progression including heat transfer,
tissue edema and decreased wound perfusion. The general
health of the patient must also be assessed with respect to
the systemic impact of the burn with malfunction of essential
metabolic processes, risk of infection and exacerbation of
inflammation [6].
In burn in murine models early excision and late excision
do not differ in wound closure rate [7]. However patient studies
show significant effects of the timing of excision, with reports
of beneficial effects of burn excision within 48 h for severe
burns [8]. In addition, prospective studies indicate early
excision (within 72 h) reduced mortality in patients aged
17–30 with no inhalation injury [9]. Other studies have shown a
better prognosis for severe burn patients who underwent early
excision surgery within 10 days of injury [10] whilst more
recent studies indicate optimal excision of burn to be 4–7 days
[11].
The magnitude of the innate inflammatory response to
injury has been shown to directly correspond to the subse-
quent down-regulation of ensuing immune responses [12,13].
In addition, high levels of innate cytokines have been
correlated with increased severity of tissue trauma [14–16]
and development of post-operative complications [17]. How-
ever there is a paucity of information that directly relates
inflammatory, innate and adaptive immune responses to early
and late excision after burn.
This study directly investigates the immune response
induced by late and early excision of the burn in a murine
model of non-severe burn. The systemic inflammatory
response, wound inflammatory and innate cell responses
and cell-mediated immunity were all assessed.
2. Methods
2.1. Mice
Adult 9 week old female C57BL/6 mice were housed under
pathogen free conditions with food and water provided
ad libitum. Approval was obtained by the Telethon Kids
Institute, Animal Ethics Committee (AEC#272), all experiments
performed in accordance with the National Health and
Medical Research Council Australia Code of Practice for the
Care and Use of Animals for Scientific Purposes.
2.2. Full thickness burn and excision trauma procedure
9 week old C57BL6/J female mice (n = 80, n = 5/group/time-
point) received a full thickness 19-mm diameter burn wound
following a previously described protocol [18]. This equates to
approximately 8% total body surface area injury (TBSA (a non-
severe injury model)). Sham injury mice received no surgical
treatment but underwent anesthesia and received the same
analgesic protocol [18]. Mice received sham or burn on day 0
followed by sham or excision surgery at day 1 or day 8. Excision
surgery removed the entire 19 mm diameter burned area as
previously described [18].
2.3. ILN tissue preparation
Inguinal lymph node preparations as described in detail
previously [19]. In brief, ILN from individual mice were
subjected to type IV collagenase digestion (1.5 mg/ml;
Worthington Biochemical, Lakewood, NJ) with type I DNase
(0.1 mg/ml; Sigma–Aldrich) to prepare single cell suspensions.
All digestions and washes were performed in glucose sodium
potassium buffer (GKN; 11 mM D-glucose, 5.5 mM KCl, 137 mM
NaCl, 25 mM Na2HPO4, 5.5 mM NaH2PO42H2O).
2.4. Skin tissue preparation
Skin wound sections were chopped and subjected to type IV
collagenase digestion, with Dispase (2 mg/ml; Roche) for 2 h at
37 8C with shaking. Digested tissue was filtered through
100 mM mesh filters to prepare single cell suspensions. All
digestions and washes were performed in GKN buffer.
2.5. FACS analysis and antibodies
Single-cell suspensions were FcR blocked (2.4G2; BD Bios-
ciences) prior to the addition of phenotyping antibodies. ILN
DC populations were identified using combinations of fluoro-
chrome labeled mAbs (BD Pharmingen) to mouse I-A/I-E (2G9);
CD11c (N418), CD11b (M1/70), CD8a (53–6.7), CD103 (M290),
B220 (RA3-6B2), CD19. T cell and innate cell populations were
identified in ILN digests using the fluorochromes CD3, CD4,
CD8, CD25, CD44, TCR g/d, and NK1.1 (PK136). Labeling was
performed in GKN buffer containing 0.2% BSA for 30 min on
ice. A FOXP3 intracellular staining kit (eBiosciences, San Diego,
CA) was used to determine intracellular Granzyme B, Ki67 (BD
Biosciences), and FOXP3 staining. All Abs were used as direct
conjugates to FITC, Phycoerythrin (PE), PE-Cy7, allophycocya-
nin (APC), APC-Cy7, Alexa Fluor 700, Brilliant Violet 421,
Brilliant Violet 650, Brilliant Violet 711, Brilliant Violet 786, PE-
CF594, or biotin and Streptavidin conjugated Brilliant Violet
421 (BD Biosciences, San Jose, CA) as required. Appropriately
matched IgG isotype controls (BD Pharmingen, WA) and
cytometer compensation settings adjusted using single-
stained controls were used for each experiment. Samples
were collected using an LSRFortessa flow cytometer (BD
Biosciences) and analyzed using FlowJo software (TreeStar).
2.6. Sera collection
Mice were warmed for 10 min in a heating box and 0.2 ml
blood collected by tail bleed, collected in serum tubes, stored at
4 8C for 30 min, centrifuged at 13,000  g for 30 min and sera
collected and stored at 20 8C.
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2.7. Cytokine analysis
Sera cytokine analysis was performed using the Bioplex Pro
mouse Cytokine, 23-Plex Assay (Bio-Rad, NSW, Australia)
according to manufacturer’s protocol. In brief, premixed
standards were reconstituted to 50 ng/ml and serially diluted
for an 8-point standard curve. Premixed beads (50 ml) were
washed twice in a 96-well plate and 50 ml standard or sample
added to each well. The plate was incubated at RT for 30 min
with shaking. After washing beads were suspended in 125 ml of
Bio-Plex assay buffer and read on a Bioplex System (Bio-Rad,
NSW, Australia).
2.8. Statistical analyses
All results were analyzed using Prism 6 (GraphPad software).
Differences between groups were compared using Kruskal–
Wallis test with Dunn’s test for multiple comparisons. All test
groups were compared to control and all groups compared to
burn excision at day 1 to identify significant changes from
baseline and early excision. p-Value of <0.05 was considered
statistically significant.
3. Results
3.1. Late excision of burn leads to an exacerbated cytokine
response
Experimental groups received either burn or sham injury on
day 0, followed by surgical excision or sham operation on day 1
or day 8 after injury. Experimental groups consist of control
(con; sham injury day 0/sham surgery day 1), burn/sham day 1
(bs1; burn day 0/sham surgery day 1), sham/excision day 1
(sx1; sham injury day 0/excision surgery day 1), burn/excision
day 1 (bx1; burn day 0/excision surgery day 1), burn/excision
day 8 (bx8; burn day 0/excision surgery day 8) and burn/sham
day 8 (bs8; burn day 0/sham surgery day 8). Sera was isolated
from the six treatment groups at day 2 or day 6 after the
excision or sham surgery and cytokine profiles obtained
(Fig. 1). All levels were compared to control levels and to the
levels after burn and excision at day 1. At day 2 after surgery
sham/excision day 1 and burn/excision day 8 serum cytokines
IL-1a, IL-1b were significantly elevated compared to control
and burn/excision day 1 whilst IL-6 was significantly elevated
compared to control (Fig. 1a). At day 6 levels remained elevated
in the burn excision day 8 group whilst significantly elevated
levels of IL-1a and IL-1b were observed in the burn/sham day 1,
with significantly increased IL-6 also observed in the burn/
excision day 1. TNFa and IL-10 were significantly elevated at
day 2 compared to the control and burn/excision day 1. On day
6, TNFa was significantly elevated for the sham/excision day 1.
These data indicate an early pro-inflammatory response after
late excision which appears to be sustained.
Fig. 1 – Late excision of burn exacerbates cytokine and
chemokine responses. Mice received a combination of
sham operation, burn and/or excision surgery and sera
were collected at the indicated time-points for immune
assay. (a) Inflammatory cytokines IL-1a, IL-1b, IL-6,
TNFa and IL-10. (b) Chemokines KC, GCSF, Eotaxin, GM-
CSF, MCP1, MIP1a, MIP1b, and (c) T cell affected
cytokines IL-2, IL-3, IL-17a, IL-4, IL-5 and IL-13. Bar
graphs indicate control (c) – sham injury day 0/sham
surgery day 1; bs1 – burn day 0/sham surgery day 1; sx1
– sham injury day 0/excision surgery day 1; bx1 – burn
day 0/excision surgery day 1; bx8 – burn day 0/excision
surgery day 8; and, bs8 – burn day 0/sham surgery day
8, as indicated. Results are shown as mean W SEM,
n = 5–10 mice/group, for at least two independent
experiments, *p < 0.05 compared to control; #p < 0.05
compared to bx1.
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Chemokine levels were also assessed (Fig. 1b). KC (CXCL1), a
neutrophil attractant increased significantly at day 2 after
sham/excision day 1 and burn/excision day 8 compared to
control. Granulocyte colony stimulating factor (G-CSF)
increases neutrophil mobilization and proliferation. A signifi-
cant increase in G-CSF occurred at day 2 after sham/excision
day 1 and burn/excision day 8, and this persisted at day 6 in
the latter group compared to control. Eotaxin, an eosinophil,
basophil, mast cell, Th2 cell and platelet attractant was
significantly increased in the burn/excision day 8 group at day
2 compared to control and burn/excision day 1 group. At day 2
GM-CSF, a cytokine that increases DC maturation and function
as well as macrophage activity [20], had significantly elevated
levels after burn/excision day 8 compared to both control and
burn/excision day 1 groups. MCP1, a monocyte, immature DC
and memory T cell attractant was significantly increased at
day 2 in the burn/excision day 8 compared to both control and
burn/excision day 1. At day 6 there was significantly increased
MCP-1 in the burn/sham day 1 and sham/excision day 1
groups. Levels in the burn/excision day 8 were not significantly
different from control. MIP1a (CCL3) and MIP1b (CCL4) attract
monocytes, T cells and polymorphonuclear cells (PMNs).
MIP1a levels were significantly elevated at day 2 for the
burn/excision day 8 compared to control and burn/excision
day 1 groups. MIP1b levels were significantly increased at
day 2 for burn excision/day 8 group compared to control. This
indicates significant induction of KC, G-CSF, GM-CSF, MCP-1,
MIP1a and MIP1b chemokine responses specific to late
excision after the burn.
T cell affected cytokines were also assessed (Fig. 1c). IL-2
and IL-3 were significantly elevated on day 2 after burn/
excision day 8 and this was down-regulated by day 6.
Importantly, the increase in IL-2 and IL3 was also significant
when compared to the burn excision at day 1. There was
significantly elevated IL-2 at day 6 for the burn/sham day 1,
sham/excision day 1 and burn/excision day 1 groups, and this
was not observed in the burn/sham day 8. IL-17 at day 2
significantly increased for the sham/excision day 1 and burn/
excision day 8, and at day 6 for the burn/sham day 1. IFN-g
showed a significant increase at day 6 after sham/excision day
1 only, with no other significant changes between groups for
IFNg, IL-12p40 or IL-12p70 (data not shown). Strikingly, IL-4, IL-
5 and IL-13 were strongly up-regulated at day 2 in the burn/
excision day 8 compared to control and burn/excision day 1
groups with significant increases at day 6 for IL-5 and IL-13 in
burn/sham day 1 and sham/excision day 1. These data
indicate that in the late burn excision group there was an
early release of IL-2 and pro-Th2 cytokines.
3.2. Cellular inflammation is increased after late surgical
excision of burn
Cellular inflammation in the wound was also investigated
([21], gating strategy, Fig. 2A).
Wound cell numbers were significantly increased at day 2
after burn/sham day 1 and burn/excision day 8. At day 6
wound cell numbers were significantly increased in the sham/
excision day 1, burn/excision day 1, and burn/excision day 8
groups compared to control (Fig. 2b). PMNs were next
examined in the wound (Fig. 2c). There was significantly
increased early neutrophil number in the wound (day 2) for the
burn/excision day and burn/sham day 8 groups. At day 6
neutrophil cell numbers were significantly increased for the
sham/excision day 1, burn/excision day 1 and burn/excision
day 8 groups. Notably the burn/sham day 8 neutrophil cell
numbers were similar to control. Eosinophil cell numbers in
the wound were significantly increased in the burn/excision
day 8 compared to the burn/sham day 1 and burn/excision day
1 at day 2. Macrophage cell numbers were not significantly
altered between treatment groups. Monocyte cell numbers
were significantly increased at day 2 for the burn/excision day
8 compared to the burn/excision day 1; and at day 6 the burn/
sham day 8 monocyte numbers were significantly increased
compared to the control. These data indicate an early wound
cellular infiltrate of eosinophil and monocytes specific to late
excision of the burn.
LC cell numbers were significantly increased at day 2 and
day 6 for burn/sham day 8 compared to the control and burn/
excision day 8, respectively (Fig. 2d). The cDC cell numbers
were not significantly altered at either day 2 or 6 between
all treatment groups (Fig. 2d). Interestingly, the Ly6Chi DC
percentage frequency of cDC in the burn/excision day 1 was
significantly increased at day 2 and 6 compared to the control
and significantly increased at day 2 compared to the burn/
excision day 8. These data indicate reduced frequency of LC
and DC, in particular monocyte-derived DC, in the wound site
after late excision of the burn.
NKT and NK were next examined in the wound at day 6
(Fig. 2e). NKT cell numbers were significantly decreased in
burn/excision day 8 compared to the control and burn/
excision day 1 groups. Conversely, the NK cell numbers in
the wound were significantly elevated for the burn/excision
day 1 and burn/excision day 8 compared to the control. NK cell
activation, as determined by CD11b up-regulation [22] was
significantly increased in the burn/sham day 1, sham/excision
day 1 and burn/excision day 1. Notably, the burn/excision day
8 did not show NK cell activation on CD11b compared to the
control. These data indicate a loss of NK cell activation in the
wound after late excision of the burn, whereas early excision
induced NK cell activation.
3.3. Innate immune cell responses in the wound draining
lymph node
Activation of innate immune cell, NKT, NK and gdT, popula-
tions in response to burn and excision surgery were next
examined in the wound draining lymph node (inguinal lymph
node, ILN (gating strategy, Fig. 3a)). Total ILN cell numbers
(Fig. 3b) were significantly increased at day 2 in the burn/sham
day 1, sham/excision day 1 and burn/excision day 8 groups.
Notably, there were significantly increased cell numbers at
day 6 in the ILN for burn/excision day 8 compared to the burn/
excision day 1 group.
NKT, NK and gdT cell numbers were determined in the
ILN. There were significantly elevated cell numbers of NKT,
NK and gdT cells at day 2 in burn sham and sham excision
groups compared to the control (Fig. 3c). Strikingly, at day 6
NKT, NK and gdT cell numbers were significantly elevated
in the burn/excision day 8 compared to burn/excision day 1
and control.
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Within the NKT cell population, at day 2, there were
significantly decreased frequency of NKT cells harboring
granzyme B in the sham/excision day 1, with a similar trend
in the burn/excision day 1 group compared to control (Fig. 3d).
Up-regulation of CD25 on NKT cells was significantly
increased at day 2 in the sham/excision day 1 and burn/
excision day 8 compared to both control and burn/excision day
1 groups (Fig. 3d). This difference was sustained to day 6.
Similarly NKT Ki67 expression, a marker of proliferation, was
significantly decreased in the burn/excision day 1 compared to
the burn/sham day 1 and burn/excision day 8 at day 2. The
sham/excision day 1 had significantly increased Ki67 expres-
sion in NKT cells at day 6 compared to the control. Therefore in
late excision of burn there appears to be activation/prolifera-
tion of NKT cells in the ILN that is not observed after early
excision of the burn.
NK cell activation was next examined in the ILN after
injury. We observed a significant decrease in granzyme B
expression in the ILN for the sham/excision day 1 and trend for
a decrease in the burn/excision day 8 group compared to the
burn/excision day 1 group at day 2. At day 6, the burn/excision
day 8 group showed significantly less granzyme B expression
in NK cells than the burn/excision day 1 group. Conversely,
there was a significant increase in CD25 expression at day 2 for
the sham/excision day 1 and burn/excision day 8 groups
compared to control which persisted to day 6 (Fig. 3e).
Interestingly, at day 6 burn/sham day 1, sham/excision day
1 and burn/excision day 1 all had significantly increased NK
cell proliferation as determined by Ki67 expression. Interest-
ingly at day 2 burn/excision day 8 had significantly suppressed
Ki67 expression compared to the control and this was
Fig. 2 – Wound increased inflammatory cell response and
decreased innate cell response after late excision of the
burn. Mice were subject to a combination of sham
operation, burn and/or excision surgery and wound cells
harvested to single cell suspension. (a) After live cell
gating on forward and side scatter, CD19-cells were
further gated CD3S, CD11b+, and NK1.1+ cells were gated
out. Remaining cells were then gated Ly6Ghi (neutrophils),
or Ly6Glo with further gating on SSC-AhiLy6Clo
(macrophages) and Ly6ChiSSC-Alo (monocytes), and SSC-
AhiLy6Ghi (eosinophils). Dendritic cell were gated CD19S,
I-A/I-EhiCD11chi with subsequent gating on CD326+ (LCs),
CD326S (DC), and the DC were further stratified for Ly6Chi
(monocyte derived DC). Innate lymphoid cells were gated
CD19SI-A/I-ESCD11cS, and subsequently CD3+NK1.1+
(NKT cells) or CD3SNK1.1+ (NK cells), NK cells were further
gated on CD11bhi. (b) Total cell number in wound. (c)
Neutrophil, eosinophil, macrophage and monocyte cell
number. (d) LC and DC cell numbers, and Ly6Chi
percentage frequency in DC population. (e) Innate immune
cells NKT and NK cell number at day 7, and CD11bhi
percentage frequency of NK cells. Bar graphs indicate
control (c) – sham injury day 0/sham surgery day 1;
bs1 – burn day 0/sham surgery day 1; sx1 – sham injury
day 0/excision surgery day 1; bx1 – burn day 0/excision
surgery day 1; bx8 – burn day 0/excision surgery day 8;
and, bs8 – burn day 0/sham surgery day 8, as indicated.
Results are shown as mean W SEM, n = 5–10 mice/group,
for at least two independent experiments, *p < 0.05
compared to control; #p < 0.05 compared to bx1.
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suppressed at day 6 compared to the burn/excision day 1
group. Therefore ILN NK cell numbers increased for burn/
sham day 1 and sham/excision day 1, however with a
combination of burn and excision no increase was observed.
Notably there was a loss of cell proliferation for the NK cell
population after late excision of the burn.
gdT frequency of granzyme B cells were significantly
reduced at day 2 in both burn excision groups compared to
control and at day 6 in the sham/excision day 1 compared to
the control (Fig. 3f). There was increased CD25 expression at
day 2 for the sham/excision day 1 and burn excision/day 8,
compared to control (Fig. 3f). These data indicate a gdT
response in the late excision after burn not observed in the
early surgical excision of the burn.
3.4. Lymph node dendritic cell response after early and
late burn excision
Total lymph node DC populations LCs, plasmacytoid DC (pDC),
cDC with delineation of CD8a+ and CD8a to determine
resident and trafficking population, respectively, and CD11b
and CD103 to determine CD8a DC subsets were determined
(Fig. 4a).
At day 2 after burn/sham day 1 there was a significant
increase in the cell number of LC, pDC and cDC compared to
the control (Fig. 4b). On day 6 there was a significant change
in the LC, pDC and cDC populations which were reduced
in the burn/excision day 1, compared to the burn/excision
day 8 group. Further examination of cDC, resident and
trafficking, revealed a significant increase in CD8a+ DC cell
frequency for burn/excision day 1 compared to burn/
excision day 8 and control groups; and the converse was
true for the CD8a trafficking DC population (Fig. 1c).
Examination of CD8a trafficking DC subsets revealed
significant cell frequency changes in the burn/sham day 1,
sham/excision day 1 and burn/excision day 1 for CD11blo DC
that was not apparent in the burn/excision day 8 (Fig. 4d).
These data indicate increased DC in the lymph node after
late burn excision, in particular CD8a cDC, however no
changes in trafficking cDC profiles indicative of activation
were observed.
Fig. 3 – Different innate immune cell response in the ILN
after early and late excision of burn. Mice were subject to a
combination of sham operation, burn and/or excision
surgery and ILN cells harvested to single cell suspension
at times indicated. (a) Gating strategy, live cells were gated
on forward and side scatter, and NKT cells gated on
CD3+NK1.1+, NK cells gated on CD3SNK1.1+, and gdT cells
gated CD3+ then gd TCR+. (b) ILN total cell numbers. (c)
NKT, NK and gdT cell numbers in ILN. (d) NKT percentage
frequency of cells with expression of granzyme B, CD25
and Ki67hi. (e) NK percentage frequency of cells with
expression of granzyme B, CD25 and Ki67hi. (f) gdT
percentage frequency of cells with expressing granzyme B,
CD25 and Ki67hi. Results are shown as mean W SEM, n = 5–
10 mice/group, for at least two independent experiments,
*p < 0.05 compared to control; #p < 0.05 compared to bx1.
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3.5. T cell response after early and late burn excision
Lymph node CD4 and CD8T cells at day 2 were increased
significantly following burn/sham day 1 and sham/excision
day 1 (Fig. 4e, g). Significantly reduced CD4 and CD8T cell
numbers were observed by day 6 for burn/excision day 1
compared to burn excision/day 8. Further analysis of CD4T
cells indicated increased frequency of CD25 expression at day
2, with increased proliferation at day 6 for the sham/excision
day 1 and burn/excision day 8 compared to control. At day 6 in
the burn/excision day 8 and burn/sham day 8 the frequency of
Treg cells significantly increased compared to control (Fig. 4f).
Within the CD8T cell compartment (Fig. 4h) there was a
reduction in Granzyme B percentage frequency of cells at day 2
in the sham/excision day 1 and burn/excision day 8 compared
to control and burn/excision day 8 groups. CD25 expression, at
day 2, increased in the burn/sham day 1 and burn/excision day
1 compared to control. Proliferation, as determined by Ki67hi
expression, was significantly reduced at day 2 in the burn/
excision day 1 compared to the control. Additionally, there
was significantly reduced Ki67hi expression in the day 6 burn/
excision day 8 compared to the burn/excision day 1 group.
Only the burn/excision day 8 showed increased CD44 expres-
sion at day 6 compared to control and burn/excision day 1
group, although CD44 expression was significantly less at day
2 in burn/excision day 8 compared to the burn/excision day 1
group.
These data indicate differential CD4 and CD8T cell responses
to early and late excision after burn. A CD4T cell response
was observed after late excision, with development of Treg
cells that was not observed after early excision. CD8T cells
were less activated after late excision and developed CD44
expression indicative of a T effector or memory cell response.
4. Discussion
Here we demonstrate a differential immune response be-
tween early and late excision of a burn. The data suggests early
Fig. 4 – Altered immune response to early and late excision
of burn. Mice were subject to a combination of sham
operation, burn and/or excision surgery and ILN cells
harvested to single cell suspension at times indicated. (a)
DC gating strategy, after forward and side scatter gating,
DCS were gated I-A/I-Ehi CD11chi. DC subpopulations were
determined as CD19-CD326+ for LCs, CD19SCD326S then
B220+ for pDC, and CD19SCD326S and B220S for cDC. The
cDC were further gated CD8a+ and CD8aS, the latter DC
subpopulation were then gated CD103+, CD11bhi and
CD11blo. (b) ILN cell number for CD326+ (LCs), pDC and
cDC. (c) cDC percentage frequency of resident CD8a+ and
trafficking CD8aS DC. (d) CD8aS DC percentage frequency
of CD11bhi, CD11blo and CD103+ subsets. (e) ILN total cell
number of CD4+ T cells. (f) CD4T cell percentage frequency
CD25+, Ki67hi, CD44+ and Treg. (g) ILN cell number of CD8+
T cells. (h) CD8T cell percentage frequency of granzyme B+,
CD25+, Ki67hi and CD44+ cells. Results are shown as
mean W SEM, n = 5–10 mice/group, for at least two
independent experiments, *p < 0.05 compared to control;
#p < 0.05 compared to bx1.
b u r n s x x x ( 2 0 1 6 ) x x x – x x x 7
JBUR-4839; No. of Pages 10
Please cite this article in press as: Fear VS, et al. Timing of excision after a non-severe burn has a significant impact on the subsequent immune
response in a murine model. Burns (2016), http://dx.doi.org/10.1016/j.burns.2016.01.013
excision is less disruptive and damaging to the subsequent
immune responses and is therefore likely to be beneficial to
patient outcomes.
We [18], and others [23–26], have previously shown that
burn and excision injury induces an inflammatory response
including IL-1a, IL-1b, TNFa, and IL-6. The stimulation of the
inflammatory response is a suggested cause of decreased
vascular tone and cardiac insufficiency after thermal injury.
IL-1 increases adhesion molecule expression on endothelial
cells to allow transmigration of immune cells and induces
hyperalgesia, vasodilation and hypertension [27]. Further IL-
1a stimulates monocyte production of IL-1b, amplifying
inflammation and recruiting macrophages [28]. TNFa, which
promotes fever and tachycardia, was similarly exacerbated
after late excision of burn.
IL-1b and TNFa stimulate IL-6 production leading to hepatic
release of C-reactive proteins and other acute phase proteins
[12]. IL-6 influences inflammation via stimulation of bone
marrow release of PMN cells [29], and is associated with
increased severity of tissue trauma [16], and multiple organ
failure [29]. Further IL-6 induces macrophage prostaglandin E2
(PGE2) release, known to decrease DC function [30] and inhibit
T cell mitogenesis and IL-2 production [31,32].
Interestingly IL-1, IL-6 and TNFa are all potent inducers of
GM-CSF [20], and overexpression of GM-CSF leads to macro-
phage accumulation and severe damage to tissue [33]. Surpris-
ingly, GM-CSF treatment increases the frequency of Treg cells
in autoimmune disease [34]. We show significantly increased
GM-CSF specific to late excision of burn where a Treg response
developed. This may exacerbate increased infection rates in
patients in intensive care with delayed burn surgery [35].
Late burn excision induced a prominent chemokine
response with early release of the chemoattractants KC
(CXCL1), Eotaxin (CCL11), MCP-1 (CCL2), MIP-1a (CCL3), MIP-
1b (CCL4) and GM-CSF. This increased chemokine response
correlated with an acute inflammatory cell response of
neutrophils, eosinophils and monocytes in the wound and
was specific to late excision. Notably there was also a loss of
innate cells in the wound including LCs and inflammatory
DCs. The changes observed in cytokine profiles broadly
suggest early excision can ameliorate the inflammatory storm
after injury and these effects are not observed with late
excision. This is supported by a previous study that showed
successive delays in burn excision decreased any positive
effects on measured cytokine levels [36].
NKT cell number and NK cell maturation/activation were
down-regulated in the wound after late excision. In the ILN
after late excision there was also a decrease in NK cell
proliferation that may reflect the observed loss of DC
activation signal at this site. Interestingly high expression of
IL-4 has been linked with repression of some key effector
functions of NK cells favoring tolerogenic or Th2 responses
[37]. Other research has similarly observed innate immune cell
paralysis [38] with normal NK cell number and reduced NK cell
function in both thermal and trauma injury [39]. NKT and NK
cell are early producers of IFNg during inflammation [38], and
dysfunction of these cellular responses at the wound site may
lead to the observed lack of an IFNg response.
Adaptive cell cytokine responses specific to late burn
excision included IL-2, IL-3, IL-17, IL-4, IL-5 and IL-13, and
these were not elevated after early excision. The adaptive
immune response after late burn excision included the
development of CD4 Treg cells and increased CD8T effector
or memory cells in the skin draining lymph node. This was not
observed after early excision. Our study identifies dysfunction
of adaptive immunity after burn treatment with late excision.
Potentially this will manifest later as a tolerance to self-
antigen or inactivity toward microbial pathogens. Similarly
after UVR exposure, the adaptive immune response is
suppressed with enhanced suppression by Treg cells [40], in
combination with DC dysfunction [41] that is suggested to lead
to reduced immune responses [42]. Accordingly, bacterial
infection rates are higher after late excision compared to early
excision of burn wounds [43].
In other research a reversal of innate NK cell dysfunction
occurs with pre-operative administration of IFNa [44]. Notably,
late burn excision IL-6 potentiation of PGE2 levels would lead to
suppression of type I IFN production. Decreased type I IFN, an
important signaling cytokine in protection against microbial
pathogens, would render patients more susceptible to infec-
tion. Therefore, PGE2 inhibitor [32] or type I IFN administration
may limit immune dysfunction and increased infection.
Whilst many of these observed changes are indicative of
increased susceptibility to infection, in this study functional
studies were not completed. It will be critical to supplement
these observational studies with further functional work.
Indeed, others have assessed functional changes and observed
changes in T cell proliferation and cytotoxic T cell function
after burn, in part changed by excision and/or grafting [45,46].
Similar assays, as well as investigation into responses to
infection and or cancer in these models will provide important
insight into the physiological consequences of the burn on
immune system function, in the acute phase and in the long-
term. In addition, the use of grafting to more closely mimic
clinical practice could also provide more insight into the
relevance of different changes after burn [45,46].
This study directly compared the immune responses after
early and late wound excision following burn. The data
highlights the extreme inflammation and subsequent im-
mune dysfunction specific to late excision (day 8) that will
directly impact on organ dysfunction and susceptibility to
infection. In addition, recent work demonstrating the impor-
tance of timing and type of inflammatory response to scar
formation and patient outcome suggests excision timing
is likely to also impact on scar [47]. Early surgical intervention
is supported to reduce the systemic impact of burn. Alterna-
tively, treatment with immune-modulatory agents may be
beneficial in cases where early excision is not feasible after
burns.
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